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Abstract 
In this study, the effect of UV radiation on cell signalling pathways and cytokine release 
in skin cells was observed. A comparison of the UV responses was made between 
normal and malignant keratinocyte and melanocytes. The keratinocyte-derived cells 
used were HEK (normal), Colo16 (SCC) and HaCaT (immortalised) cells, while the 
melanocyte-derived cells were HEM (normal) and MM96L (melanoma) cells. In this 
study the cells were exposed to UVA, UVB and a combination thereof. The UV doses 
used were of physiological relevance and the high doses corresponded to that observed 
in 1 MED while the low doses corresponded to 0.1 MED. Trypan blue exclusion was 
used to measure cell viability and western blots were performed to observe the 
activation of p38 MAPK, JNK and NFκB pathways post-irradiation. ELISA was utilised 
to quantify TNFα levels and pathway specific inhibitors were used to delineate 
pathways involved in this process. The antioxidant assays (DPPH and Fenton reaction) 
were performed to test for antioxidant properties if any in mussel crude lipid extract 
(MCLE) and scymnol and their efficacy in inhibiting TNFα release in  
melanocyte-derived cells were also observed.  
  
In keratinocyte-derived cells, the UV response of HEK cells completely differed to that 
of HaCaT and Colo16 cells. Moreover, the results obtained showed that HaCaT cells 
exhibited similar responses in activation of cell signalling pathways and cytokine 
release to that of Colo16 cells. HEK cells were least susceptible to UV radiation 
followed by HaCaT and Colo16 cells. High doses of UVB, UVA+B and UVB+A 
radiation induced greater cell death (< 50%) than the corresponding low doses and UVA 
radiation. In HEK cells, the activation of the JNK and NFκB pathways were immediate 
and transient whereas in HaCaT and Colo16 cells it was prolonged. Although the 
pattern of activation (immediate and transient) of the p38 MAPK pathway was almost 
  
 
- 2 - 
similar in all three cell types, the level of phospho-p38 was higher in HaCaT and 
Colo16 cells. HEK cells released higher TNFα levels than HaCaT and Colo16 cells 
following exposure to high dose UV-irradiation. These levels were highest following 
UVB+A radiation in HEK cells (1549 pg/mg) while those in HaCaT (7 pg/mg) and 
Colo16 (91 pg/mg) cells were induced by UVA+B radiation. UVA radiation had no 
effect in inducing TNFα release in either HaCaT or Colo16 cells. The addition of IL1α 
(10 ng/ml) enhanced the release of TNFα 16.2-fold in UVB-irradiated HaCaT cells,  
4.9-fold in Colo16 cells 2.2-fold in HEK cells. Of interest was that IL1α had a minimal 
effect on increasing the activation of cell signalling pathways.  
 
In melanocyte-derived cells, the activation of cell signalling pathways and cytokine 
release differed between HEM and MM96L cells. HEM cells were less susceptible to 
UV radiation than were MM96L cells. Low UV dose was less detrimental to these cells 
than was high dose. UVA radiation induced less cell death (< 20%) compared to the 
other UV types. The HEM cells exhibited a uniformed activation of each pathway (p38 
MAPK, JNK and NFκB) irrespective of the UV types used while those of MM96L cells 
were erratic and UV-type dependent. High dose UV radiation alone induced low levels 
(< 13 pg/mg) of TNFα but when IL1α was added these levels increased dramatically. In 
HEM cells, IL1α induced a 130-fold increase in TNFα levels after UVB+A-irradiation 
while there was a 97-fold increase in UVB-irradiated MM96L cells. Although IL1α 
augmented TNFα release in these melanocyte-derived cells, they did not have a 
pronounced effect on activating the cell signalling pathways. In UVB-irradiated HEM 
cells only the p38 inhibitor SB202190 significantly inhibited TNFα release from 1343 
pg/mg to 9 pg/mg. The JNK and NFκB inhibitors on the other hand had no effect. When 
treated with either SB202190 or the NFκB inhibitor, sulfasalazine, TNFα levels fell 
from 539 pg/mg to ~258 pg/mg in UVB-irradiated MM96L cells. Although anisomycin 
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was a potent activator of both the p38 MAPK and JNK pathways, it suppressed TNFα 
release in irradiated HEM and MM96L cells. This suggests that UV-mediated TNFα 
release may occur via different p38 MAPK pathway intermediates compared to that of 
anisomycin. In the HEM and MM96L cells, α-tocopherol scavenged DPPH and 
hydroxyl radicals while scymnol only stabilised hydroxyl radicals and MCLE had no 
effect. All three compounds inhibited TNFα release in HEM cells but had no effect in 
MM96L cells following UV radiation.  
 
In conclusion, HaCaT cells do not appear to be a suitable substitute to study cell 
signalling pathways and cytokine release in normal keratinocytes as their UV-induced 
responses mirrored those of Colo16 cells. Therefore, these cells (HaCaT) may be better 
suited as a model to study solar keratoses or precancerous lesions. The key finding in 
this study was that normal and malignant cells exhibited different responses to UV 
radiation in activating cell signalling pathways which are involved in TNFα release. 
Since these pathways (p38 MAPK, JNK and NFκB) were regulated differently in 
cancerous cells, further intervention into these pathways may provide an insight on how 
the malignant status of these cells is maintained. As inflammation is involved in skin 
carcinogenesis, the finding that p38 MAPK is involved in UV-induced TNFα release 
may help to treat skin cancer as specific tumour-targeted inhibitors can be designed to 
reduce inflammation. In contrast, the malignant cells (Colo16 and MM96L) in this study 
produced low levels of TNFα which may be necessary to suppress immunosurveillance. 
In closing, the pathways and cytokines studied in this project may have therapeutic 
potential but their functional roles in malignancy still needs to be further investigated.  
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1.1 Introduction 
Globally, an estimated 2.5 million non-melanoma skin cancers and 132,000 malignant 
melanomas are diagnosed each year [1]. It is estimated that, one in five North 
Americans and one in two Australians will suffer from a skin cancer in their lifetime 
[1]. Ultraviolet (UV) radiation is recognized as the main etiological agent causing skin 
cancer [2]. This environmental carcinogen acts as both a tumour initiator and promoter 
[3]. In order to eradicate the harmful effects of UV radiation on skin cells, it is crucial to 
understand the underlying mechanisms that are involved in this process.  
 
1.2 Ultraviolet radiation 
The sun emits different types of light, which can be categorised according to their 
wavelength in the electromagnetic spectrum (Figure 1.1) [4]. Of interest is that of UV 
light, due to (a) its effects on biological systems and (b) the depleting ozone layer. 
Three forms of ultraviolet light exist; UVA (320-400 nm), UVB (280-320 nm) and 
UVC (100-280 nm). The energy level of UV light is inversely related to its wavelength 
 
 
 
with UVC possessing higher energy than UVB, while UVA has the lowest energy level 
[5]. The stratospheric ozone layer blocks wavelengths below 290 nm, which includes all 
of UVC and a large portion of UVB light. As UVC does not reach the Earth’s surface, 
Figure 1.1 The electromagnetic spectrum of sunlight [4]. There are three types of UV 
light. 
X-Rays                            Ultraviolet Light                       Visible Light             Infrared 
VUV 
UVC UVB UVA 
    100                       280         320        400      
Wavelength (nm) 
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its effects will not be discussed in great detail. However, it should be noted that there 
are numerous reviews in the literature on the effects of UVC radiation on cellular 
signalling pathways [6-10]. Of the UV light which reaches the surface of the Earth, 
approximately 5% is UVB while the remaining 95% is UVA [11].  
 
The level of UV which reaches the surface of the Earth varies due to several factors 
(ozone layer, clouds, reflectance of the ground, altitude above sea level, etc) [12]. The 
Global Solar UV Index (UVI) provides information on level of UV on the Earth’s 
surface and a higher index value would indicate a greater risk to exposure (Figure 1.2) 
[12]. According to the scientific assessment of ozone depletion by the World 
Meteorological Organization, total column ozone of the Northern and Southern 
 
Figure 1.2 A typical global distribution of the erythemal UV radiation [13]. 
-120 -60 0 60 120 
-120 -60 0 60 120 
-
60
 
60
 
0 
-60
 
60
 
0
 
0 2 4 6 8 10 12 14 16 18 
UV INDEX 
 - 9 - 
Hemisphere mid-latitudes for the period of 2002-2005 was lower than the period of 
1964-1980 [13]. As a result of ozone layer depletion, the amount of harmful UV 
radiation that is reaching the Earth’s surface has increased during this period. On a more 
positive note, the implementation of the Montreal Protocol has resulted in the slowing 
down of ozone depletion and a recovery of its atmospheric levels. It has been predicted 
that the ozone hole over Antarctica should be filled by 2065 [13, 14]. 
 
Apart from the sun, tanning beds, arc welding lamps, germicidal lamps and lasers also 
emit UV radiation [12]. Of particular interest are tanning beds, which emit mainly UVA 
and probably some UVB light. Tanning salons are popular with mostly fair-skinned 
caucasians who sunburn easily and may run a risk of developing skin cancer [2, 15, 16]. 
Case control and cohort studies showed that subjects who had tanning bed exposure 
were vulnerable to occurrence of cutaneous melanoma and this may be preceded by 
normal sun exposure history as well [17].  
 
1.3 Skin  
The skin is the target of exposure to UV radiation. It is composed of an epidermal, 
dermal and hypodermal layer [18]. The epidermis consists of five layers; stratum basale, 
stratum spinosum, stratum granulosum, stratum lucidum and stratum corneum. The 
stratum basale is the inner most layer of the epidermis. It contains rapidly proliferating 
and differentiating keratinocytes, Merkel cells and melanocytes. The stratum spinosum 
lies above the stratum basale and contains Langerhans cells, which are part of the 
immune system. As the keratinocytes migrate through the layers, it becomes cornified, 
forming the top most layer of the epidermis, the stratum corneum. It is several layers 
thick and contains keratinized cells. The dermis is made of collagenous and elastic 
connective tissues, which constitutes a variety of cell types (adipocytes, fibroblasts, 
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lymphocytes, macrophages, mast cells and mesenchymal cells), a network of blood 
vessels, lymph vessels and nerve fibres [18, 19]. The hypodermis that lies beneath the 
dermal layer is largely made up of loose connective tissues and adipocytes [18]. The 
UVB component of sunlight only penetrates into the epidermis while the longer 
wavelength UVA component penetrates deeper into the underlying dermis (Figure 1.3). 
This brings about a myriad of reactions, which can be both advantageous and 
disadvantageous to the human body. 
 
 
1.4 Advantages of ultraviolet radiation 
UV light has gained much of our attention for the deleterious effects it can cause. 
However, it can also have beneficial effects. UV light is well known for its role in 
phototherapy and vitamin D3 production. 
 
1.4.1 Ultraviolet phototherapy 
Skin diseases have been treated with UV radiation alone or in conjunction with other 
compounds like psoralen since the early 1970’s [20]. Psoralen plus UVA (PUVA) and 
UVB radiations are used to treat several skin abnormalities like atopic dermatitis, 
Epidermis 
Dermis 
Sun 
UVB UVA 
Figure 1.3 Penetration of UV radiation into the skin layers. 
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cutaneous T-cell lymphoma, psoriasis and vitiligo [21-24]. PUVA and UVB treatment 
for psoriasis causes diminished epidermal and lymphocyte activation [22]. One 
advantage of using UVB radiation over PUVA is the convenience of treatment without 
any oral or topical medication [23]. Although broad (290-320 nm) band UVB radiation 
can be used to treat skin disorders, narrow (311-312 nm) band UVB is preferred due to 
its greater therapeutic effects and fewer number of treatments required [21, 23, 24].   
 
UV phototherapies can induce acute and chronic adverse effects in recipients [21]. 
PUVA and UVB treatment causes acute effects like erythema, which are reversible after 
discontinuation of therapy [21, 25]. A long-term effect of PUVA treatment is the risk of 
developing non-melanoma skin cancer [26]. However, another study showed that 
PUVA-treated patients did not incur any PUVA-specific mutations but had mostly UVB 
fingerprint mutations. This may imply that patients develop skin cancer due to a history 
of UVB exposure (therapeutic or natural) and that repeated PUVA therapy may 
aggravate skin carcinogenesis via immunosuppression [21, 27]. The risks posed by UV 
phototherapy are still controversial as studies use different regimens, UV doses and 
parameters to assess the adverse effects.  
 
1.4.2 Ultraviolet-induced vitamin D3 production 
UVB penetrates into the epidermis and causes the photoconversion of  
7-dehydrocholesterol to previtamin D3 which then undergoes heat-induced 
isomerization to vitamin D3 [28]. Vitamin D3 enters the circulation and is metabolized 
into 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 [29-31].  
1,25-dihydroxyvitamin D3 has been shown to confer photoprotection by reducing the 
formation of thymine dimers and dose-dependently decreasing the presence of sunburn 
cells in UV-irradiated mice [32].  
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1.5 Disadvantages of ultraviolet radiation 
The detrimental effects of UV radiation seem to outweigh its benefits. In Australia, a  
15-20 min exposure to sunlight is sufficient for daily vitamin D production [33]. 
However, due to occupational, recreational and tanning activities, people receive high 
cumulative UV exposures. This may bring about a range of responses at a molecular 
level, which may progress onto a cellular level and eventually cause changes to the 
skin’s structural integrity (Figure 1.4). The skin’s response may vary from acute to 
chronic effects, which depends on the UV type, dose and episodes of exposure. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
1.5.1 Skin photoresponse - Structure and histology 
UV radiation generates a range of biological responses in the skin, which includes 
adaptive, inflammatory and immunological reactions. Photoadaptation of the skin 
consists of stratum corneum thickening, pigmentation and epidermal hyperplasia  
Figure 1.4 A three-tiered model of the initiation of UV response. 
 
Molecular Level 
Cellular Level 
Structural  
Level 
UV Radiation 
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[5, 34]. The onset of stratum corneum thickening leads to the recovery of the 
permeability barrier of the murine epidermis from cellular damage evoked by  
UVB-irradiation [35]. UV-induced skin pigmentation occurs in two phases. It 
commences with immediate pigment darkening followed by delayed formation of new 
melanin [21]. The presence of melanin in the upper epidermis seems to confer 
protection against DNA damage caused by UV radiation [36]. Research carried out 
using Asian and Caucasian skin showed that following UV exposure, hyperplasia of the 
epidermis was the main route of adaptation of the skin which contains lesser amounts of 
melanin compared to African skin types [34]. As the cumulative exposure to UV 
increases, these photoadaptations may not be sufficient to protect the skin from  
solar-induced damage.  
 
The epidermis is in the front line of damage caused by UV exposure. Sunburn cells 
develop following long exposure to UV radiation [5, 37]. These are damaged 
keratinocytes that die by apoptosis in the epidermal layer [37]. It was also reported that 
UV radiation causes the formation of dyskeratotic cells (sunburn cells) in human skin 
biopsies due to a decrease in keratinosomes [38]. Langerhans cell depletion occurred 
following cumulative UVA [0.5 MED (Minimal Erythemal Dose)] and SSR (Solar 
Simulated Radiation) (0.5 MED) exposure [39]. A cumulative exposure of 0.6 to 0.8 
kJ/m2 of UVB radiation caused complete loss of membrane markers like ATPase and Ia 
antigens in Langerhans cells, which may lead to the impairment of their antigen 
presenting function [40]. In the human dermis, an increased presence of inflammatory 
cells were observed following repeated exposure to UVA (0.5 MED) [39]. Among the 
inflammatory cells present, lymphocytes and mast cells were in abundance. A 
proportional relationship between increased UVB exposure and mast cell number were 
observed in the skin [41]. 
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An early inflammatory event soon after UV exposure is the occurrence of erythema and 
redness due to vasodilation of cutaneous blood vessels [5]. This is often followed by the 
development of sunburn cells and oedema [5, 21]. Chronic exposure to UV results in 
skin photoageing, which is characterized by irregular pigmentation, dryness of the skin, 
wrinkling and elastosis [21]. Different types of skin respond differently to UV radiation. 
There are six different kinds of skin type which are classified according to their ability 
to sunburn and/or tan (Table 1.1). People who belong to Type I tend to sunburn easily 
and never tan compared to people who have Type VI skin [42, 43]. Type I people are 
more susceptible to UV-induced damage, like photoageing and in more severe cases 
skin cancer [42, 43]. Moreover, UV-induced skin damages like actinic keratosis and 
melanocytic lesions may progress into invasive and malignant forms of skin cancer [44, 
45]. 
 
 
Skin 
Type Description Major Ethnic Group 
I Severely sunburns and rarely tans Celts 
II Usually sunburns and sometimes tans Northern European 
III Moderately sunburns and usually tans Mid to Northern European 
IV Sometimes sunburns and often tans Northern Asian, Indian and Mediterranean 
V Rarely burns and tans easily 
Southern Asian, Hispanics,  
Native American,  Middle 
Eastern and African-American 
VI Hardly burns and tans very easily African 
 
Table 1.1 Types of skin and their susceptibility to sunburn and tanning [42, 43]. 
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1.5.2 Skin cancer  
UV radiation is the primary carcinogen known to cause skin cancer [21, 46]. There are 
three main types of skin cancer; squamous cell carcinoma (SCC), basal cell carcinoma 
(BCC) which are collectively called non-melanoma skin cancers (NMSC) and 
cutaneous malignant melanoma (CMM) [46]. Although SCC and BCC are more 
common compared to CMM, they are less aggressive and in general rarely metastasize 
[46]. Armstrong et al. [47] have reported that ambient UV radiation causes an increase 
in incidence of SCC, BCC and to a lesser extent CMM.  
 
Skin cancer arises through mutations caused by UV radiation. p53 mutations are 
prevalent in SCC and BCC [47]. The loss of a single functional copy of p53 gene leads 
to an increased occurrence of UV photocarcinogenesis in keratinocytes [5]. On the other 
hand, the mutations in the INK4a gene is more common in CMM [47]. It has been put 
forward that UVA may be indirectly involved in melanoma occurrence via 
immunosuppression or stimulation of growth factors in the skin [48, 49]. Other studies 
have suggested that UVB, but not UVA, initiates melanoma [50, 51]. Therefore, it is 
still not clear as to which type of UV light predominates in causing each of these 
carcinomas. However, it is possible that both UVA and UVB could be involved in 
synergistically initiating and promoting skin carcinogenesis through their signature 
effects at the molecular level [52, 53]. 
 
1.5.3 Skin molecular response - Activators of cell signalling pathways 
The formation of skin cancer and other structural and histological alterations are 
orchestrated at a molecular level. It is the reaction of the multifactorial substances in the 
skin cells that determine the course of direction (eg. cell survival, apoptosis, migration, 
proliferation) taken by the cells following UV radiation. UV-irradiation itself can cause 
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multimerization and clustering of cell-surface receptors, which can activate the JNK 
(Jun N-terminal Kinase) signalling pathway [54]. A wide array of molecules have been 
identified to be activated, altered or produced by UV radiation. Some of these molecules 
include: receptors, DNA/RNA, ROS (Reactive Oxygen Species), cytokines, adhesion 
molecules, MMP (Matrix Metalloproteinases), cis-urocanic acid and several other 
transcriptional targets of UV radiation (Figure 1.5) [5, 55, 56]. Often these molecules 
are produced by a network of signalling pathways and in turn may trigger these 
pathways in an autocrine or paracrine fashion as well. UV is a stimulus that activates 
multiple signalling cascades, but how these pathways are activated is not yet fully 
understood. Research done in this area has suggested a number of ways by which UV 
mediates its cellular responses. This review will focus on some multifunctional 
molecules that are involved in triggering UV-induced signal transduction pathways. 
 
Figure 1.5 A Venn diagram showing some activators of cell signalling 
pathways and the overlaps between these elements. 
Cytokines 
Matrix 
Metalloproteinases 
Receptors & 
Cell Membrane 
Proteins 
ROS 
DNA/RNA  
Damage 
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1.5.3.1 Receptors 
Recently aryl hydrocarbon receptors (AhR) have been implicated in UVB-induced 
signalling [57]. Fritsche et al. [57] identified tryptophan as a chromophore of UVB 
radiation. Its photoproduct 6-formylindolo[3,2-b]carbazole is an AhR ligand. This 
photoproduct activates the cytoplasmic AhR complex and induces its translocation into 
the nucleus. 6-formylindolo[3,2-b]carbazole was also reported to be involved in the 
EGFR (Epidermal Growth Factor Receptor)/ERK1/2 (Extracellular Signal-Regulated 
Kinase 1/2) pathway as well [57, 58]. In support of this finding, AhR-knockout mice 
exhibited inhibition of EGFR internalisation and ERK1/2 activation [57]. Several 
studies have suggested the involvement of different tyrosine kinases [EGFR, FGFR 
(Fibroblasts Growth Factor Receptor), HGFR (Hepatocyte Growth Factor Receptor)] 
and cytokine receptors [IL-1R (Interleukin-1 Receptor) and TNFR1/R2  
(TNF-Receptor)] in UV-induced signalling [6, 55, 59, 60]. However, to date, not one 
main receptor has been identified as being the major putative receptor involved in  
UV-induced responses.  
 
1.5.3.2 DNA and RNA damage 
DNA bases are made up of ring structures and conjugated bonds. These bonds and ring 
structures can absorb UV wavelengths of around 200 nm and over 300 nm, respectively 
[46]. It has been suggested that DNA damage is involved in activating signalling 
pathways following UV-irradiation [6]. This is because DNA acts as a chromophore by 
absorbing UV radiation between 245-290 nm, which results in the formation of 
pyrimidine dimers and pyrimidine-pyrimidone photoproducts [2, 5, 21, 61]. It has been 
suggested that DNA damage can delay transcription, which can then initiate signalling 
cascades. RNA damaged by UV-irradiation can mediate the ribotoxic stress response 
signalling in the ribosome [62]. Iordanov et al. [62] showed that oxidative damage at 
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the 3’ end of 28S ribosomal RNA could inhibit protein synthesis and activate JNK and 
p38 MAPK (Mitogen-Activated Protein Kinase) pathways. On the other hand, cell 
enucleation experiments have shown that the nuclear signal is not necessary for NFκB 
activation [63]. 
 
1.5.3.3 Reactive oxygen species 
ROS are also implicated in activating signal transduction pathways. They are formed 
from the reaction between light and photosensitizers in the presence of molecular 
oxygen [61]. ROS can phosphorylate cell surface receptors which in turn activate the 
MAPK signalling pathway [64, 65]. The addition of an antioxidant, diphenylene 
iodonium chloride, reduced ROS production which in turn decreased the 
phosphorylation of p38 MAPK in both normal human keratinocytes and HaCaT cells 
following exposure to UVB (0.6 kJ/m2) [65]. In another study, plasma membrane 
instability and apoptosis in melanocytes was reduced through the application of the 
antioxidant α-tocopherol [66]. This suggests that ROS may play a role in activating cell 
death pathways following UV exposure. ROS production is predominantly linked to 
UVA radiation [66, 67]. There is evidence to suggest that UVB radiation also induces 
ROS production, though it may not necessarily be the main mediator of UVB signalling 
[65, 66]. It is possible that ROS may (a) function as an enhancement to increase the 
signal for activation of pathways besides the main UVB-induced DNA damage 
signalling or (b) act as an alternative mechanism, when DNA damage has been repaired 
and as a result signalling does not progress via this route.  
  
1.5.3.4 Cytokines 
Changes in the cytokine profile have been observed in various cell types within the skin 
following UV exposure [5, 56].  Regulation of these cytokines via signalling pathways 
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is important in mediating UV responses. Cells in the epidermal and dermal layer 
produce a range of cytokines including IL-1, IL-4, IL-6, IL-8, IL-10, IL-12, IL-15 and 
TNFα [5, 56]. Of these cytokines, TNFα is considered to play an important role in  
UV-induced inflammatory and immunological responses [5, 56]. 
 
TNFα belongs to the TNF ligand superfamily [68-70]. It is a 26 kDa type II 
transmembrane protein, which can be cleaved to its 17 kDa soluble form (sTNFα) by 
the action of the metalloproteinase, TACE (TNFα Converting Enzyme) [71-73]. TNFα 
in turn can bind to one of the two receptors, TNFR1 and TNFR2 [68]. Soluble forms of 
TNF receptors can neutralise the biological effect of TNFα by interacting with sTNFα 
[68]. UV-induced TNFα is involved in the formation of sunburn cells, suppression of 
contact hypersensitivity, Langerhans cell migration from the skin, diminished antigen 
presentation and loss of immunosurveillance [5, 56, 74, 75].  
 
Köck et al. [76] found that there was a significant amount of TNFα produced in human 
keratinocytes following low dose UVB (0.1 kJ/m2) exposure. The cell mixing 
experiment with selected ratios of Langerhans cells to keratinocytes showed that 
epidermal murine keratinocytes predominantly generated TNFα, which suggests that 
keratinocytes may be the primary source of TNFα in the epidermis [76, 77]. In the 
dermis, mast cells, macrophages, Langerhans cells and fibroblasts release varying 
quantities of TNFα depending on the UV type and dose [78-80]. The injection of TNFα 
antibodies in Balb/c mice after UVB-irradiation showed a reduction but not a complete 
absence of sunburn cells [81]. Moreover, increasing the dose of TNFα antibodies did 
not cause any further reduction in the formation of sunburn cells [81]. Therefore, it was 
concluded that TNFα is involved in sunburn cell formation, which is a multifactorial 
event that probably involves a combination of other cytokines.  
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While there is little/no evidence that melanocytes are capable of TNFα production, this 
cytokine seems to be implicated in ICAM-1 expression on human melanocytes and 
melanoma cells [82]. If TNFα is added to these cells there is an increase in ICAM-1 
expression. This adhesion molecule is involved in cell-to-cell interaction, tumour 
invasion and metastasis [82]. UV radiation can by itself induce ICAM-1 expression on 
melanoma cells [82]. Therefore, epidermal keratinocyte-derived TNFα could contribute 
to the metastasis of malignant melanomas following UV exposure. 
 
Although, TNFα is known to be cytotoxic to some tumour cell lines, it may mediate 
UV-induced tumorigenesis in others [5, 83].  In TNFR1- and TNFR2-knockout mice, 
there was a reduced incidence of skin tumours in response to UVB-irradiation [83]. 
Amerio et al. [84] found the contact hypersensitivity response was impaired to a greater 
degree in the wild-type mice than the TNFR1/R2 gene-targeted mutant mice following 
UVB-irradiation (0.96 kJ/m2) which suggests that TNFα may not play a role in  
UVB-induced immunosuppression [85]. Skov et al. [86] found that UVA1 (3 MED) 
radiation caused a decrease in TNFα levels but an increase in cis-urocanic acid levels in 
suction blisters of human skin. However, in UVB-irradiated skin, high levels of TNFα 
was detected, suggesting that UVA mediated immunosuppression may occur via  
cis-urocanic acid unlike that seen following UVB exposure [86].  Amerio et al. [84] 
also found that TNFα was not primarily involved in cis-urocanic acid mediated  
UVB-immunosuppression, which questions the role it plays in this process. It is 
probably likely that TNFα is involved in skin carcinogenesis via its inflammatory role 
rather than immunosuppression [87]. 
 
 
 
 - 21 - 
Figure 1.6 Activation of the p38 MAPK signalling pathway. 
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1.6 Cell signalling pathways 
Cells respond to signals produced from UV exposure by activating signalling cascades. 
Disturbance to the signalling pathways due to the effects of UV could lead to 
malfunction of the cell, disruption of homeostasis, altered gene expression, regulation of 
cytokines and loss of cell cycle control, all of which can cause the cell to become 
carcinogenic [46]. In this review, I have focused on the MAPK signalling cascade (p38 
MAPK, JNK and ERK1/2) and NFκB signalling pathways because they have been 
shown to be activated by UV and may be linked to the regulation of TNFα production 
and release from skin cells [7, 8, 79, 88-90].  
 
1.6.1 p38 mitogen activated protein kinase pathway 
A range of pro-inflammatory cytokines and environmental stress can trigger the p38 
MAPK cascade. It is widely known as the stress-sensitive pathway [91]. Activated RTK 
(Receptor Tyrosine Kinases) activate Ras, which in turn causes the downstream 
activation of Raf, MAPKK (MAPK-Kinase) and MAPK (Figure 1.6) [92]. Activated 
MAPKs phosphorylate different proteins giving rise to different cellular responses. p38  
MAPKs can exist as one of four isoforms: α, β, γ, and δ [93-96]. Of these isoforms, 
p38α has been comprehensively studied and probably the most physiologically relevant 
kinase involved in the inflammatory response [97]. In addition, UV-activated p38 
MAPK is also involved in cell survival and cell death pathways [88, 98]. 
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1.6.1.1 p38 MAPK pathway and UV light 
Chouinard et al. [88] have shown that in UV-irradiated human keratinocyte cells p38 
activity was higher compared to that of JNK activity irrespective of the type and dose of 
UV radiation used (Figure 1.7). Intriguingly, they also found that in normal 
keratinocytes p38 MAPK was activated earlier and to a greater extent than that observed 
in HaCaT cells [88]. Schieke et al. [89] also showed that p38 protein levels were 
elevated in comparison to JNK protein levels in normal keratinocytes. Taken together 
this suggests that the p38 MAPK pathway is the main signalling pathway activated by 
UV exposure in keratinocytes. In HaCaT cells, 250 kJ/m2 UVA induced an immediate 
phosphorylation of p38 MAPK, which persisted for 60 min [99]. Similarly, in human 
dermal fibroblasts 200 kJ/m2 UVA activated p38 MAPK which persisted for an hour 
[100]. This result shows that despite the differences in cell type, high dose UVA 
radiation can activate p38 MAPK. Low dose UVB-irradiation (0.15 kJ/m2) of human 
keratinocytes, caused an immediate and prolonged phosphorylation of p38 MAPK 
which persisted for 48 h (Figure 1.8) [101]. The total p38 protein levels in the irradiated 
cells were the same to that seen in non-irradiated controls regardless of cell type, UV 
type or dose used which suggests that UV-irradiation does not increase p38 protein 
synthesis but rather increases phospho-p38 activity in the cells (Figure 1.8) [79, 93, 
102]. It should also be noted that p38 MAPK levels were not measured prior to 30 min 
post UVB-irradiation in Pfundt’s study unlike that seen for Chouinard’s study where 
these levels were quantified between 2-120 min [88, 101]. As such, it is possible that the 
activation of p38 MAPK in Pfundt’s study could have occurred in the earlier time 
period. 
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Figure 1.8 Phosphorylated p38 protein levels following UVB-irradiation (0.15 kJ/m2) 
in human keratinocytes. Lane1: non-irradiated control, Lane2-6: 30 min, 60 min, 240 
min, 48 h and 72 h following UVB-irradiation [101]. 
Total p38 
Phosphorylated p38 
1          2           3        4             5             6   
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B 
Figure 1.7  Activation of JNK and p38 in normal human keratinocytes exposed to 
UVA, UVB and UVC radiation. p38 kinase activity was measured using  
MAPK-Activated Protein Kinase 2 (MAPK-APK2) [88].  
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1.6.1.2 p38 MAPK pathway and UV-induced responses  
p38 MAPK is involved in mediating both cell survival and death in UV-irradiated 
epidermal keratinocytes and HaCaT cells (Table 1.2) [88, 98, 103, 104]. Chouinard et 
al. [88] showed that human keratinocytes and HaCaT cells exhibit anti- and  
pro-apoptotic responses respectively, following UV-induced activation of p38 MAPK 
via a p53 dependent pathway. This study showed that protection from UV-induced 
apoptosis was conferred by p38 MAPK-dependent phosphorylation along with the 
stabilization and accumulation of wild-type p53 tumour suppressor protein in the 
cytoplasm of normal keratinocytes. As a result of the cytoplasmic sequestration of p53, 
apoptosis was prevented in these cells. However, as HaCaT cells contain a mutated 
form of p53, they found that it was mainly confined to the nucleus as its regulation was 
independent of p38 activity, which explained the pro-apoptotic events that occurred in 
these cells following UV exposure [88]. In contrast, Hildsheim et al. [98] found that 
phosphorylated p38 MAPK was involved in apoptosis in normal keratinocyte cells via a 
p53-dependent pathway induced by UVB radiation. The dose used in this study was 
high (2.0 kJ/m2) and this would have stimulated apoptosis while Chouinard et al. [88] 
used a lower UVB dose (0.6 kJ/m2), where repair of genetic damage and cell survival 
would have probably occurred. Therefore, the different UVB doses used in these studies 
would have elicited a different effect on observed cellular responses.  
 
Interestingly, following UVA radiation (250 kJ/m2), p38 MAPK mediates cell survival 
in both normal keratinocytes and HaCaT cells via post transcriptional regulation of  
Bcl-XL which belongs to the anti-apoptotic Bcl-2 family [104]. Inhibition of p38 MAPK 
by SB202190 resulted in a dose-dependent increase in caspase activation, Poly  
ADP-Ribose Polymerase (PARP) cleavage as well as the release of cytochrome c from
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the mitochondria [104]. The results were confirmed when keratinocytes expressing a 
p38 MAPK were exposed to UVA where the complete absence of p38 MAPK activity 
gave rise to apoptotic events like DNA fragmentation and apoptotic bodies [104].   
 
Conversely, UVB-activated p38 MAPK can signal through pro-apoptotic Bax to 
mediate apoptosis. p38 controls Bax translocation from the cytosol to mitochondria, 
which is associated with mitochondrial cytochrome c release and caspase activation 
resulting in apoptosis [105]. The p38 MAPK inhibitor SB203580, disrupted Bax 
relocation to the mitochondria with a resultant decrease in apoptotic cells confirming its 
Response elicited by UV radiation 
UVA UVB Cell Type 
Dose 
(kJ/m2) Response 
Dose 
(kJ/m2) Response 
Reference 
HEK  250 Immediate p38 
activation which 
lasted for 1h  
post-irradiation 
0.15 Immediate and 
prolonged p38 
activation which 
lasted for 48 h 
post-irradiation 
Silvers et 
al. [99] 
Pfundt et 
al. [101] 
Fibroblast 200 Immediate p38 
activation which 
lasted for 1h  
post-irradiation 
  Le Panse 
et al. [100] 
HEK   2.0 p38/p53 mediated 
apoptosis  
post-irradiation 
Hildsheim 
et al. [98] 
HEK 250 p38/ Bcl-XL 
mediated cell 
survival  
post-irradiation 
0.3 p38/p53 mediated 
cell survival  
post-irradiation 
Bachelor 
et al. [104]  
Chouinard 
et al. [88] 
HaCaT 250 p38/ Bcl-XL 
mediated cell 
survival  
post-irradiation 
0.3 Apoptosis  
post-irradiation 
which was not 
mediated by the 
p38 pathway 
Bachelor 
et al. [104]  
Chouinard 
et al. [88] 
MCF 7 150 Bcl-2 mediated 
apoptosis  
post-irradiation 
  Wang et 
al. [106] 
 
Table 1.2 A comparison of the effect UVA and UVB radiation have on p38-mediated 
responses in irradiated skin cells.  
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role in UVB-induced Bax translocation. The overexpression of Bcl-2 also prevented 
Bax from undergoing conformational change and its subsequent translocation from the 
cytosol into the mitochondria [105]. Furthermore, inhibition of p38 MAPK disallows 
redistribution of Bax in the basal layer of epidermis where sunburn cells are found in 
the skin, which suggests that Bax may play a role in sunburn cell formation [105]. 
 
Wang et al. [106] have shown that Bcl-2 expression was downregulated and apoptotic 
events were upregulated following UVA-irradiation (150 kJ/m2) of MCF 7 cells. A 
significant reduction of Bcl-2 expression was observed in those cells exposed to 50-200 
kJ/m2 of UVA. As a result of its downregulation, at high UVA doses, the inhibitory 
effect of Bcl-2 on Bax diminishes and the cells undergo apoptosis. This paradigm 
makes sense as at high UV doses more damage to the cells is expected and the natural 
response would be to downregulate anti-apoptotic genes and eliminate cells that are 
unable to be repaired. 
 
Ivanov et al. [107] found that p38 MAPK protects UVC-treated melanoma cells from 
cell death. In this study, the use of MKK6-DD (constitutive active form of MKK6) led 
to an increase in cell survival and dominant negative p38 caused a 50% increase in the 
level of cell death in UVC-irradiated (0.06 kJ/m2) melanoma cells (LU1205) [107]. This 
suggests that p38 MAPK is involved in pro-survival events, which may be mediated by 
the upstream activator MKK6.  
 
It has been suggested that the p38 MAPK pathway could play a role in the UV-induced 
inflammatory response by regulating Cyclooxygenase-2 (COX-2) activity [93, 102]. 
Curcumin downregulates COX-2 expression by inhibiting UVB-induced p38 
MAPK/AP-1 (Activator Protein-1) activation [102]. Kim et al. [93] also suggested that 
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the p38 MAPK pathway may be involved in COX-2 expression via MAPK-APK2 
(MAPK-activated protein kinase 2). In support of these findings, Subramaniah et al. 
[108] have shown that activated p38 MAPK phosphorylates MAPK-APK2 that 
stabilizes COX-2 mRNA, while AP-1 activation by p38 MAPK induces COX-2 
expression.  
 
Pro-inflammatory cytokine production in keratinocytes can also be regulated by p38 
MAPK activity. Kim et al. [93] found that the p38 inhibitor, SB242235 significantly 
reduced IL-6 and IL-8 production in UVB-irradiated murine epidermis. It is unknown if 
p38 MAPK regulates these cytokines at the transcriptional, translational or  
post-translation level. Another inflammatory mediator, NO (Nitric Oxide), is involved 
in vasodilation and erythema formation following UVB-irradiation [109]. Inhibition of 
p38 MAPK caused a decrease in NO production in macrophages in an inhibitor  
dose-dependent manner suggesting a role for p38 MAPK in inflammation [79].  
 
1.6.1.3 p38 MAPK pathway and TNFα 
It has been shown that p38 MAPK plays a key role in inflammation as it is involved in 
TNFα-mediated downstream signalling pathways as well as the production of TNFα 
itself [110]. p38 MAPK has been shown to play a role at the transcriptional and 
translation level of TNFα biosynthesis and was shown to be involved in its release from 
macrophages [79, 110, 111]. Johansen et al. [112] found that in cultured human 
keratinocytes, enhanced MAPK-APK2 activity correlated with increased TNFα levels. 
Transfection of these cells with MAPK-APK2-specific small interfering RNA, reduced 
both MAPK-APK2 and TNFα expression. This suggests that MAPK-APK2  
post-transcriptionally regulates TNFα. As p38 MAPK activates MAPK-APK2, it is 
likely that it could be involved in TNFα regulation via MAPK-APK2 activity [112, 
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113]. In sham-irradiated keratinocytes, IL-1β stimulated p38 MAPK activation, which 
led to an increase in TNFα levels [112]. It may be possible that the IL-1β/p38/TNFα 
pathway also exists in UV-irradiated keratinocytes as it has been shown that UV 
radiation can also signal through IL-1α/β receptors [54, 114]. 
 
1.6.2 Jun N-terminal kinase (JNK) pathway 
Jun N-terminal kinase (JNK) like p38 MAPK belongs to the family of serine/threonine 
protein kinases [115]. It exists in 3 isoforms: JNK1, JNK2 and JNK3 [116, 117]. 
Though JNK3 is a neuronal isoform, it has been shown to be activated in keratinocytes 
following UV radiation [117, 118]. JNKs are activated in a similar fashion to p38, but 
there are different upstream protein kinases involved [115]. JNKs are activated by 
MKK4 and MKK7, which are the MAPKK involved in this pathway. These MAPKKs 
are activated by MAPKKK (MAPKK-Kinase) like MEKK1, MEKK2, MLKS (Mixed 
Lineage Kinases) and a wide variety of others depending on cell type and stimuli [119]. 
It is unknown which of these MAPKKKs are involved in UV-induced activation of the 
JNK pathway.  
 
1.6.2.1 JNK pathway and UV light 
Chouinard et al. [88] found that there was an immediate activation and higher degree of 
JNK activity following UVA-irradiation (30 kJ/m2) compared to UVB-irradiation  
(0.3 kJ/m2) in human keratinocytes (Figure 1.9). Since dissimilar UV doses were used 
in the above study, it is hard to distinguish if the difference in observed JNK activity is 
a result of the different UV types or the different doses used. Therefore, further tests 
should be done to confirm this result, preferably using equivalent doses to determine if 
the difference in UV types has an effect on JNK activity. Its activity in human 
keratinocytes peaked from 15 to 30 min post-UVB-irradiation (0.3 kJ/m2) [88].  
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Schieke et al. [89] also showed that the relative protein levels of phosphorylated JNK 
quantified post-UVB-irradiation (0.1 kJ/m2) were maximal between 15 to 30 min in 
human keratinocytes but was lower than that of p38 MAPK activity in these cells. 
However, in macrophages, JNK activity appeared to be higher than p38 MAPK activity 
following UVB-irradiation (0.5 kJ/m2) [79]. This difference could be due to the fact that 
keratinocytes were exposed to UV radiation under physiological conditions while the 
macrophages were not. 
 
 
Assefa et al. [90] compared JNK activation between normal keratinocytes and HaCaT 
cells exposed to 0.4 kJ/m2 UVB. JNK1 activation was induced at lower levels in normal 
keratinocytes, which lasted for a longer duration compared to HaCaT cells. c-Jun levels 
in HaCaT cells peaked at 0.4 kJ/m2 UVB-irradiation and at 0.6 kJ/m2 in normal 
keratinocytes. This result suggests that HaCaT cells activate the JNK signalling cascade 
to a greater extent following lower doses of UV radiation compared to normal 
keratinocytes [90]. Like that seen for total p38 protein levels, there was no change in the 
total amount of JNK protein levels present pre- and post-irradiation, which suggests that 
UV-irradiation does not regulate JNK synthesis but rather its level of activity via 
phosphorylation.  
Figure 1.9 Activation of JNK in normal human keratinocytes exposed to UVA  
(30 kJ/m2) and UVB (0.3 kJ/m2) radiation [88]. 
R
el
at
iv
e 
K
in
as
e 
A
ct
iv
ity
 
(F
o
ld
) 
R
el
at
iv
e 
K
in
as
e 
A
ct
iv
ity
 
(F
o
ld
) 
 
 JNK 
Post-Irradiation Time (min) 
 UVA 
Post-Irradiation Time (min) 
 
 JNK UVB 
80 
70 
60 
50 
40 
30 
20 
10 
0 
45 
40 
35 
30 
25 
20 
15 
10 
5 
0 
0               2              5             10            15            30           60 0          2          5        10        15       30       60         90      120 
 - 30 - 
1.6.2.2 JNK  pathway and UV-induced responses  
There is much controversy on the role JNK plays in UV-induced apoptosis. It has been 
suggested that JNK has an anti-apoptotic role while some others propose that it has a 
pro-apoptotic role [117, 119-121]. A possible reason for its biphasic function could be 
dependent on crosstalk with other signalling pathways, type of stimuli, cell type, the 
intensity and duration of activation [120]. It has been suggested that strong and 
prolonged JNK activation leads to TNFα-induced cell death while a modest and 
transient activation promotes TNFα-induced cell proliferation [119]. 
  
JNK was shown to play a role in UV-induced death pathway in murine embryonic 
fibroblasts (MEF) [117]. Tournier et al. [117] showed that JNK1-/-JNK2-/- MEF cells 
were almost completely protected against UVC-induced apoptosis at a dose of 0.06 
kJ/m2, but in JNK2-/- MEF cells there was a marked decrease in cell viability and 
increase in DNA fragmentation, whereas JNK1-/- MEF cells were partially protected 
from cell death. The results show that of the two JNK isoforms, JNK1 plays a major 
role in UV-associated cell death, which agrees with that seen previously [122]. While 
JNK1 plays an important role in cell proliferation pre-irradiation, its role may be altered 
following exposure to UV-irradiation [117].   
 
Furthermore, JNK regulates UV-induced apoptosis by inducing mitochondrial 
cytochrome c release [117]. Cytochrome c was released from mitochondria in wild type 
MEF exposed to UVC (0.06 kJ/m2) but not in JNK-deficient MEF. This finding 
correlated with the decreased cell viability observed in wild type MEF compared to 
JNK-/- MEF cells [117]. 1,25-dihydroxyvitamin D3 inhibited JNK activation which 
reduced mitochondrial cytochrome c release from human keratinocytes as the rate of 
apoptosis fell [123]. The results of these experiments confirm JNK’s role in  
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UV-induced apoptosis. JNK has also been shown to mediate cell survival [121]. 
Wisdom et al. [121] found that there was a UVC dose-dependent (0.01-0.04 kJ/m2) 
decrease in cell viability in c-Jun null fibroblast cells whereas the wild type cells were 
more resistant to apoptosis.  The difference in UVC-induced response observed in these 
studies could be due to the different doses of UV used [117, 121].  
 
There is overlap between the JNK and p38 MAPK pathways as they use intermediate 
proteins such as AP-1 and MKK4 [124, 125]. Cho et al. [102] found that apart from p38 
MAPK, JNK was also involved in UVB-induced COX-2 expression (Figure 1.10). 
Curcumin was shown to inhibit JNK activity, which correlated with a reduction in 
COX-2 expression. The fact that JNK and p38 are involved in both AP-1 activity and 
COX-2 transcriptional induction via AP-1, it is possible that both pathways may 
undergo signalling crosstalk in eliciting certain UV-induced responses [102, 124, 126]. 
JNK is also involved in UV-induced inflammatory responses through regulating the 
overexpression of COX-2 [102].   
 
 
 
 
Figure 1.10 Inhibition of UVB induced COX-2 expression by SB  
(p38 inhibitor, SB203580), SP (JNK inhibitor, SP600125) and Curcumin [102]. 
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1.6.2.3 JNK pathway and TNFα 
Walsh [127] suggested that mast cell degranulation following UVB-irradiation gave rise 
to the expression of TNFα-induced CD62E (E-selectin/ELAM-1) and CD54 adhesion 
molecules in endothelial cells. Read et al. [60] have shown that TNFα can activate the 
JNK, p38 and NFκB pathways in human endothelial cells to regulate transcription of the 
E-selectin promoter. E-selectin is involved in leukocyte recruitment during 
inflammatory responses. In this study, ATF-2 (Activating Transcription  
Factor-2) and c-Jun were shown to be part of the E-selectin cytokine-induced enhancer 
complex. JNK phosphorylates both ATF-2 and c-Jun, but p38 only activates ATF-2. 
Following TNFα-treatment, JNK and p38 were found to be strongly and transiently 
activated whereas NFκB activation lasted for hours. Read et al. [60] also suggested that 
possible crosstalk occurs between the three pathways where phosphorylation of JNK 
and p38 can activate NFκB, though the point of interaction was unclear. It has been 
suggested that the overexpression of MEKK1 can activate the NFκB pathway but this 
remains to be confirmed. In conclusion, there is experimental evidence which suggests 
that the TNFα-activated JNK pathway, besides p38 MAPK and NFκB is involved in 
inflammatory response via E-selectin regulation.  
 
Kobayashi et al. [128] suggested that the JNK signalling pathway may be involved in 
TNFα production. Through the use of the JNK specific inhibitor SP600125, there was a 
reduction in the UV-induced upregulation of TNFα expression in human keratinocytes. 
Since TNFα can activate JNK via TNF-R1 and can also be produced via JNK signalling, 
it is possible that autocrine TNFα secreted by JNK activation could in turn activate JNK 
itself via TNF-R1 (Figure 1.11) [60, 128]. 
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Figure 1.11 Activation of TNF-R1 by autocrine TNFα produced by UV-induced JNK 
activation. 1) Activation of JNK by UV; 2) TNFα production via activated JNK and 3) 
autocrine or paracrine activation of TNF receptors by TNFα. 
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1.6.3 Extracellular signal-regulated kinase (ERK) pathway 
The extracellular signal-regulated kinases (ERK) are a group of proteins that belong to 
the MAPK cascade [96, 129, 130]. They exist in different isoforms; ERK1/2, ERK3/4, 
ERK5 and ERK7/8 [129]. Among the isoforms identified, ERK1/2 is the best 
characterised. Like that of p38 and JNK, ERK1/2 activation follows a three-tiered 
mechanism [129, 130]. This involves various stimuli and receptors which activate 
MAPKKK (Raf-1, B-Raf, A-Raf). The activated MAPKKK triggers MAPKK  
(MEK1 and MEK2) phosphorylation, which in turn phosphorylates ERK1/2 [129, 130]. 
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The phosphorylated ERK1/2 activates its downstream targets like, Elk 1, c-Fos and 
c-Myc [130].  
 
1.6.3.1 ERK1/2 pathway and UV light 
In HaCaT cells, ERK1/2 showed a delayed and sustained activation following 
UVA radiation (240 kJ/m2) [131]. Phosphorylated forms of ERK1/2 was first observed 
at 3 h post-irradiation and increased until 15 h [131]. This finding correlated with the 
increased phosphorylation of Elk-1, a downstream target of ERK1/2, 3 h after UVA 
exposure, which indicates the induction of ERK1/2 kinase activity. Furthermore, the 
expression of phospho-ERK1/2 was enhanced in a dose-dependent manner 6 h post 
UVA radiation (40-320 kJ/m2) [131]. Similarly in A431 cells (human epidermoid 
carcinoma cell line), ERK1/2 activation was observed 1 h post UVA radiation  
(240 kJ/m2) and remained elevated for 6 h [131].  
 
However, when HaCaT and A431 cells were irradiated by UVB (0.2 kJ/m2) ERK1/2 
was phosphorylated after 15 min and remained activated for a further 6 h [131]. 
Exposure to UVC (0.2 kJ/m2) radiation only caused a rapid but transient activation of 
ERK1/2 in both of these cell lines [131]. Although, this data may provide an indication 
of UV type-dependent phospho-ERK1/2 expression, it may not necessarily be 
comparable as the UV doses used were not of equivalent energy level. In human dermal 
fibroblasts, phospho-ERK1/2 was activated within 15 min of UV-irradiation (275-380 
nm, 0-0.75 kJ/m2), but its level returned to those of controls by 30 min [132]. Similarly, 
in human epidermal melanocytes, ERK1/2 was phosphorylated at 15 min after being 
exposed to a low UVA dose (1 kJ/m2) [133]. 
 
 
 - 35 - 
1.6.3.2 ERK1/2 pathway and UV-induced responses  
The ERK1/2 pathway has been implicated in generating anti-apoptotic signals in HaCaT 
cells [131]. The attached viable cells displayed phospho-ERK1/2 expression 24 h post 
UVA radiation (240 kJ/m2) but caspase 3 activation was not observed. However, in the 
detached apoptotic cells, phospho-ERK1/2 expression was absent but caspase 3 was 
activated, this suggested that phosphorylation of ERK1/2 could inhibit caspase 3 
activation following UVA radiation. The MEK1 inhibitor (PD98059) prevented 
ERK1/2 activation and increased the level of apoptosis in UVA-irradiated HaCaT cells 
which suggested that ERK1/2 plays an important role in allowing compromised cells to 
evade apoptosis and to pass on mutations to daughter cells [131].  
 
MMPs (matrix metalloproteinases) may be involved in tumour progression and 
metastasis through breakdown of collagen and degradation of extracellular matrix 
proteins [132, 134]. Ramos et al. [134] found that inhibition of ERK1/2 by the MEK1 
inhibitor, PD98059 prevented the induction of MMP-1 and MMP-10 in the UVA- and 
UVB-irradiated squamous cell carcinoma cell line, SCL-1 cells. ERK1/2 appears to be 
constitutively activated in melanoma cell lines unlike that in melanocytes [55, 135]. 
This suggests that ERK1/2 is involved in mediating cell proliferation and transformation 
of melanoma cells [135]. The inhibition of ERK1/2 pathway by the MEK1/2 inhibitor, 
U0126, in normal melanocytes had a minimal effect on cell proliferation. However, in 
the various choroidal melanoma cells lines (OCM-1, MKT-BR, and SP6.5 cells), 
inhibition of ERK1/2 activation completely abolished cell proliferation in two of the 
three cell lines [135].  
 
Another characteristic of a tumorigenic cell line is its transformed phenotype in which 
cells have anchorage-independent growth. In order to determine the role of the ERK1/2 
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pathway in the acquisition of a transformed phenotype, a clonogenic assay was 
performed to observe the ability of melanoma cell lines to form colonies in soft agar 
under anchorage-independent growth conditions [135].  All three melanoma cell lines 
(OCM-1, MKT-BR, and SP6.5 cells) formed many large colonies in soft agar, U0126 
inhibited both ERK1/2 phosphorylation and colony formation of these melanoma cell 
lines, which suggests that this signalling molecule plays a role in cell proliferation 
(Figure 1.12) [135]. It can be seen from the literature that the ERK1/2 pathway plays an 
important role in carcinogenesis and therefore it is crucial to unravel the upstream 
activators of this pathway [55, 132, 134, 135]. Mutations of the BRAF gene rather than 
Ras were present in most of the melanoma cell lines that have been examined (Table 
1.3) [55, 135, 136]. Satyamoorthy et al. [55] suggested that BRAF mutation could be 
one of the main upstream activators involved in the constitutive activation of ERK1/2 in 
melanomas as those cell lines without BRAF mutations showed a lesser degree of 
ERK1/2 activation. 
 
Figure 1.12 The B-Raf/MEK/ERK pathway is required for 
melanoma cell transformation [135]. 
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1.6.3.3 ERK1/2 pathway and TNFα 
Pastore et al. [59] observed that in keratinoctyes there was an increase in ERK1/2 
activation over a 30 min period following TNFα stimulation. The EGFR tyrosine kinase 
inhibitor, PD168393 inhibited both basal and TNFα associated ERK1/2 activation in 
these cells [59]. This suggests that ERK1/2 is activated via a TNFα/EGFR/ERK1/2 
mechanism. It is possible that a similar pathway may exist in UV-irradiated 
keratinocytes, though no experimental data is available to support this suggestion.  
 
1.6.4 Nuclear factor-κB pathway 
NFκB is a transcriptional factor that forms dimeric complexes with the Rel protein 
family [137-139]. It consists of five members; p65 (RelA), RelB, c-Rel, p50/p105 
Cell line Stage N-Rasa H-Rasa K-Rasa BRAF (exon 11)b BRAF (exon 15)b 
FOM74 Normal –c – – – – 
WM1789 RGP d – – – – A1798G (K600E) 
WM35 RGP d – – – – – 
WM793 VGP e – – – – T1796A (V599E) 
WM902B VGP  e – – – – T1796A (V599E) 
WM39 VGP  e – – – – T1796A (V599E) 
WM75 VGP  e – – – – T1796A (V599E) 
WM1361A VGP  e – – – – – 
WM983A VGP  e – – – – T1796A (V599E) 
WM983B Metastatic – – – – T1796A (V599E) 
WM9 Metastatic – – – – T1796A (V599E) 
1205Lu Metastatic – – – – T1796A (V599E) 
Table 1.3 Ras and BRAF mutations in melanoma cell lines [55]. 
a
 Exons 1 and 2 of N-Ras, H-Ras, and K-Ras were amplified by genomic PCR and 
sequenced. b Exons were screened by CSCE followed by sequencing. c –, no mutation 
detected. d RGP- Radial Growth Phase. e VGP- Vertical Growth Phase. 
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(NFκB1), and p52/p100 (NFκB2) [137]. The inactive NFκB/Rel complex is localized in 
the cytoplasm bound by IκB proteins. In order to activate the NFκB/Rel complex, IκB 
(Inhibitory-κB) is phosphorylated by IKK (IκB kinases) which are in turn activated by 
cytokines, growth factors, antigen receptors, MAPKKKs and other kinases  
[137, 140-142]. Once phosphorylated IκB is targeted for ubiquitination and is 
subsequently degraded by 26S proteasomes [137, 141]. Once the NFκB/Rel complex is 
freed from IκB proteins, it can translocate into the nucleus where it can induce the 
expression of targeted genes, this process is known as the canonical pathway. NFκB/Rel 
complex can also signal through a non-canonical pathway [142].  
 
1.6.4.1 NFκB pathway and UV light 
Lin and Karin [8] have suggested that UVC activation of the NFκB pathway occurs 
through a mechanism independent of IKK activation. While proteasomal 
unbiquitination of IκBα occurred in irradiated HeLa cells, UVC exposure (0.04 kJ/m2) 
did not activate the IKK complex and its subsequent phosphorylation of IκBα. The use 
of IκBα mutant and IKK mutant cells still elicited activation of NFκB similar to that 
seen in wild type cells, which suggests that UV radiation mediates through a pathway 
distinct from the classical activation of NFκB, i.e. via IKK phosphorylation of IκBα [8].  
 
Wu et al. [7] found that NFκB is activated via translational inhibition of IκB synthesis 
following UVC-irradiation in wild-type mouse embryo fibroblasts. This is a novel 
mechanism, which involves PERK (Protein kinase-like Endoplasmic Reticulum Kinase) 
and eIF2α (Eukaryotic Translation Initiation Factor 2α). Inhibition of IκB mRNA 
translation was due to UVC-induced (0.03 kJ/m2) phosphorylation of eIF2α at its Ser51 
residue through activation of PERK leading to early phase activation of NFκB. 
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UVC-irradiation (0.06 kJ/m2) caused a delayed and prolonged activation of NFκB in 
HeLa cells [6]. Late phase activation was caused by UV-related DNA damage-induced 
signalling which led to cleavage of the IL-1α precursor by activated proteases to release 
mature IL-1α. This in turn binds to its receptor and activates the IKK complex [6]. The 
late phase NFκB activation appears to be due to DNA damage-dependent activation of 
the IKK complex while early phase activation is independent of DNA damage. Simon et 
al. [143] also showed that UV-induced DNA damage was not required for NFκB 
activation following UVB-irradiation by using nucleus-free cytosolic protein extracts 
from A431 human epidermal carcinoma cells. 
 
Lewis et al. [144] found that UVB-induced NFκB activation did not follow the 
canonical pathway involving IκBα degradation. They observed that IκBα 
phosphorylation or degradation did not increase to significant levels but NFκB 
activation was seen to increase gradually post-UVB-irradiation (0.4 kJ/m2). There 
appears to be two different mechanisms by which UV radiation may activate NFκB; (a) 
activation via IκBα phosphorylation and proteasomal degradation and (b) independent 
of IκBα control [6, 8, 144]. The route taken for NFκB activation could be dependent on 
the cell, the stimuli (TNFα), UV type and dose used. 
 
1.6.4.2 NFκB pathway and UV-induced responses  
Abeyama et al. [145] showed that the NFκB pathway is involved in UV-induced 
(0.05-0.1 kJ/m2) secretion of VEGF (Vascular Endothelial Growth Factor), IL-6, TNFα 
and IL-1β in Pam 212 keratinocytes, NS47 fibroblasts and XS106 Langerhans cells. 
NFκB decoy ODNs (oligodeoxynucleotides) were shown to block the binding of 
nuclear factors to promoter sites on their target genes which reduced the secretion of  
IL-1, IL-6, TNFα and VEGF in the cell lines examined in this study (Figure 1.13). This 
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study showed that the pro-inflammatory transcription factor, NFκB was required for the 
production of cytokines. 
 
 
 
 
 
 
 
 
 
 
 
NFκB is implicated as having an anti-apoptotic role by inhibiting the JNK pathway [9]. 
It has been shown that UVC-irradiation (0.04 kJ/m2) can activate NFκB via a PI3K 
(Phosphatidylinositol-3-kinase)/AKT2 dependent pathway [9]. After UVC exposure, 
IKKα is phosphorylated by AKT2 and subsequent activation of NFκB occurs through 
IκB degradation. AKT2/NFκB was also shown to inhibit JNK activation but the 
mechanism of inhibition is not known. It has been suggested that activated JNK is 
dephosphorylated by AKT2/IKKα, though the exact mechanism is unclear [9]. As 
inhibition of PI3K/AKT pathway protected human epithelial cancer cells from apoptosis 
following UVC-irradiation (0.3 kJ/m2) it was concluded that the PI3K/AKT2/NFκB 
mediated inhibition of JNK conferred protection from cell death. [9]. NFκB can also 
mediate pro-apoptotic events. Liu et al. [146] have suggested that following  
UV-irradiation, NFκB is required for JNK activation via initiation of PKCδ (Protein 
Kinase Cδ). The loss of PKCδ only affected UV-stimulated JNK activation but not that 
Figure 1.13 Impact of NFκB decoy ODNs on UV-stimulated cytokine production 
[145]. 
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activated by TNFα or IL-1β. RelA/NFκB was shown to be involved in  
UV-induced apoptosis through augmentation of JNK activation and immediate 
induction of Fas ligand [146]. 
 
1.6.4.3 NFκB pathway and TNFα  
NFκB may be involved in IL-6 synthesis via TNFα signal transduction [67, 141]. At 
4°C, TNF-R1 multimerization was prevented following UV exposure of the cells as was 
reduction of IκB degradation was also observed in these cells. These events correlated 
to the reduction in IL-6 released from the cells at 4°C [141]. TRAF-2 (TNF  
Receptor-Associated Factor-2), a downstream protein of TNF-R1 signalling complex 
has a role in NFκB activation and TRAF-2-deficient HeLa cells also released low 
amounts of IL-6 [67, 141]. These results suggest that NFκB maybe involved in IL-6 
synthesis via a TNF-R1/TRAF-2-mediated signalling pathway that is directly activated 
by UV radiation (Figure 1.14). However, it is unclear if TNF-R1 is activated (a) directly 
by UV radiation or (b) via UV-induced TNFα activation. In order to find out which of 
Figure 1.14 Activation of TNF-R1 by (a) UV or (b) TNFα. 
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these two pathways is involved, quantification of TNFα, IκB and IL-6 levels in  
UV-irradiated HeLa cells need to be performed. The results should be compared to that 
from irradiated cells expressing a dominant-negative TNFα. In this way the role TNFα 
plays in mediating IL-6 production via TNF-R1/NFκB activation can be confirmed.  
 
As the TNFα promoter region contains a consensus binding site for NFκB it is highly 
likely that UV-induced TNFα secretion could occur via the NFκB pathway. It has been 
 shown in keratinocytes that, FK506 (tacrolimus) inhibited UVB-induced TNFα 
secretion by suppressing NFκB activation and its subsequent translocation into the 
nucleus [147]. Activation of NFκB is inhibited by preventing IκB degradation. This 
finding suggests that NFκB is involved in UV-induced TNFα secretion. Pupe et al. 
[148] suggested that the cycloxygenase and lipoxygenase pathways are involved in 
TNFα mRNA expression and NFκB activation in human keratinocytes following  
UVB-irradiation (0.32 kJ/m2) [148]. This finding suggests that other pathways are 
involved in triggering NFκB activation in the cell. 
 
Pöppelmann et al. [149] found that following IL-1β treatment of UVB-irradiated KB 
human epithelial carcinoma cells, the observed increase in TNFα shed from the cell 
correlated with those undergoing UVB-induced apoptosis. These responses seem to be 
NFκB dependent as the use of mutant IκB reversed the responses. Genes regulated by 
NFκB like TRAF-1, TRAF-2 and TRAF-6 were downregulated following IL-1β plus 
UVB treatment [149]. These findings suggest that upon IL-1β plus UVB treatment, 
NFκB was activated causing the immediate production and release of TNFα, which in 
turn stimulated TNF-R1 and TRADD (TNF Receptor-Associated Protein with Death 
Domain) recruitment (Figure 1.15). The downregulation of the TRAF genes alleviated 
NFκB activation via IL-1β. In addition, the repression of anti-apoptotic FLIP  
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(FLICE-Inhibitory Protein) and c-IAP (Inhibitor of Apoptosis Protein) genes by IL-1β 
plus UVB treatment prevented the inhibition of effector caspases that shifts the scales 
towards pro-apoptotic events. This resulted in FADD (Fas-Associated Death Domain 
Protein) binding, caspase activation and cell death [149].  
 
 
1.6.5 Crosstalk between the MAPK cascade and the NFκB pathway 
Crosstalk occurs between pathways at different stages. It can occur through various 
stimuli, upstream activators, pathways (p38 MAPK, JNK, NFκB) and downstream 
targets. The involvement of p38 MAPK in the NFκB signalling pathway is 
controversial. Lewis et al. [144] found that in normal human keratinocytes, the 
inhibition of p38 MAPK pathway, upregulated NFκB activation following  
UVB-irradiation (0.4 kJ/m2). Ravi et al. [150] found that caffeine inhibited NFκB 
activation via the ATM (Ataxia Telangiectasia Mutated)/PKC/p38 MAPK pathway in 
UV-irradiated A2058 melanoma cells. On the contrary, in 3T3 fibroblasts and HeLa 
Figure 1.15 Suggested pathway for IL-1β mediated enhancement of UVB-induced 
apoptosis [149]. 
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cells, p38 MAPK was involved in UV-mediated NFκB activation via inducing CK2 
(Casein Kinase II) dependent phosphorylation of IκBα [151]. Sayed et al. [152] found 
that phosphorylated p38 MAPK associate directly to both the α and β subunits of CK2. 
p38 MAPK was also shown to be implicated in the canonical activation of NFκB via 
Gadd45a in bone marrow cells [10]. Gadd45a-/- cells did not show any activation of p38 
MAPK activity and phosphorylation and degradation of IκBα following  
UVC-irradiation (0.25 kJ/m2). Gadd45b was found to diminish MKK4 activation and 
the resultant decrease in JNK activity following UVC radiation [10].  
 
Peus et al. [153] investigated the ability of UVB-induced ROS to activate both the p38 
MAPK and ERK1/2 pathways. The addition of the antioxidant, ascorbic acid decreased 
ROS levels and downregulated ERK1/2 and p38 MAPK phosphorylation in UVB-
irradiated (0.2 kJ/m2) human keratinocytes [153]. ROS have also been shown to activate 
the NFκB and JNK pathways [154, 155]. Crosstalk between pathways has been shown 
to exist via MAPK kinase [60, 124, 125]. The molecular mechanisms leading to MAPK 
activation by UV-induced ROS production is not fully understood (Figure 1.16). It was 
reported that UV-induced ROS can phosphorylate EGF receptors and form complexes 
with SOS and Grb2 [64]. The complex propagates the signal downstream, triggering the 
MAPK cascade and inturn activating p38 MAPK, ERK1/2 or JNK pathways [90].  It 
has been suggested that crosstalk can also occur when ROS can cause both upregulation 
and downregulation of the different MAPKs in response to UV radiation by selectively 
inhibiting and activating MAPK phosphatases [153]. It was also postulated that  
UV-induced H2O2 may inhibit tyrosine phosphatases thereby enabling the 
phosphorylation of EGF receptors [156]. It is possible that H2O2 could play a dual role 
by inhibiting the phosphatases and inducing autophosphorylation of the EGF receptors. 
Since JNK and p38 MAPK share some common upstream activators, it is possible that 
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many of the UV responses could involve activation of both pathways at varying degrees 
and bi-directional stimulation where one pathway is activated and the other is inhibited.  
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Figure 1.16 Suggested UV-induced ROS signalling and crosstalk. (1) UV radiation 
alone or via ligand binding can phosphorylate RTK/EGFR which can trigger 
downstream activation of MAPKs and subsequent activation or inactivation of NFκB 
pathway [144]. (2) UV radiation can react with endogenous photosensitizers to produce 
ROS [61]. (3) UV-induced RTK/EGFR phosphorylation activates the NADPH oxidase 
complex which can result in ROS production [65]. (4) ROS may induce RTK/EGFR 
phosphorylation leading to downstream activation of MAPK/NFκB pathways [159]. (5) 
ROS may inhibit tyrosine kinase phosphatase thereby enabling phosphorylation of 
EGFR by UV or ROS [156]. (6) ROS may activate or inhibit MAPK phosphatases 
which can result in phosphorylation or dephosphorylation of MAPKs respectively [153]. 
(7) The activated MAPK and NFκB pathways can translocate into the nucleus to initiate 
gene transcription [159]. 
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1.7 Antioxidants 
It has been well established that UV radiation can produce ROS in skin cells [65-67]. 
ROS can activate the MAPK cascade and the NFκB pathway triggering events to either 
protect the cells from ROS-induced damage or propagating the ROS signal in inducing 
cell damage. Therefore, the use of antioxidants may prove to be beneficial in eradicating 
the detrimental effects of ROS signalling and to test their efficacy as a pharmacological 
aid in combating effects of ROS in context to skin carcinogenesis. 
 
Ding et al. [154] found that exogenous H2O2 activated the p38 MAPK, JNK and ERK 
pathways but UVB (4 kJ/m2) or UVC-induced (0.06 kJ/m2) H2O2 production only 
activate the p38 MAPK and JNK pathways in mouse epidermal C141 cells. This shows 
that different molecular mechanisms may exist between UV-induced H2O2 production 
and exogenous H2O2. Van Laethem et al. [65] suggested that UVB (0.6 kJ/m2) radiation 
can stimulate the EGF receptor which may be involved in the assembly of an active 
NADPH oxidase system that gives rise to early sources of ROS at the plasma membrane 
in keratinocytes. The EGFR-specific tyrosine kinase inhibitor, AG1487 attenuated 
UVB-induced EGFR induction, ROS production, Ask-1, MKK3/6 and p38 MAPK 
activation [65]. This implies that ROS may signal through an Ask-1/MKK3/6/p38 
MAPK pathway. Moreover, the p38 inhibitor, PD169316 protected keratinocytes from 
UVB-induced apoptosis suggesting a role for this pathway in activating the 
mitochondrial apoptotic cascade [65]. 
 
Xing et al. [157] found that polypeptide from Chlamys farreri (PCF) could inhibit the 
activation of the JNK pathway by UVA (80 kJ/m2) radiation in HaCaT cells. PCF also 
possesses antioxidant properties as it caused a decrease in UVA-induced intracellular 
ROS production, expression of acid sphingomyelinase (ASMase) and apoptosis in 
 - 47 - 
HaCaT cells. The use of Desipramine (ASMase inhibitor) confirmed that JNK was 
downstream of the ASMase pathway and is involved in UVA-induced apoptosis of 
HaCaT cells [157]. A PCF dose-dependent decrease of JNK activation was also 
observed which indicates that ROS may signal through ASMase/JNK pathway resulting 
in apoptosis.  
 
ERK pathway has also been implicated in photoageing of the skin [158]. It may be 
involved in downregulation of aquaporins resulting in decreased water permeability of 
the keratinocytes leading to skin dehydration via activation by UV-induced ROS. The 
antioxidant N-acetyl-L-cysteine and MEK/ERK inhibitor blocked the downregulation of 
aquaporin and ERK activation. The use of all-trans retinoic acid caused an upregulation 
of aquaporin expression via trans-activation of EGFR and inhibition of ERK. Together, 
these findings indicate that H2O2/MEK/ERK signalling is involved in skin dehydration.  
 
The NFκB pathway maybe involved in proinflammatory cytokine release and may 
activate the transcription of genes that encode for proteins involved in cell cycle and 
inflammation [159]. Sharma et al. [159] showed that UVB (1.2 kJ/m2) radiation 
increased the expression of iNOS (inducible nitric oxide synthase), COX-2 and cyclin 
D1 proteins in SKH-1 hairless mice. After treatment with dietary grape seed 
proanthocyanidins (GSP), UVB-induced activation of the NFκB pathway, iNOS,  
COX-2 and cyclin D1 protein expression were markedly decreased [159]. GSP was also 
found to prevent the depletion of intracellular antioxidants, inhibit UVB-induced ROS 
production and activation of MAPK proteins. These findings suggested that  
UVB-induced oxidative stress may regulate NFκB dependent gene transcription via the 
ROS/MAPK/NFκB pathway [159]. The use of pathway specific inhibitors would have 
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confirmed the postulated link between UVB-induced activation of MAPK and NFκB in 
regulating gene transcription.  
 
1.8 Conclusion 
In summary, the p38 MAPK, JNK, ERK1/2 and NFκB pathways are multifunctional as 
they are involved in both anti- and pro-apoptotic signals, cytokine production and other 
inflammatory and immunological events. The UV-induced cell signalling responses 
depend on the type, dose and mode of irradiation, cell type, duration of activation of the 
pathways and signal crosstalk between pathways [6, 120]. Therefore, it is highly likely 
that one or more of these pathways are the main pathway(s) activated following UV 
exposure. Further research into specific UV responses which may include activation of 
these pathways, TNFα production and antioxidant efficiency may provide valuable 
information on events leading to skin carcinogenesis.  
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1.9 Outline and scope of thesis 
As highlighted in this chapter, skin cancer is prevalent in most western countries and 
mortality rates have been increasing yearly. Although, measures are in place to treat 
patients inflicted with skin cancer, it is imperative for early diagnosis and more efficient 
treatment. In order to achieve this, a better understanding of skin cancer epidemiology 
and physiology is required. Cell signalling pathways and cytokines have been a target 
for research in understanding numerous diseases. They may as well be a focal point in 
skin cancer initiation and progression. This project will focus on investigating  
UV-induced activation of cell signalling pathways (p38 MAPK, JNK and NFκB) and 
TNFα production in skin cells and delineate if these responses are specific to  
UV-irradiation. The findings from this project may be a useful tool in furthering our 
understanding on how skin cancer develops. It may identify molecular targets that could 
be involved in skin cancer progression. The results may lead to further research in 
providing an alternate and more targeted therapy for skin cancer via the use of specific 
pathway and cytokine inhibitors or structuring therapeutic drugs to prevent, control or 
cure skin cancer.    
 
In this project we aim to: 
1. Observe the effect of different doses (A, B and combinations thereof) of UV 
radiation have on signalling pathway (p38 MAPK, JNK and NFκB) in human skin 
cells. 
2. Observe whether the signalling pathways are altered as a result of carcinogenesis 
through the use of human skin cancer cultures. 
3. Determine by which signalling pathway does UV enhance TNFα release from 
human skin cells.  
4. Observe if antioxidants alter the p38 MAPK signalling pathway and TNFα release 
in melanocytes.  
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CHAPTER 2 
 
MATERIALS AND METHODS 
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2.1 Materials 
The following chemical and biochemicals: RPMI (Roswell Park Memorial Institute) 
medium 1640, Epilife Medium, Medium 254, Human Keratinocyte Growth 
Supplement, Human Melanocyte Growth Supplement, Penicillin-Streptomycin 
-Glutamine, PBS (Phosphate-Buffered Saline), Trypsin-EDTA solution and phenol-red 
free HBSS (Hank’s Buffered Salt Solution) were obtained from Invitrogen (Melbourne, 
Australia); FBS (Foetal Bovine Serum) and BSA (Bovine Serum Albumin) were from 
Bovogen (Melbourne, Australia); 0.4% (w/v) Trypan Blue solution, Phosphatase 
inhibitor, 2-Mercaptoethanol, Bichinchoninic Assay Kit, Tris, Ammonium Persulfate, 
TEMED, Ponceau S, Acetic acid, Tween 20, β-Actin mouse monoclonal antibody, 
Human recombinant IL1α 2,2-Diphenyl-1-picrylhydrazyl (DPPH), Potassium 
dihydrogen orthophosphate, Ascorbic acid, 2-Deoxy-D-ribose, FeCl3, Thiobarbituric 
acid, Trichloroacetic acid and Ethylaminediaminetetraacetic acid (EDTA), were from 
Sigma (Sydney, Australia); Glycine, Sodium Dodecyl Sulfate (SDS) and NaCl were 
from Astral Scientific (Sydney, Australia); MG115 (proteasome inhibitor) was from 
Sapphire Bioscience Biochemicals (Sydney, Australia); Complete Protease inhibitor 
cocktail tablets were from Roche (Sydney, Australia); SB203580 (p38 MAPK 
inhibitor), SP600125 (JNK inhibitor), NFκB Inhibitor II, Methanol, 30% (w/v) H2O2 
and Ethanol were from Merck (Melbourne, Australia); 40% Acrylamide Bis solution, 
TEMED, Kaleidoscope Prestained Standards were from Biorad (Sydney, Australia); 
Chemilucent kit, Goat HRP conjugated anti-rabbit immunoglobin and anti-mouse 
immunoglobin were from Millipore (Sydney, Australia); Phospho-p38 rabbit polyclonal 
antibody, phospho-JNK rabbit polyclonal antibody and phospho-IκBα mouse 
monoclonal antibody were from Genesearch (Gold Coast, Australia); and AccuKine 
Human TNFα ELISA Kit was from Scientifix (Melbourne, Australia).  
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The following lab-ware: 75 cm2 canted-neck tissue culture flask, 60 mm × 15 mm tissue 
culture-treated petri dishes and 6-well clear tissue culture-treated microplates were 
obtained from DKSH (Melbourne, Australia); 96-well flat bottom microtest plates were 
from Sarstedt (Adelaide, Australia); 1.5 ml microcentrifuge tubes were from All-Lab 
Scientific (Sydney, Australia); Borex 12 × 75 mm culture tubes were from 
ThermoFisher Scientific (Melbourne, Australia); 15 ml centrifuge tubes were from 
Interpath (Melbourne, Australia); Nitrocellulose Membrane was from Amersham 
Biosciences (Sydney, Australia); and Microcon YM-10 micro-concentrators (10 kDa) 
was from Millipore (Sydney, Australia). 
 
2.2 Cell types 
HEK (Human Epidermal Keratinocyte) and HEM (Human Epidermal Melanocytes) 
were obtained from Banksia Scientific (Brisbane, Australia), HaCaT (Human adult skin 
keratinocytes propagated under low Ca2+ conditions and elevated temperature), Colo16 
(squamous cell carcinoma) and MM96L (malignant melanoma) cell types were kindly 
supplied by Professor Peter Parsons (QIMR, Brisbane, Australia). All solutions used in 
the series of experiments described in this thesis were kept at 37°C for HaCaT, Colo16 
and MM96L cells while those for HEK and HEM cells were kept at RT (20°C) unless 
specified otherwise. 
 
2.3 Cell culture techniques 
2.3.1 Cell culture 
2.3.1.1 HEK and HEM cells 
HEK cells were cultured with Epilife Medium supplemented with 1% (v/v) Human 
Keratinocyte Growth Supplement, 0.09 mM CaCl2 and 1% (v/v) Penicillin 
-Streptomycin-Glutamine (Appendix A.1.1). HEM cells were cultured with Medium 
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254 supplemented with 1% (v/v) Human Melanocyte Growth Supplement and 1% (v/v) 
Penicillin-Streptomycin-Glutamine. The spent culture media was discarded and 
replaced with fresh media every two to three days. The cells were grown in 75 cm2 
tissue culture flasks which were placed in a 5% CO2 cell incubator that was maintained 
at 37°C. 
 
2.3.1.2 HaCaT, Colo16 and MM96L cells 
HaCaT, Colo16 and MM96L cells were cultured with RPMI medium 1640 
supplemented with 5% (v/v) FBS and 1% (v/v) Penicillin-Streptomycin-Glutamine. 
Spent culture media was removed and discarded every three to four days and replaced 
with fresh RPMI media. The cultures were maintained in 75 cm2 tissue culture flasks 
and placed in the incubator as described in section 2.3.1.1.  
 
2.3.2 Subculture 
2.3.2.1 HEK and HEM cells 
HEK and HEM cultures normally reached confluency between five to seven days. 
Confluence was monitored visually using an inverted microscope (Olympus CK2). 
Once confluent, the spent culture media was aspirated and the cells washed with sterile 
Trypsin-EDTA solution (Appendix A.1.1). After which, the cells were incubated with 3 
ml of sterile Trypsin-EDTA solution for 3 min. Cells were dissociated by gentle tapping 
of the flask. The trypsinised cell suspension was collected in a 15 ml centrifuge tube 
containing 4 ml of 1% (v/v) Trypsin Neutraliser (Appendix A.1.1) and centrifuged (400 
g for 5 min at 20°C) in Universal 16 R centrifuge (HD Scientific, Melbourne, 
Australia). The supernatant was discarded and the cell pellet resuspended in 1 ml of 
their respective media. Approximately 250 µl of the cell suspension was added to a  
75 cm2 tissue culture flask containing 20 ml tissue culture media. Then the flask was 
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capped and sprayed with 70% (v/v) ethanol before being placed in the cell incubator as 
described in section 2.3.1.1 For the purpose of experiments, once the cultures in the 
flask reached 70% confluency, the cells were trypsinised and added to 20 ml of tissue 
culture media. This cell suspension was seeded onto 5 petri dishes or 2×6-well plates 
where 4 ml of cell suspension was added to each petri dish while 2 ml was added per 
well of a 6-well plate using a pipette.  
 
2.3.2.2 HaCaT, Colo16 and MM96L cells 
HaCaT, Colo16 and MM96L cell cultures usually reached confluency between four to 
five days. Confluence was monitored using a inverted microscope. Once confluent, the 
spent cell media was aspirated and the cells washed twice with sterile PBS. After which, 
they were washed once with sterile Trypsin-EDTA solution, then 2 ml of sterile 
Trypsin-EDTA was added to the cells for 3-4 min. Cells were dissociated by gentle 
tapping of the flask. An aliquot [three to four drops (~ 0.15-0.20 ml)] of cell suspension 
was added to a new cell culture flask containing 20 ml RPMI media supplement with 
FBS, glutamine and penicillin streptomycin (Section 2.3.1.2). The cell suspension was 
dispersed by repeated pipetting and the flasks were placed in the incubator as described 
in section 2.3.2.1. In order to establish cultures to be used in experiments, once flasks 
reached 70% confluency the trypsinised cell suspension (2 ml) was added to 20 ml 
tissue culture media. The contents of one 75 cm2 flask were used to seed 5 petri dishes 
or 2×6-well plate. In each petri dish 4 ml of cell suspension was added, while 2 ml was 
added per well of a 6-well plate using a pipette.  
 
 
 
 
 - 55 - 
2.4 UV-irradiation 
2.4.1 UV lamp output 
The UV cabinet (Wayne Electronics, Sydney, Australia) housed 6 UV fluorescent 
lamps: 3 UVA Phillips Ultraviolet TLK 40W/10 R lamps (Phillips, Eindhoven, 
Holland) and 3 UVB Phillips Ultraviolet TL 20W/01 RS lamps (Phillips, Eindhoven, 
Holland). The UV light emitted from UVA lamps ranged from 350-400 nm with a peak 
at 365 nm while that of UVB lamps were between 311-312 nm [160, 161]. The 
variation in the output (mW/cm2) of the UV lamps was measured using a relevant UV 
detector (UVA or UVB) attached to an IL-1400A Photometer (International Light, 
Newburyport, USA) (Appendix A.2). The outputs of the UVA and UVB lamps in the 
middle and the sides of the cabinet on the top shelf were measured, with the highest 
doses observed in the middle of the top shelf.  
 
2.4.2 UV type, dose and exposure time 
UVA and UVB radiations and combinations thereof were used in the experiments 
described in this thesis. As mentioned in section 2.4.1, the outputs of UV lamps were 
measured and the following UV doses and their exposure times were calculated 
(Appendix A.2 and Table 2.1).  
 
 
 
 
 
 
 
UV Type UV Dose (kJ/m2) Exposure Time (s) 
Low Dose 4 77 UVA 
High Dose 40 770 
Low Dose 0.2 18 UVB 
High Dose 2 185 
Low Dose (4 + 0.2) (77 + 18) UV A + B 
High Dose (40 + 2) (770 + 185) 
Low Dose (0.2 + 4) (18 + 77) UV B + A 
High Dose (2 + 40) (185 + 770) 
Table 2.1 UV types, doses and exposure times used in the experiments 
outlined in this thesis. 
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UV doses and types used were those which induced 1 MED in sun exposed skin. In 
caucasian skin, this represents an approximate 15-30 min period of exposure and was 
calculated to be 40 kJ/m2 UVA and 2 kJ/m2 UVB (Table 2.1) [87]. The low and high 
doses used in this thesis represented the respective UV (A and B) components of either 
0.1 or 1 MED [87]. Since a solar simulator was unavailable, a combination of UVA+B 
and UVB+A was used to mimic the UV component of sunlight. The two different 
combinations were used to observe if the change in UV light sequence will affect the 
signalling response of the cells.  
 
2.4.3 UV-irradiation of cells 
Cells that were irradiated were cultured in 60 mm petri dishes (Section 2.3.2) for cell 
viability experiments (Section 2.5), cell signalling pathway intermediates (Section 
2.7.1) and ELISA (Section 2.8). The distance of exposure from the UV lamps to the 
base of the petri dish is 7 cm. Once the cultures in the petri dish reached ~70% 
confluency, the spent media was discarded and the cells were gently washed twice with 
PBS. After which, the PBS was discarded and 1.5 ml of phenol red free-HBSS was 
gently added to the side of the petri dish to prevent dislodging the cells. The UV lamps 
were pre-warmed for 5 min prior to UV-irradiation of the cells. The petri dish was then 
placed in the middle of the top shelf in the UV cabinet and exposed to UV-irradiation 
with the lid removed. The cells were exposed to the type and dose of UV radiation as 
outlined in Table 2.1. A 10 mm thick piece of glass window was placed over the petri 
dishes to prevent the entry of residual UVB light when exposing the cultures to UVA 
radiation. Prior to irradiating the cultures, the UV lamps were switched on for 5 min to 
ensure maximal output. 
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After irradiation, the HBSS was aspirated from the petri dish and 1.5 ml fresh tissue 
culture media was gently added to the side of the petri dish. The petri dish was returned 
to the cell incubator for various time points as described in the results (Section 3.2, 4.2 
and 5.2). In order to preserve phospho-IκBα in cell lysates for western blotting 
experiments, a proteasome inhibitor, MG115 (carbobenzoxy-L-leucyl-L-leucyl 
-norvalinal) was used. MG115 is a substrate analogue and inhibits the chymotrypsin 
-like activity of the proteasome thereby preventing the protesomal degradation of 
phospho-IκBα [162]. The cells in the petri dish were incubated for 60 min with 1.5 ml 
of fresh media containing 0.05 mM MG115 prior to irradiation. After irradiation, the 
media containing MG115 was added to the petri dish and returned to the cell incubator 
for various time points (5, 15, 30, 60 and 120 min). 
 
2.5 Cell viability 
Cell viability was determined 24 h after UV radiation using the Trypan Blue exclusion 
method. At the end of this time period, the media in the petri dish was removed and 
placed in a 15 ml centrifuge tube. The cells were washed twice with PBS and the 
washings added to this centrifuge tube which was centrifuged (400 g for 5 min at 4°C). 
The supernatant was discarded and the cell pellet resuspended in 1 ml ice-cold (4°C) 
PBS. A 50 µl aliquot of this cell suspension was added to 50 µl of 0.4% (w/v) Trypan 
Blue solution in a microfuge tube and mixed well by pipetting. A 50 µl aliquot from the 
microfuge tube was added to a haemocytometer (Neubauer improved bright-line) and 
the cells were counted using an Olympus BH2 light microscope. This count represented 
the number of detached cells in the culture.  
 
The attached cells on the petri dish were detached by adding 1 ml of Trypsin-EDTA 
solution and the dish was incubated for 3-4 min. The cells were dislodged from the base 
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of the petri dish by gentle washing action using a pipette. The suspended cells were 
transferred to a 15 ml centrifuge tube that contained 1 ml of 5% (v/v) Trypsin 
Neutraliser (Appendix A.1.1). The dish was washed twice with PBS to remove any 
remaining cells and the washings added to the centrifuge tube. The tubes were 
centrifuged (400 g for 5 min at 4°C) and the cell pellet resuspended in 3 ml PBS. Cell 
viability was determined with Trypan Blue exclusion as described above and this count 
represented the number of attached cells in the culture. Cell viability was calculated as a 
percentage of viable or dead (attached or detached) cells of the total cell population 
(attached and detached viable and dead cells) (Appendix A.3).  
 
2.6 Inhibitor and anisomycin studies 
In this study, all the signalling pathway inhibitors and anisomycin were dissolved in 
DMSO. In the inhibitor studies, cells cultured in 60 mm petri dishes were pre-treated for 
1 h with either 2.5-20 µM SB203580 (p38 MAPK inhibitor, Stock solution: 2 mM),  
2.5-20 µM SP600125 (JNK inhibitor, Stock solution: 2 mM) or 0.625-5 mM 
sulfasalazine (NFκB inhibitor, Stock solution: 0.25 M). After which the inhibitor 
solution was removed and the cell culture was irradiated as described in section 2.4.3. 
Immediately following radiation, the inhibitor solution was added to the culture and was 
incubated for various time points as seen in the results section. In the anisomycin 
studies, irradiated cell cultures were incubated with 20-100 µM anisomycin (Stock 
solution: 20 mM) for various time points as seen in the results section. 
 
2.7 Western blotting 
2.7.1 Protein extraction 
Following UV exposure, the cells in 60 mm petri dishes were harvested at various time 
points (5, 15, 30, 60 and 120 min). At the end of this time, the media was removed from 
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the petri dish and discarded. The attached cells were washed twice with PBS (4°C) prior 
to the addition of 200 µl of ice-cold (4°C) Lysis buffer (Appendix A.1.2). The cells 
were dislodged using a cell scraper and the lysates collected in a 1.5 ml microfuge tube 
that was placed on rocking platform for 20 min at 4°C. The microfuge tubes were then 
centrifuged (8,500 g for 5 min at 4°C) and the supernatant (cell protein lysate) collected 
and placed in a fresh microfuge tube. A 5 µl aliquot of the supernatant was used to 
determine the protein level utilising the Bichinchoninic (BCA) assay (section 2.7.2). In 
a microfuge tube, 80 µl of supernatant (cell protein lysate) was added to 20 µl of 
Laemmli’s sample buffer [163] (Appendix A.1.2) at a ratio of 4:1 and boiled for 5 min 
at 95°C. These samples were stored at -80°C until they were used for SDS PAGE gel 
electrophoresis (Section 2.7.3).  
 
2.7.2 Protein concentration determination 
The Bichinchoninic Assay (BCA) was used to determine protein levels (Section 2.7.1 & 
2.8) as per the manufacturer’s instructions (Sigma). BSA was used as the protein 
standard. Briefly, protein standards were added to a 96-well plate in increasing order of 
concentration (0-10 µg of BSA). In each well, 5 µl of supernatant was added in 
duplicates. After this, 200 µl of BCA working reagent was added to each well and the 
samples incubated at 37°C for 1 h. After incubation, the plates were read at 560 nm 
using a Perkin Elmer Victor3 plate reader (Wallac, Turku, Finland). The concentration 
of cell protein in each well was calculated against the protein standards on each plate 
(Appendix A.4).  
 
2.7.3 SDS PAGE gels 
The SDS PAGE gel was set in a Mini Protean II Multicasting Chamber (BioRad) and 
consisted of a 10% running gel (Appendix A.1.3). Once the running gel had set, the 
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stacking gel (Appendix A.1.3) was laid on top with a sample comb. Once the stacking 
gel had set, the sample comb was removed and the gel was immersed in a tank 
containing Running buffer [25 mM Tris, 192 mM Glycine, 3.5 mM SDS, (pH8.8)]. In 
each gel 4 µl of Kaleidoscope Prestained Standards was added to the first lane while cell 
lysates (20-30 µg) were added to each subsequent lane (Figure 2.1A). The gel was run 
for 45 min at a constant voltage of 150 V. 
 
2.7.4 Immunoblotting 
Once the gel electrophoresis was completed, the proteins were electro-transferred onto a 
pre-wet nitrocellulose membrane, which had been pre-soaked (10 min) in cold (4°C) 
Transfer buffer [25 mM Tris, 192 mM Glycine, 20% (v/v) Methanol], using a semi-dry 
transfer unit (BioRad) at a constant voltage of 24 V for 1.25 h. At the end of this time, 
the efficiency of the semi-dry transfer was determined by soaking the nitrocellulose 
membrane in Ponceau S solution [0.1% (w/v) Ponceau S in 0.05% (v/v) CH3COOH] for 
2 min and rinsing with water. The membrane was stained with Ponceau S solution to 
ensure that the transfer of protein had taken place successfully. The nitrocellulose 
membrane was then placed in Blocking buffer [5% (w/v) BSA in TBST (Tris-buffered 
saline tween-20)] and left on an orbital shaker for 2 h at RT. After which the membrane 
was incubated in a dish with 3 ml of 5% (w/v) BSA containing the relevant primary 
antibody [1:1000 phospho-p38 rabbit polyclonal antibody, 1:1000 phospho-JNK rabbit 
polyclonal antibody, 1:1000 phospho-IκBα mouse monoclonal antibody, 1:1000 β-actin 
(loading control)] overnight with gentle agitation on a rocker at 4°C (Figure 2.1B-D). 
The β-actin antibody was used as a loading control to ensure that a constant mass of cell 
lysate was loaded into each lane. Although, total p38 MAPK and JNK1/2 proteins have 
been used as loading controls, total IκBα cannot be used as its levels do not remain 
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Figure 2.1 (A) A SDS page gel showing the migration of kaleidoscope prestained 
standards. (B) A standard curve representing distance migrated by kaleidoscope 
prestained standards during gel electrophoresis. (W) marks the molecular weight (43.4 
kDa) and distance migrated by phospho-p38 protein (43 kDa). (C) (X) marks the 
molecular weight (46.7 kDa) and distance migrated by phospho-JNK1 (46 kDa) and (Y) 
marks (54.3 kDa) that of phospho-JNK2 protein (54 kDa). (D) (Z) marks the molecular 
weight (40.8 kDa) and distance migrated by phospho-IκBα protein (41 kDa). 
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constant after UV-irradiation. Therefore, to maintain consistency throughout this study, 
β-actin antibody was used as a loading control. The next day, the membrane was 
washed thrice (10 min per wash) with TBST [20 mM Tris, 138 mM NaCl, 0.05% (v/v) 
Tween 20, pH 7.6] (RT). After this, it was placed in a dish containing 3 ml of 5% (w/v) 
BSA containing the appropriate secondary antibody (1:1000 Goat HRP conjugated anti-
rabbit immunoglobin or 1:1000 Sheep HRP conjugated anti-mouse immunoglobin) and 
left on an orbital shaker for 1 h at RT. At the end of this time, the membrane was 
washed again thrice (10 min per wash) with TBST (RT).  
 
2.7.5 Protein detection 
After the final TBST wash, the membrane was exposed to 2 ml Chemilucent solution 
(peroxide solution : peroxide buffer : luminol/enhancer solution, 1:1000:1000) for 30 s. 
The membrane was then placed in a Chemidox XRS unit (BioRad) and the 
chemiluminescence was detected by a CCD camera connected to the Chemidox XRS 
unit and a digital output was obtained. The digital image was analysed for densitometry 
using Quantity One Digital Imaging Software Version 4.5.1 (BioRad). The protein 
levels in non-irradiated control sample were expressed as 100% while those in the 
treated samples were expressed as a percentage of this value. Since phospho-JNK exists 
as two isoforms (JNK1 and JNK2), each isoform was expressed as a percentage of total 
phospho-JNK1/2 from non-irradiated control sample (Appendix A.5). The same 
calculations were performed for inhibitor and anisomycin studies.  
 
2.8 ELISA 
The levels of TNFα released from the UV-irradiated cell cultures were measured 24 h 
post UV-irradiation using an AccuKine Human TNFα ELISA Kit as per the 
manufacturer’s instructions (Scientifix). Immediately after UV exposure, 1.5 ml of fresh 
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media was added to the cells in 60 mm petri dishes. In some experiments, 10 ng/ml of 
IL1α was added to the media as it has been shown to stimulate TNFα release from  
UV-irradiated keratinocytes [164]. After 24 h incubation, media from each petri dish 
was collected in 15 ml tubes and were centrifuged (400 g for 5 min at 4°C). The 
supernatant was further concentrated using Microcon YM-10 micro-concentrators (10 
kDa) as per the manufacturer’s instructions. Briefly, 0.5 ml media samples were placed 
in the microcon sample reservoirs on a microfuge tube and centrifuged (10,000 g for 30 
min at 4°C). These micro-concentrated media samples were added to the wells as 
described below. 
 
ELISA was performed as per the manufacturer’s instructions (Scientifix). Briefly, 
96-well plates were coated with 100 µl/well capture antibody and were left overnight at 
4°C. After incubation, the wells were washed thrice with Plate Washing Buffer (0.05% 
(v/v) Tween 20 in PBS) and then were blocked with 300 µl/well of Assay Buffer  
[1% (w/v) BSA in PBS] for 1 h at 37°C. After this, the wells were washed thrice with 
Plate Washing Buffer. In each well 100 µl of TNFα standards (0-2 ng/ml) or 0.5 ml 
micro-concentrated media samples were added in duplicates and incubated for 1 h at 
37°C. After incubation, the wells were washed thrice with Plate Washing Buffer. Then 
100 µl/well of Detection Antibody prediluted in Assay Buffer (1:200) was added and 
incubated for 1 h at 37°C. All the wells were washed again thrice with Plate Washing 
Buffer. After which, 100 µl/well of prediltued Streptavidin-HRP was added and placed 
in a darkened cupboard for 20 min at RT. Then the wells were washed three times with 
Plate Washing Buffer before 100 µl of substrate solution (1:1, substrate reagent A: 
substrate reagent B) was added to each well. After 30 min at 20-25°C, 50 µl of stop 
solution (1 M H2SO4) was added to each well and the absorbance was read at 450 nm 
using the Perkin Elmer Victor3 plate reader (Appendix A.6).  
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2.9 Antioxidant studies 
2.9.1 Test compounds 
MCLE (Mussel Crude Lipid Extract) and Scymnol (Shark’s bile extract) were provided 
by the Natural products research laboratory, RMIT (Melbourne, Australia). MCLE was 
extracted by CO2 supercritical fluid extraction using tartaric acid-stabilised freeze-dried 
Perna canaliculus mussel powder obtained from McFarlane Marketing Pty Ltd 
(Melbourne, Australia) [165]. MCLE contains cholesterol esters, triglycerides, free fatty 
acids, diglycerides, cholesterol, phospholipids and monoglycerides out of which the free 
fatty acid component seemed to exhibit anti-inflammatory properties [165, 166]. 
Scymnol (5β-Scymnol) is a 27-carbon alcohol steroid and is derived from 5β-Scymnol 
sulphate which is present in the bile of sharks [167]. 5β-Scymnol sulphate is isolated 
from freeze-dried bile as described by Macrides et al. [167] and hydrolysed to form 
scymnol according to the method of Amiet et al. [168]. Cells cultured in 60 mm petri 
dishes were pre-treated for 24 h with either 0.2-62.5 µg/ml α-Tocopherol, MCLE or 
Scymnol (Stock solution: 30 mg/ml ethanol) [167, 169, 170]. After which media was 
removed and the cell cultures were irradiated as described in section 2.4.3. Immediately 
following radiation, the test compounds were added to the culture and were incubated 
for various time points as seen in the results section 5.2. 
 
2.9.2 DPPH assay 
DPPH is a stable free radical which has a strong spectral absorbance at 517/490 nm 
[171]. Once it accepts an electron or hydrogen radical (from an antioxidant), the 
reduction of DPPH (violet colour) to DPPH2 (clear) forms a stable product which loses 
absorbance at 517/490 nm [171]. First, test compounds (α-Tocopherol, MCLE & 
Scymnol) were serially (2-fold) diluted in ethanol (0, 0.08, 0.2, 0.3, 0.6, 1.3, 2.5, 5 & 10 
mg/ml) to determine at which concentration the test compounds were effective in 
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scavenging the DPPH radical. In a 96-well plate, 10 µl of diluted test compounds or 
ethanol (control) alone were added to each well in triplicates. In each well containing 
the test compounds, 210 µl of DPPH (100 µM DPPH in ethanol) was added to 
commence the scavenging reaction. Once DPPH was added its absorbance (517/490 
nm) was immediately measured at varying time points over a 24 h period using a Perkin 
Elmer Victor3 plate reader. The change in absorbance was used to determine the ability 
of test compounds to reduce DPPH to DPPH2. 
 
2.9.3 Fenton reaction assay 
In this assay, the iron-EDTA complex reacts with H2O2 in the presence of ascorbic acid 
to generate hydroxyl radicals [172]. The addition of antioxidants competes with 
deoxyribose for these hydroxyl radicals. Since ethanol reacts with the Fenton reaction 
assay, either 10 µl of test compounds (10 mg/ml) or ethanol (control) on their own were 
added to each cuvette. The ethanol was evaporated by introducing air into the cuvettes 
via a tube connected to the air supply for 30 min. In the cuvettes 800 µl Potassium 
phosphate buffer (10 mM KH2PO4, pH 7.4 with 10 M KOH) was added and vortexed. 
After which, 50 µl each of Deoxyribose (56 mM 2-Deoxy-D-ribose), 2 mM Ascorbic 
acid and 20 mM H2O2 [30% (w/v) H2O2] were added to the cuvettes, vortexed and 
incubated for 5 min at 37°C. The reaction was commenced when 50 µl of FeCl3/EDTA 
(54 mg FeCl3, 77.4 mg EDTA and 100 ml H2O) was added after which the cuvette  was 
vortexed and incubated for 15 min at 37°C. The reaction was stopped by adding 1 ml 
TBA (Thiobarbituric acid) [1 g TBA in 100 ml NaOH (0.05 M), pH 3.5] and TCA 
(Trichloroacetic acid) [2.8% (w/v) TCA] to the reaction mixture and incubated for 15 
min at 95°C. After incubation, the absorbance was read at 532 nm using a UV-160A 
UV-visible recording spectrophotometer (Shimadzu Corporation, Japan). 
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2.10 Statistical analysis 
In this study, the Microsoft Excel program (Version 2002, Microsoft Corporation) was 
used to perform statistical analysis. For all studies which include cell viability, western 
blotting, ELISA and antioxidant assays, the results were expressed as the means  
± Standard Deviation (SD) from triplicate samples. All data are representative of three 
independent experiments. The statistical significance was determined by the use of 
Student’s paired, one-tailed t-test with p ≤ 0.05 deemed to be significant. 
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3.1 Introduction 
Keratinocytes are the main group of cells found in the epidermal layer of the skin [173]. 
They constitute 90-95% of the cells present in the epidermis and originate from stem 
cells present in the stratum basale [173]. These cells differentiate through the various 
layers of the skin eventually forming corneocytes in the stratum corneum before being 
shed from the skin [173]. Keratinocytes can be transformed by a stress stimulus ( e.g. 
UV radiation) into squamous and basal cell carcinomas [174]. These types of skin 
cancers are more prevalent but rarely metastasize unlike that of cutaneous melanoma. 
The molecular changes within keratinocytes and SCC cells can be evoked by UVA and 
UVB radiation which penetrates the epidermal layer. These molecular changes may be 
in the form of mutations, triggering cell signal transduction and cytokine regulation 
among others. 
 
In this study, the main focus is on UV-mediated activation of cell signalling pathways 
like p38 MAPK, JNK and NFκB. The RTKs have been largely suggested to initiate  
UV-induced signalling events within keratinocytes. Both the p38 MAPK and JNK 
pathways belong to the MAPK family of proteins. The p38 MAPK and JNK proteins 
can be phosphorylated by stress signals like UV radiation through a three-tiered MAPK 
cascade [96, 129, 130]. When these pathways are activated, p38 MAPK is 
phosphorylated by upstream proteins like MEK3 and MEK6 whereas the JNK pathway 
can be activated by MEK4 and MEK7 [129, 130]. These phosphorylated proteins can 
activate transcription factors like c-Fos, c-Jun, ATF2 and others [115, 175]. On the 
other hand, the NFκB complex is rendered inactive when bound to IκBα protein [176]. 
This complex becomes freed and activated when IKK phosphorylates IκBα which is 
then tagged for ubiquitination by a proteasome [176]. The freed NFκB complex can 
translocate into the nucleus to initiate the transcription of specific genes. Some studies 
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on cell signalling pathways have utilised very high UV dose or UVC radiation which is 
not physiologically relevant and can induce high levels of cell death [131, 150, 177]. 
Therefore it is of interest to profile the activation of pathways using physiological doses 
(1 MED) of UV radiation in this study.  
 
These pathways (p38 MAPK, JNK and NFκB) have been implicated in skin 
carcinogenesis of keratinocyte-derived cells [178-180]. Junttila et al. [180] suggested 
that p38α and p38δ isoforms were involved in promoting head and neck SCC. They 
found that the dominant-negative forms of p38α and p38δ prevented the invasion of 
SCC cells through collagen and also induced cell death. Moreover, the dominant 
-negative p38 isoforms also prevented implantation of SCC cells on immunodeficient 
mice. Gross et al. [178] found that the JNK activity was greater in 1438 HNSCC cells 
(head and neck SCC) than in the normal oral epithelium. The JNK inhibitor SP600125, 
inhibited the growth of 1438 HNSCC xenografts and decreased microvessel density 
thereby reducing angiogenesis. This suggests that the JNK pathway plays a role in skin 
carcinogenesis where it is involved in tumour proliferation and angiogenesis. Squarize 
et al. [179] found that different HNSCC cell lines (HN12, HN13, HN30) had a 
constitutive NFκB activity whereas HaCaT cells did not. On the other hand, Dajee et al. 
[181] have shown that epidermal SCCs lacked p65 (NFκB subunit) nuclear distribution. 
They found that coexpression of Ras and IκBα (inhibitory protein of NFκB) in human 
epidermal tissue caused an inhibition of NFκB and gave rise to neoplasms which were 
akin to SCC. Collectively, these studies have shown that the pathways have tumour 
promoting or suppressing roles in skin tumorigenesis.  
 
The other focus of this study is on the signalling pathway(s) involved in the formation 
and release of the proinflammatory cytokine TNFα which may be implicated in skin 
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carcinogenesis [83, 182]. It was shown that the blockade of TNFα receptor 1 by using 
neutralising antibodies reduced SCC tumour growth in three SCC cell lines (A431, 
SCC25 and CAL27) [183]. Faurschou et al. [182] found that TNFα-treated HaCaT cells 
had a high number of cyclobutane pyrimidine dimers (CPD) after UVB-irradiation then 
did untreated cells. TNFα seemed to block the G2/M checkpoint allowing the unrepaired 
cells possessing CPDs to enter cell cycle [182]. The TNFα-treated HaCaT cells which 
were pulse labelled with BrdU and stained with CPD antibody showed that the CPD 
positive cells were able to cycle in S and M phase [182]. This shows that TNFα can 
block cell cycle arrest and allow compromised cells to enter cell cycle leading to 
tumorigenesis.  
 
In normal keratinocytes, the p38 MAPK, JNK and NFκB pathways are normally 
involved in maintaining cellular homeostasis, growth and differentiation [184]. As 
supported by evidence from other studies, it is possible that these pathways may be 
involved in various functions in SCC cells and as such the pathways may be activated 
differently to that in normal keratinocytes when the cells are exposed to UV radiation 
[178-181]. Therefore, in this chapter, the differences in the effect of UV radiation on 
viability, cell signal transduction (p38 MAPK, JNK and NFκB) and cytokine regulation 
(TNFα) between human epidermal keratinocytes (HEK) and squamous cell carcinoma 
(Colo16) will be investigated.  The immortalized keratinocytes, HaCaT cells have been 
used in place of HEK cells because these cells are easier to passage and have similar 
differentiating capacity like HEK cells [185]. However, HaCaT cells possess molecular 
alterations which may interfere with cell signalling events and cytokine regulation [186, 
187]. Therefore, from these studies evidence can be obtained to evaluate whether 
HaCaT cells are indeed a good model for HEK cells in terms of studying cell signal 
transduction and cytokine regulation. Furthermore, the role of cell signalling pathways 
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in UV-induced TNFα release will be examined through the use of cell signalling 
inhibitors like SB202190 (p38 MAPK inhibitor), SP600125 (JNK inhibitor) and 
sulfasalazine (NFκB inhibitor).  
 
3.2 Results 
3.2.1 The effect of UV radiation on the viability of keratinocyte-derived 
cells 
The effect of UV radiation (UVA, UVB, UVA+B or UVB+A) on the viability of HEK, 
HaCaT and Colo16 cells were measured 24 h post-irradiation using trypan blue 
exclusion (Figure 3.1). The UV doses used were equivalent to 1 MED (high dose) or 0.1 
MED (low dose). In the figures, the ‘detached cells’ are those which had dissociated 
from the surface of the culture vessel, while ‘attached cells’ referred to those which had 
not. 
 
All three keratinocyte-derived cell types were susceptible to UV radiation but differed 
in their degree of susceptibility (Figure 3.1). The high UV doses caused a greater 
decrease in the percentage of attached viable cells compared to the low UV doses in all 
three cell types. In addition, UVB, UVA+B and UVB+A radiation were more 
detrimental to the cells than UVA radiation. HEK cells had a higher percentage of 
attached dead cells in sham-irradiated controls (32%) than did HaCaT (5%) or Colo16 
(6%) cells. 1% (v/v) trypsin was used to remove attached cells from the petri dish. Since 
HEK cells were found to be more sensitive to trypsin, the high level of cell death may 
have been due to trypsin-induced cell damage. Since the incubation time of trypsin was 
kept constant throughout the experiment, any difference observed in the viability results 
is most likely to the effect of UV radiation and not trypsin. 
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Figure 3.1 The viability of (A) HEK, (B) HaCaT and (C) Colo16 cell cultures at  
24 h post UV-irradiation. Cell viability was performed using trypan blue exclusion. 
Results expressed as the means ± SD from triplicate samples. Data are representative of 
three independent experiments. Comparisons were made between sham-irradiated 
control and UV-irradiated cultures using Student’s paired t-test where significance was 
recorded as p ≤ 0.05 (*). 
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HEK cells were least susceptible to UV radiation as they had a higher percentage of 
attached viable cells (Sham-irradiated control: 68%, high dose UVA: 56%, UVB: 53%, 
UVA+B: 46% and UVB+A: 54%) (Figure 3.1A). HaCaT cells had fewer attached 
viable cells than HEK cells after UV radiation (Sham-irradiated control: 95%, high dose 
UVA: 77%, UVB: 70%, UVA+B: 60% and UVB+A: 61%) (Figure 3.1B). In both of 
these cells types, maximal decrease in viability was observed after high dose UVA+B 
radiation. Colo16 cells were most susceptible to UV radiation as they had the lowest 
percentage of attached viable cells (Sham-irradiated control: 94%, high dose UVA: 
77%, UVB: 50%, UVA+B: 47% and UVB+A: 43%) (Figure 3.1C). Correspondingly, 
these cells (Colo16) had the highest percentage of detached dead cells after UV 
radiation (Sham-irradiated control: 1%, high dose UVA: 8%, UVB: 37%, UVA+B: 34% 
and UVB+A: 44%). In general the UV doses used in this study were not overly 
cytotoxic as >50% of the cells were viable after high dose UV exposure in all three cell 
lines. Therefore, it can be confirmed that the UV doses used in this study are not 
pathological doses and reflect that of a physiological dose. 
 
3.2.2 The effect of UV radiation on the activation of p38 MAPK, JNK 
and NFκB pathways in keratinocyte-derived cells  
The activation of p38 MAPK, JNK and NFκB pathways was observed over the first 120 
min following UV radiation in HEK, HaCaT and Colo16 cells. These cells were 
exposed to either a low or a high dose of UVA, UVB, UVA+B or UVB+A radiation 
(Table 2.1) to observe the effect these doses have on activating the signalling pathways 
in surviving cells (low dose) and cells that may have accumulated a certain degree of 
damage (high dose) (Figure 3.1). Once irradiated, the cell cultures were left to incubate 
for various amounts of time and cell protein lysates were extracted at the end of these 
time points to perform western blots (Section 2.7).  
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3.2.2.1 p38 MAPK pathway 
The p38 MAPK pathway is activated when p38 MAPK is phosphorylated [175]. 
Therefore, phospho-p38 MAPK expression was observed to indicate the activation of 
the p38 MAPK pathway following UV radiation in HEK, HaCaT and Colo16 cells. A 
polyclonal phospho-p38 MAPK antibody was used to probe for phospho-p38 MAPK 
protein (43 kDa) on western blots (Figure 3.2). The expression of the phospho-p38 was 
calculated as a ratio of UV-irradiated sample over sham-irradiated control  
(control = 100%). 
 
 
 
Figure 3.2 A representative western blot probed for phospho-p38 MAPK in (A) HEK, 
(B) HaCaT and (C) Colo16 cells. The samples from lanes 2 to 5 in blot (A) and lanes 2 
to 6 in blots (B & C) were exposed to low dose UVB radiation. The samples from lanes 
6 to 9 in blot (A) and lanes 7 to 11 in blots (B & C) were exposed to high dose UVB 
radiation. The lanes marked from 1 to 9 in blot (A) represents Lane 1: Sham-irradiated 
control, 2 & 6: 5 min, 3 & 7: 15 min, 4 & 8: 30 min, 5 & 9: 120 min post-irradiation. 
The lanes marked from 1 to 11 in blots (B & C) represents Lane 1: Sham-irradiated 
control, 2 & 7: 5 min, 3 & 8: 15 min, 4 & 9: 30 min, 5 & 10: 60 min, 6 & 11: 120 min 
post-irradiation.  
Colo16 
Phospho-p38 
β-Actin 
Phospho-p38 
β-Actin 
Phospho-p38 
β-Actin 
A 
B 
C 
1     2     3     4    5     6    7     8     9 
1   2   3    4    5    6   7    8   9   10  11 
1    2    3    4     5    6   7   8   9  10  11 
HaCaT 
HEK 
 - 75 - 
3.2.2.1.1 HEK cells 
In HEK cells, following exposure to low dose UVA, phospho-p38 levels peaked at 5 
min (321%) post-irradiation (Figure 3.3A). These levels fell to 124% by 30 min and 
remained constant up to 120 min (127%) post-irradiation. After exposure to high dose 
UVA, the phospho-p38 levels also peaked at 5 min (245%) before falling gradually to 
128% at 120 min post-irradiation. The level of phospho-p38 after low dose UVA was 
76% greater than that of high dose UVA at 5 min post-irradiation. However, after 15-30 
min post-irradiation, there was a fall in phospho-38 levels in cells exposed to low dose 
UVA compared to those exposed to the higher dose.  
 
In the case of low dose UVB, phospho-p38 levels increased to 156% at 5 min and 
remained constant until 30 min before decreasing to 127% at 120 min post-irradiation 
(Figure 3.3B). After exposure to high dose UVB, the phospho-p38 levels immediately 
increased to 308% at 5 min, peaking at 15 min (316%) and then declined towards 
control levels (100%) at 120 min post-irradiation.  Exposure to high dose UVB caused 
an increase in phospho-p38 levels by 157% compared to low dose at 15 min 
post-irradiation. 
 
Low dose UVA+B radiation elevated the levels of phospho-p38 at 5 min (196%) which 
dropped to 127% at 15 min and remained constant until 120 min (120%)  
post-irradiation (Figure 3.3C). After exposure to high dose UVA+B radiation  
phospho-p38 levels increased to 245% at 5 min, peaking at 15 min (348%) before 
decreasing gradually to 129% at 120 min post-irradiation. Low dose UVA+B radiation 
caused an immediate but short-lived activation of the p38 MAPK pathway whereas high 
dose caused an immediate activation of the pathway which slowly decreased over the 
15-120 min time period.  
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Figure 3.3 The effect of UV radiation on the expression of phospho-p38 protein in HEK 
cells. Cell cultures were irradiated with either a low (0.1 MED) or high (1 MED) UV 
dose of (A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation and proteins were 
extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of cell 
lysate was used to perform western blotting. Results expressed as the means ± SD from 
triplicate samples. Data are representative of three independent experiments. 
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †). [High dose UV (*); Low dose UV (†)]. 
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After low UVB+A exposure, phospho-p38 levels increased to 163% at 5 min and 
peaked at 15 min (204%) post-irradiation (Figure 3.3D). These levels dropped back to 
167% at 30 min and remained constant until 120 min (169%) post-irradiation.  High 
dose UVB+A radiation caused an immediate increase of phospho-p38 levels at 5 min 
(297%) which peaked at 367% after 15 min and then declined to 137% at 120 min 
post-irradiation.  
 
3.2.2.1.2 HaCaT cells 
In HaCaT cells, low dose UVA caused an increase in phospho-p38 levels to 191% at 5 
min which remained constant until 30 min (200%), before falling to 137% at 120 min 
post-irradiation (Figure 3.4A). After exposure to high dose UVA, phospho-p38 levels 
rose immediately to 364% at 5 min which increased gradually to 484% at 30 min before 
falling to 138% at 120 min post-irradiation. The pattern of phospho-p38 expression after 
low or high dose UVA was immediate and sustained but high dose UVA induced 
greater levels of phospho-p38 in these cells than did low dose radiation. 
 
The exposure to low dose UVB caused a minimal expression of phospho-p38 (Figure 
3.4B). There was a gradual increase in these levels by 15 min (138%), after which they 
fell to 117% at 30 min before increasing to 151% at 120 min post-irradiation. After high 
dose UVB exposure, there was a dramatic increase in phospho-p38 levels to 648% at 5 
min which immediately declined to 346% at 15 min after which it slowly fell to 187% 
at 120 min post-irradiation. High dose UVB caused an immediate but transient 
expression of phospho-p38 while low dose caused a steady incline in expression 
although these levels were low over the 120 min time period.  
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Figure 3.4 The effect of UV radiation on the expression of phospho-p38 protein in 
HaCaT cells. Cell cultures were irradiated with either a low or high UV dose of  
(A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins 
were extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of 
cell lysate was used to perform western blotting. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments. 
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †). [High dose UV (*); Low dose UV (†)]. 
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After exposure to low dose UVA+B, the level of phospho-p38 peaked at 15 min (155%) 
after which it gradually decreased reaching 133% at 120 min post-irradiation (Figure 
3.4C). High dose UVA+B radiation caused an immediate peak in phospho-p38 levels at 
5 min (514%) after which it fell to 393% at 30 min post-irradiation. These levels 
increased again at 60 min (423%) before declining to 142% at 120 min 
post-irradiation. The levels of phospho-p38 at 5 min following high dose UVA+B 
radiation was 359% higher than the maximal level induced by low dose radiation. 
 
In the case of low dose UVB+A, there was an increase in phospho-p38 levels at 5 min 
(193%) which dropped at 15 min (164%) post-irradiation (Figure 3.4D). These levels 
increased slightly to 199% at 30 min before falling to 159% at 120 min post-irradiation. 
After high dose UVB+A exposure, phospho-p38 levels increased rapidly to 571% at 5 
min, after which they rose to 711% at 60 min before falling to 315% at 120 min 
post-irradiation. The phospho-p38 expression was instant and prolonged after high dose 
UVB+A radiation in these cells.   
 
3.2.2.1.3 Colo16 cells 
In Colo16 cells, following low dose UVA exposure, phospho-p38 levels increased 
slightly to 121% at 5 min after which they remained constant over the next 115 min 
(Figure 3.5A). High dose UVA radiation caused a slightly higher peak in phospho-p38 
levels at 15 min (127%) after which the levels remained largely constant over the next 
105 min. Since both the low and high UVA doses had a similar pattern and minimal 
level of phospho-p38 expression, it suggests that UVA radiation alone does not activate 
this pathway in these cells.  
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Figure 3.5 The effect of UV radiation on the expression of phospho-p38 protein in 
Colo16 cells. Cell cultures were irradiated with either a low or high UV dose of  
(A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins 
were extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of 
cell lysate was used to perform western blotting. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments. 
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †). [High dose UV (*); Low dose UV (†)]. 
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In the case of the low dose UVB, the level of phospho-p38 increased to 131% at 15 min, 
then fell to 111% at 60 min and rose to 147% at 120 min post-irradiation (Figure 3.5B). 
After high dose UVB exposure, phospho-p38 levels peaked at 5 min (218%) and 
remained constant until 15 min (215%) before declining to 120% at 120 min 
post-irradiation. The expression of phospho-p38 was instantaneous but transient 
following high dose UVB radiation whereas that of low dose increased gradually over 
the 120 min time period.  
 
After low dose UVA+B exposure, phospho-p38 levels peaked at 5 min (151%) before 
slowly falling to 118% at 120 min post-irradiation (Figure 3.5C). High dose UVA+B 
radiation caused an immediate increase of phospho-p38 levels to 200% at 5 min which 
continued to rise to 440% at 30 min, before falling to 109% at 120 min post-irradiation. 
High dose UVA+B radiation induced an instant but transitory expression of phospho-38 
in these cells. 
 
Low dose UVB+A radiation caused a gradual increase in phospho-p38 levels which 
peaked at 30 min (205%) before falling to 120% at 120 min post-irradiation (Figure 
3.5D). After exposure to high dose UVB+A, phospho-p38 levels also peaked at 30 min 
(500%), after which they fell to 220% at 120 min post-irradiation. High dose UVB+A 
caused a greater expression of phospho-p38 than did low dose radiation. The  
phospho-p38 levels following high dose UVB+A was 295% higher than that seen for 
the lower dose radiation at 30 min post-irradiation.  
 
3.2.2.2 JNK pathway 
Similar to the p38 MAPK pathway, the JNK pathway is activated when the JNK protein 
is phosphorylated by upstream activators. Since the JNK1 and JNK2 isoforms are 
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predominantly activated in skin cells, the expression of both phospho-JNK1 and -JNK2 
was observed over the 120 min time period to indicate the activation of the JNK 
pathway following UV-irradiation in HEK, HaCaT and Colo16 cells [115]. In order to 
detect phospho-JNK1/2 protein, a polyclonal phospho-JNK1/2 antibody was utilised in 
western blots (Figure 3.6). The expression of UV-induced phospho-JNK1 (46 kDa) or  
-JNK2 (54 kDa) was calculated as a percentage of total phospho-JNK (JNK1 and JNK2) 
levels in sham-irradiated control (0 min) where phospho-JNK1 + -JNK2 = 100% 
(Appendix A.5). 
 
 
 
Figure 3.6 A representative western blot probed for phospho-JNK1/2 in (A) HEK,  
(B) HaCaT and (C) Colo16 cells. The samples from lanes 2 to 5 in blot (A) and lanes 2 
to 6 in blots (B & C) were exposed to low dose UVB radiation. The samples from lanes 
6 to 9 in blot (A) and lanes 7 to 11 in blots (B & C) were exposed to high dose UVB 
radiation. The lanes marked from 1 to 9 in blot (A) represents Lane 1: Sham-irradiated 
control, 2 & 6: 5 min, 3 & 7: 15 min, 4 & 8: 30 min, 5 & 9: 120 min post-irradiation. 
The lanes marked from 1 to 11 in blots (B & C) represents Lane 1: Sham-irradiated 
control, 2 & 7: 5 min, 3 & 8: 15 min, 4 & 9: 30 min, 5 & 10: 60 min, 6 & 11: 120 min 
post-irradiation.  
HEK 
HaCaT 
Colo16 
Phospho-JNK1 
β-Actin 
β-Actin 
β-Actin 
B 
C 
Phospho-JNK2 
Phospho-JNK1 
Phospho-JNK2 
Phospho-JNK1 
Phospho-JNK2 
1     2     3     4     5    6     7    8      9 
1   2    3   4    5   6    7   8    9  10   11 
1    2    3   4   5   6    7   8   9   10  11 
A 
 - 83 - 
3.2.2.2.1 HEK cells 
In HEK cells, following exposure to low dose UVA, phospho-JNK1 increased from 
44% (0 min) to 205% at 5 min, after which it fell to 99% at 30 min and remained 
constant over the next 90 min (Figure 3.7A). Phospho-JNK2 levels on the other hand 
remained constant over this 2 h period (56%-65%) following exposure to low dose 
UVA. After exposure to high dose UVA, phospho-JNK1 levels rose from 49% (0 min) 
to 200% at 15 min, after which they fell to 74% at 120 min post-irradiation. The 
phospho-JNK2 levels rose from 51% (0 min) to 107% at 30 min, after which they fell to 
55% at 120 min post-irradiation.  
 
Low dose UVB radiation induced a gradual increase in phospho-JNK1 levels from 53% 
(0 min) to 104% (30 min) before they fell to 69% at 120 min post-irradiation (Figure 
3.7B). The pattern of phospho-JNK2 expression was similar to that of phospho-JNK1 
but these levels (phospho-JNK2) were lower at 0 min (47%), peaking at 30 min (66%) 
post-irradiation. High dose UVB radiation caused an immediate increase in 
phospho-JNK1 levels from 0 min (52%) to 5 min (240%), after which they fell rapidly 
to 91% at 30 min before declining steadily to 59% at 120 min post-irradiation. The 
phospho-JNK2 levels were much lower than that of phospho-JNK1 between 0 min 
(48%) to 15 min (116%) after which the levels of both isoforms were the same until 120 
min post-irradiation.  The trend of activation of phospho-JNK1 after high dose UVB 
radiation was immediate and short-lived, unlike that seen for low dose radiation. 
 
After low dose UVA+B exposure, phospho-JNK1 levels increased from 53% (0 min) 
peaking at 5 min (213%), after which they fell to 109% at 15 min post-irradiation 
(Figure 3.7C). These levels increased again at 30 min (126%) before declining over the 
next 90 min. The phospho-JNK2 levels remained fairly constant over this 2 h period
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Figure 3.7 The effect of UV radiation on the expression of phospho-JNK1/2 protein in 
HEK cells. Cell cultures were irradiated with either a low or high UV dose of (A) UVA, 
(B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins were 
extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of cell 
lysate was used to perform western blotting. Results expressed as the means ± SD from 
triplicate samples. Data are representative of three independent experiments. 
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †, §, θ). [High dose UV: phospho-JNK1(*), -JNK2 (†); Low dose UV:  
phospho-JNK1(§), -JNK2 (θ)]. 
Legend:    (High Dose UV – phospho-JNK1)       (Low Dose UV – phospho-JNK1)               
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increasing from 47% (0 min) to 65% at 120 min. After high dose UVA+B exposure, 
phospho-JNK1 levels rose from 53% (0 min) peaking at 5 min (123%) before falling to 
60% at 120 min post-irradiation. The levels of phospho-JNK2 increased from 47% (0 
min) to 85% at 15 min before declining back to control levels by 120 min. High dose 
UVA+B induced a greater expression of phospho-JNK2 than did low dose radiation. 
The opposite was seen for phospho-JNK1 levels in cells exposed to high dose UVA+B 
radiation. 
 
In the case of low dose UVB+A exposure, phospho-JNK1 levels rose from 55% (0 min) 
peaking at 15 min (268%) before gradually falling to 91% at 120 min post-irradiation 
(Figure 3.7D). The phospho-JNK2 levels gradually increased from 45% (0 min) to 59% 
over the same period of time. High dose UVB+A radiation induced a rapid increase in 
phospho-JNK1 levels from 55% (0 min) to 175% at 5 min which were maintained until 
30 min (184%) after which they fell back towards control levels. The expression of 
phospho-JNK1 in the cells was immediate and sustained after high dose UVB+A 
radiation. The phospho-JNK2 levels rose from 45% (0 min) and peaking at 30 min 
(83%) before falling to 70% at 120 min following exposure to high dose UVB+A 
radiation.  
 
3.2.2.2.2 HaCaT cells 
In HaCaT cells, low dose UVA radiation increased the level of phospho-JNK1 from 
53% (0 min) peaking at 5 min (126%), before falling to 72% at 15 min and then 
remained constant for the next 105 min (Figure 3.8A). The phospho-JNK2 levels 
remained at control (47%) levels throughout the 120 min time period. After exposure to 
high dose UVA radiation, the phospho-JNK1 levels increased from 54% (0 min) to  
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Figure 3.8 The effect of UV radiation on the expression of phospho-JNK1/2 protein in 
HaCaT cells. Cell cultures were irradiated with either a low or high UV dose of  
(A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins 
were extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of 
cell lysate was used to perform western blotting. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †, §, θ). [High dose UV: phospho-JNK1(*), -JNK2 (†); Low dose UV:  
phospho-JNK1(§), -JNK2 (θ)]. 
Legend:    (High Dose UV – phospho-JNK1)       (Low Dose UV – phospho-JNK1)               
 (High Dose UV – phospho-JNK2)       (Low Dose UV – phospho-JNK2)               
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547% at 15 min and remained the same at 60 min (522%) before falling to 109% at 120 
min post-irradiation. The phospho-JNK2 levels rose from 46% (0 min) to 300% at 5 
min and remained constant until 60 min (360%) before declining to 81% at 120 min 
post-irradiation. 
 
Following exposure to low dose UVB radiation, there was a slight and short-lived 
activation of phospho-JNK1 but almost no activation was observed with phospho-JNK2 
(Figure 3.8B). The phospho-JNK1 levels rose from 47% to peak at 5 min (175%), after 
which it dropped gradually to 51% at 120 min post-irradiation. However, 
phospho-JNK2 levels remained unchanged (~53%) throughout this time period. High 
dose UVB radiation caused a gradual increase in phospho-JNK1 levels from 54% (0 
min) peaking at 30 min (239%), after which it fell to 68% at 120 min post-irradiation. In 
response to high dose UVB radiation, phospho-JNK2 levels increased gradually from 
46% (0 min) to 95% at 30 min (95%) before decreasing back to control levels (0 min). 
The expression of phospho-JNK2 was slightly higher following exposure to high dose 
UVB compared to that seen for low dose. 
 
In the case of low dose UVA+B radiation, phospho-JNK1 levels rose from 50% (0 min) 
to peak at 15 min (99%), before falling to 63% (30 min) and then remained constant for 
the next 90 min (Figure 3.8C). In these irradiated cells phospho-JNK2 levels were 
unchanged over this 120 min period. Following exposure to high dose UVA+B 
radiation, the phospho-JNK1 levels rose rapidly from 53% (0 min) to 665% (5 min) and 
then fell to 73% at 120 min post-irradiation. The phospho-JNK2 levels increased from 
47% (0 min) to 176% (5 min) and continued to rise to 229% at 30 min, after which they 
fell to control levels at 120 min post-irradiation. Low dose UVA+B radiation stimulated 
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an instantaneous and transient activation of the JNK pathway whereas high dose 
induced a prolonged activation.  
 
Low dose UVB+A radiation increased phospho-JNK1 levels from 58% (0 min) to 152% 
at 15 min, after which they returned to control levels by 120 min (Figure 3.8D). 
Phospho-JNK2 levels on the other hand gradually increased from 42% (0 min) to 70% 
at 60 min before returning to control levels by 120 min post-irradiation. In comparison 
to the low dose UVB+A radiation, phospho-JNK1 levels were higher in the cells 
following high dose UVB+A radiation. These levels rose from 58% (0 min) to 795% at 
30 min, before falling to 222% at 120 min post-irradiation. The pattern of  
phospho-JNK2 expression was similar to that of phospho-JNK1 in the cells when 
exposed to high dose UVB+A radiation. The phospho-JNK2 levels increased steadily 
from 42% (0 min) to 296% at 30 min before declining to 85% at 120 min  
post-irradiation. 
  
3.2.2.2.3 Colo16 cells 
Low dose UVA radiation increased phospho-JNK1 levels from 61% (0 min) to 351% at 
15 min, after which they decreased to 287% at 30 min before falling back to control 
levels (61%) at 120 min post-irradiation (Figure 3.9A). The level of phospho-JNK2 also 
increased from 39% (0 min) to 71% at 15 min before falling to control levels (39%) by 
120 min post-irradiation. Following exposure to high dose UVA radiation, 
phospho-JNK1 levels increased rapidly from 55% (0 min) to 558% at 5 min, after which 
it fell slightly to 495% at 15 min post-irradiation. The levels increased again to 641% at 
30 min before falling to 501% at 120 min post-irradiation. Phospho-JNK2 levels 
increased from 45% (0 min) to 436% at 30 min before falling to 374% at 120 min  
post-irradiation. The activation of JNK pathway was rapid and short-lived following  
 - 89 -  
* 
* 
* 
* 
† 
† 
† † 
§ § 
§ § 
θ 
 
θ 
 
Figure 3.9 The effect of UV radiation on the expression of phospho-JNK1/2 protein in 
Colo16 cells. Cell cultures were irradiated with either a low or high UV dose of  
(A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins 
were extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of 
cell lysate was used to perform western blotting. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †, §, θ). [High dose UV: phospho-JNK1(*), -JNK2 (†); Low dose UV:  
phospho-JNK1(§), -JNK2 (θ)]. 
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exposure to low dose UVA but it was more sustained than that seen for high dose 
radiation.  
 
Following exposure to low dose UVB, phospho-JNK1 levels increased from 65% 
(0 min) to a peak of 425% at 5 min, before they fell to 83% at 120 min post-irradiation 
(Figure 3.9B). Phospho-JNK2 levels were minimally activated compared to JNK1 and 
rose from 35% (0 min) to 107% at 15 min, before falling to 61% at 120 min  
post-irradiation. The maximum expression of phospho-JNK1 at 5 min was 318% greater 
than that of phospho-JNK2 at 15 min following exposure to low dose UVB radiation. 
High dose UVB radiation induced a steep increase in phospho-JNK1 levels from 55% 
(0 min) to a peak of 710% at 15 min, after which they gradually decreased to 379% at 
120 min post-irradiation. Phospho-JNK2 levels increased from 45% (0 min) to a peak of 
355% at 30 min before falling to 181% at 120 min post-irradiation. The pattern of 
activation of phospho-JNK1/2 was similar after high and low dose UVB radiation. 
 
Low dose UVA+B radiation increased phospho-JNK1 levels from 47% to 132% (15 
min), before they fell back to control levels at 120 min post-irradiation (Figure 3.9C). 
The phospho-JNK2 levels on the other hand were low and did not change over this time 
period. Following high dose UVA+B radiation, phospho-JNK1 levels increased from 
54% (0 min) to 599% (5 min), after which they fell to 520% by 30 min. Phospho-JNK1 
levels then rose to 1063% at 60 min before finally falling back to 488% at 120 min  
post-irradiation. Phospho-JNK2 levels also increased rapidly from 46% (0 min) to 
474% at 5 min and then rose to 740% by 60 min before falling to 183% at 120 min  
post-irradiation. Both phospho-JNK1 and JNK2 expression was prolonged at high levels 
after high dose UVA+B radiation when compared to low dose exposure.   
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Following exposure to low dose UVB+A radiation, phospho-JNK1 levels rose from 
60% (0 min) peaking at 30 min (465%) before falling to 190% at 120 min 
post-irradiation (Figure 3.9D). Phospho-JNK2 levels also gradually increased from 40% 
(0 min) to 172% at 60 min before falling to 87% at 120 min post-irradiation. Following 
high dose UVB+A radiation, phospho-JNK1 levels increased from 60% (0 min) to 
785% (30 min) before falling to 137% at 120 min post-irradiation. Phospho-JNK2 
levels also increased from 40% to peak at 30 min (398%), after which they fell back to 
control levels (40%) at 120 min post-irradiation. High dose UVB+A radiation induced a 
higher and more sustained activation of the JNK1 and JNK2 isoforms compared to that 
seen when these cells were exposed to low radiation.   
 
3.2.2.3 NFκB pathway 
The NFκB dimeric complex is freed when phospho-IκBα is phosphorylated and 
removed by the proteasome [137, 138]. The use of MG115 (proteasome inhibitor) 
prevents the degradation of phospho-IκBα thereby allowing its accumulation within the 
cell [188]. As such, the higher levels of phospho-IκBα present would indicate an 
increase in NFκB activation. Therefore, phospho-IκBα protein (41 kDa) was used to 
observe the activation of the NFκB pathway by using monoclonal phospho-IκBα 
antibody in western blots (Figure 3.10). The expression of phospho-IκBα was calculated 
as a ratio of UV-irradiated sample over sham-irradiated control (control = 100%). 
 
3.2.2.3.1 HEK cells 
In HEK cells, low dose UVA radiation increased phospho-IκBα levels from 100% (0 
min) to 201% at 5 min, after which it decreased gradually to 167% at 30 min 
before rising to 199% at 120 min post-irradiation (Figure 3.11A). High dose UVA 
exposure induced a higher level of phospho-IκBα in these cells than did low dose.  
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These levels increased from 100% (0 min) to 221% at 30 min before falling to 178% at 
120 min post-irradiation. After exposure to low dose UVB radiation, phospho-IκBα 
levels gradually increased from 100% (0 min) to 239% at 120 min post-irradiation 
(Figure 3.11B). In contrast, high dose UVB radiation caused an immediate induction of 
phospho-IκBα at 5 min (279%) which fell to 187% at 15 min and remained unchanged 
until 120 min post-irradiation. The activation of the NFκB pathway was sustained 
following low dose UVB radiation but was transient after high dose UVB exposure. 
 
Figure 3.10 A representative western blot probed for phospho-IκBα in (A) HEK,  
(B) HaCaT and (C) Colo16 cells. The samples from lanes 2 to 5 in blot (A) and lanes 2 
to 6 in blots (B & C) were exposed to low dose UVB radiation. The samples from lanes 
6 to 9 in blot (A) and lanes 7 to 11 in blots (B & C) were exposed to high dose UVB 
radiation. The lanes marked from 1 to 9 in blot (A) represents Lane 1: Sham-irradiated 
control, 2 & 6: 5 min, 3 & 7: 15 min, 4 & 8: 30 min, 5 & 9: 120 min post-irradiation. 
The lanes marked from 1 to 11 in blots (B & C) represents Lane 1: Sham-irradiated 
control, 2 & 7: 5 min, 3 & 8: 15 min, 4 & 9: 30 min, 5 & 10: 60 min, 6 & 11: 120 min 
post-irradiation.  
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Figure 3.11 The effect of UV radiation on the expression of phospho-IκBα protein in 
HEK cells. Cell cultures were irradiated with either a low or high UV dose of (A) UVA, 
(B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins were 
extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of cell 
lysate was used to perform western blotting. Results expressed as the means ± SD from 
triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †). [High dose UV (*); Low dose UV (†)]. 
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Following exposure to low dose UVA+B radiation, there was an increase in 
phospho-IκBα levels reaching a peak of 171% at 30 min, after which it fell to 139% at 
120 min post-irradiation (Figure 3.11C). After exposure to high dose UVA+B, there 
was an increase in phospho-IκBα levels reaching a peak of 197% at 15 min, which then 
fell to 156% at 30 min and remained constant for the next 90 min. High dose UVA+B 
induced phospho-IκBα levels to a peak of 197% at 15 min which was earlier than that 
induced by low dose radiation (171% at 30 min). 
 
Low dose UVB+A radiation caused an increase in phospho-IκBα levels which peaked at  
15 min (156%), before falling to 114% at 120 min post-irradiation (Figure 3.11D). High 
dose UVB+A radiation induced a peak in phospho-IκBα levels at 5 min (230%), after 
which they fell to 112% at 120 min post-irradiation. The expression of phospho-IκBα 
was rapid and transient following exposure to high dose UVB+A radiation than to low 
dose. 
 
3.2.2.3.2 HaCaT cells 
In HaCaT cells, following exposure to low dose UVA, phospho-IκBα levels peaked at 5 
min (216%) then fell to 126% at 60 min before rising up to 182% at 120 min  
post-irradiation (Figure 3.12A). Following high dose UVA radiation, phospho-IκBα 
levels immediately fell below control levels (100%) at 5 min (52%) before recovering 
and increasing to 127% at 120 min post-irradiation. Low dose UVA induced a higher 
expression of phospho-IκBα than did high dose radiation. 
 
Low dose UVB radiation increased phospho-IκBα levels at 5 min (140%) which 
remained relatively constant over the next 115 min (Figure 3.12B). Cellular expression 
of phospho-IκBα levels was lower following exposure to high dose UVB radiation 
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Figure 3.12 The effect of UV radiation on the expression of phospho-IκBα protein in 
HaCaT cells. Cell cultures were irradiated with either a low or high UV dose of  
(A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins 
were extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of 
cell lysate was used to perform western blotting. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †). [High dose UV (*); Low dose UV (†)]. 
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where there was slight increase in phospho-IκBα levels from 100% (0 min) to 128% at 
5 min, after which it fell to 82% at 30 min and then remained constant over the next 90 
min.  
 
Following exposure to low dose UVA+B, there was an immediate increase in 
phospho-IκBα levels from 100% (0 min) to 210% at 5 min post-irradiation (Figure 
3.12C). These levels fell steadily to 128% at 60 min but increased to 160% at 120 min 
post-irradiation. After exposure to high dose UVA+B, phospho-IκBα expression was 
lower than control levels (100%) at 5 min (48%) and remained constant until 60 min 
(47%), after which it rose to 153% at 120 min post-irradiation. 
 
Low dose UVB+A radiation stimulated minimal expression of phospho-IκBα (Figure 
3.12D). These levels were low at 117% (5 min) which dropped gradually to 98% at 120 
min post-irradiation. A similar result was seen following high dose UVB+A exposure, 
where phospho-IκBα levels fell slightly to 92% (5 min), after which it increased to 
101% at 15 min before steadily declining to 76% at 120 min post-irradiation.  
 
3.2.2.3.3 Colo16 cells 
In Colo16 cells, low dose UVA exposure caused a drop in phospho-IκBα levels from 
100% (0 min) to 73% at 5 min, after which it gradually increased to 120% at 120 min 
post-irradiation (Figure 3.13A). Following exposure to high dose UVA, the levels of 
phospho-IκBα decreased from control levels (100%) to 45% (5 min) which decreased 
further at 30 min (35%) post-irradiation. These levels then increased to 122% at 120 
min post-irradiation. Low and high dose UVA induced a similar pattern of  
phospho-IκBα expression which showed an increase in expression between 60 to 120 
min post-irradiation. 
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Figure 3.13 The effect of UV radiation on the expression of phospho-IκBα protein in 
Colo16 cells. Cell cultures were irradiated with either a low or high UV dose of  
(A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins 
were extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of 
cell lysate was used to perform western blotting. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †). [High dose UV (*); Low dose UV (†)]. 
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Low dose UVB radiation increased phospho-IκBα levels from 100% (0 min) to 150% at 
120 min post-irradiation (Figure 3.13B). In the case of high dose UVB, phospho-IκBα 
levels remained below control levels (100%) throughout this time period. The levels 
initially dropped to 87% at 5 min and remained fairly constant over the next 115 min 
reaching 89% at 120 min post-irradiation. Low dose UVB was shown to stimulate 
higher levels of phospho-IκBα in the cell than did high dose radiation. 
 
Following exposure to low dose UVA+B radiation, phospho-IκBα levels dropped 
slightly from 100% (0 min) to 92% (5 min) and then remained constant over the next 10 
min, before increasing to 165% at 120 min post-irradiation (Figure 3.13C). High dose 
UVA+B radiation caused a rapid decrease in phospho-IκBα levels below that of control 
levels (100%), falling to 25% at 30 min before recovering to 99% at 120 min  
post-irradiation. High and low UVA+B radiation both seemed to induce a late phase 
activation of the NFκB pathway in these cells. 
 
Low dose UVB+A caused phospho-IκBα levels to drop below control levels (100%) at 
5 min (74%), after which they rose to 101% (30 min), before falling to 75% at 60 min 
and then rising to 119% at 120 min post-irradiation (Figure 3.13D). High dose UVB+A 
caused phospho-IκBα levels to increase to 123% at 15 min, after which it steadily 
declined to 77% at 120 min post-irradiation. Only high dose UVB+A induced an 
immediate stimulation of phospho-IκBα levels in these cells unlike that seen for low 
dose radiation. 
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3.2.3 The effect of UV radiation and IL1α on TNFα release in 
keratinocyte-derived cells  
The effect of UV radiation on TNFα release in HEK, HaCaT and Colo16 cells were 
measured 24 h post-irradiation using ELISA. In this study only high dose UV radiation 
was used as the low dose UV did not stimulate detectable amounts of TNFα in 
irradiated media samples (result not shown). There were two treatment groups in this 
study. In group (1) the cell cultures received high dose UV radiation (UVA, UVB, 
UVA+B or UVB+A) and in group (2) the cell cultures received high dose UV radiation 
plus IL1α (10 ng/ml) added immediately post-exposure. Bashir et al. [164] found that 
IL1α upregulated TNFα levels via increased gene transcription following UVB radiation 
in keratinocytes [164]. Moreover, it has been shown that keratinocytes within the skin 
can produce IL1α in response to UV radiation [189]. Therefore, the addition of 
exogenous IL1α may simulate a similar situation in an in vitro study.  
 
The level of TNFα secreted from sham-irradiated HEK cells was only 35 pg/mg cell 
protein. This value increased in UV-irradiated cells irrespective of the type of UV used 
(UVA: 331 pg/mg, UVB: 1296 pg/mg, UVA+B: 1448 pg/mg and UVB+A: 1549 
pg/mg) (Figure 3.14A). When the sham-irradiated HEK cells were treated with IL1α, 
there was an increase in the level of TNFα (317 pg/mg) released into the medium over 
24 h. However, in the UV-irradiated cells that had been treated with IL1α, there was a 
much greater increase in the level of TNFα secreted from the cells (UVA+IL1α: 942 
pg/mg, UVB+IL1α: 2861 pg/mg, UVA+B+IL1α: 2733 pg/mg and UVB+A+IL1α: 2918 
pg/mg) over the same period. Higher levels of TNFα were seen in cells exposed to UVB 
compared to UVA radiation. The levels of TNFα released after UVA+B- or  
UVB+A-irradiated cells were similar to that seen for cells only exposed to UVB 
radiation. 
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Figure 3.14 The effect of high dose UV radiation and IL1α on TNFα release in  
(A) HEK, (B) HaCaT and (C) Colo16 cells. Cell cultures were UV-irradiated with a 
high dose and treated with or without 10 ng/ml of IL1α. The media was collected 24 h  
post-irradiation and assayed for TNFα using an AccuKine Human TNFα ELISA Kit. 
Results expressed as the means ± SD from triplicate samples. Data are representative of 
three independent experiments. Statistical analysis was performed using a Student’s 
paired t-test where significance was recorded as p ≤ 0.05. (*) Significant difference 
between Control and UV-irradiated sample (with and without IL1α). (†) Significant 
difference between (Control + IL1α) and UV-irradiated sample (with IL1α). 
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The levels of TNFα shed from sham-irradiated HaCaT cells over 24 h were below the 
level of detection (0 pg/mg). There was a slight increase in TNFα levels released from 
those cells exposed to UV radiation except for UVA-irradiated cells (UVA: 0 pg/mg, 
UVB: 3 pg/mg, UVA+B: 7 pg/mg and UVB+A: 6 pg/mg) (Figure 3.14B). TNFα levels 
in in the media of the sham-and UVA-irradiated HaCaT cells were also undetectable (0 
pg/mg) when the cells were treated with IL1α. However, TNFα levels were significantly 
elevated in irradiated cells treated with IL1α (UVB+IL1α: 57 pg/mg, UVA+B+IL1α: 63 
pg/mg and UVB+A+IL1α: 33 pg/mg). UVA+B induced similar levels of TNFα as seen 
in UVB-irradiated cells. However, they were lower (33%) when the cells were exposed 
to UVB before UVA radiation.  
 
Like those seen in HaCaT cells, the levels of TNFα were undetectable (0 pg/mg) in the 
media of sham- and UVA-irradiated Colo16 cells. However, these levels increased 
when the cells were exposed to UVB, with or without UVA (UVB: 82 pg/mg, UVA+B: 
91 pg/mg and UVB+A: 53 pg/mg) (Figure 3.14C). IL1α did not enhance the levels of 
TNFα released from sham- and UVA-irradiated cells (0 pg/mg). However, when 
exposed to the other UV types, IL1α treatment increased the level of TNFα secreted 
from these cells (UVB+IL1α: 402 pg/mg, UVA+B+IL1α: 415 pg/mg and 
UVB+A+IL1α: 169 pg/mg). UVB and UVA+B radiation induced similar levels of 
TNFα released from Colo16 cells which was higher than that seen in UVA-irradiated 
cells. However, when the cells were irradiated with UVB before UVA, the level of 
TNFα released from IL1α treated cells fell (169%) when compared to UVB-irradiated 
cells.  
 
HEK cells shed the highest levels of TNFα following exposure to UV radiation while 
HaCaT cells released the lowest (Figure 3.14). In HEK cells, irrespective of treatment 
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with or without IL1α, TNFα release was observed following UVA radiation which was 
not observed in either HaCaT or Colo16 cells. Although HEK cells released the highest 
amount of TNFα, the relative effect of IL1α on augmenting TNFα levels in HaCaT cells 
was greater (Table 3.1). UVB radiation induced maximal increase in TNFα levels in 
these cells in the presence of IL1α compared to the other UV types. Moreover, IL1α had 
the greatest effect in augmenting TNFα levels in HaCaT followed by Colo16 and HEK 
cells, the reasons for which are not clear.   
 
 
 
 
3.2.4 The effect of UV radiation and IL1α on the activation of the p38 
MAPK, JNK and NFκB pathways in keratinocyte-derived cells 
In section 3.2.3, IL1α was shown to enhance the release of TNFα from UV-irradiated 
keratinocyte-derived cells. It may enhance the release of TNFα from these cells by 
regulating the cell signalling pathways. As a result, the activation of p38 MAPK, JNK 
and NFκB pathways was investigated following UV radiation and IL1α (10 ng/ml) 
treatment in HEK, HaCaT and Colo16 cells. These cells were exposed to high doses of 
UVA, UVB, UVA+B or UVB+A radiation (Table 2.1) and of IL1α (10 ng/ml) was 
Cell Line Sham UVA UVB UVA+B UVB+A 
HEK 9.1 2.8 2.2 1.9 1.9 
HaCaT ND ND 16.2 8.9 6.1 
Colo16 ND ND 4.9 4.6 3.2 
Table 3.1 Effect of IL1α on the release of TNFα from UV-irradiated  
keratinocyte-derived cell line. 
All values are calculated as the fold increase of irradiated cell treated with 
IL1α compared to their corresponding irradiated counterparts. (ND) Not 
determined as one or more values were below detectable levels.  
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added immediately post-irradiation. Once irradiated, the cell cultures were left to 
incubate at various time points and cell protein lysates were extracted at the end of these 
time points to perform western blots (Section 2.7). The phospho-p38 and JNK1 
expression was observed from 5-30 min while that of phospho-IκBα was observed at 
120 min post-irradiation as earlier studies showed that expression of these proteins was 
mostly maximal at these time points (Figures 3.3-3.5, 3.7-3.9, 3.11-3.13 ).  
 
3.2.4.1 p38 MAPK pathway 
The polyclonal phospho-p38 MAPK antibody was used to probe for phospho-p38 
MAPK protein on the western blots (Figure 3.15). The expression of the phospho-p38 
was calculated as a ratio of UV-irradiated sample over sham-irradiated control (control 
= 100%).  
Figure 3.15 A representative western blot probed for phospho-p38 MAPK in (A) HEK, 
(B) HaCaT and (C) Colo16 cells exposed to high dose UVB radiation with IL1α 
treatment. The samples from lanes 4-6 and 10-12 in blots (A-C) were treated with 10 
ng/ml IL1α in sham-irradiated control (lanes 1-6) or after high dose UVB radiation 
(lanes 7-12). The lanes marked from 1 to 12 in blots (A-C) represents Lane 1 & 4: 5 
min, 2 & 5: 15 min, 3 & 6: 30 min after treatment in sham-irradiated control, 7 & 10: 5 
min, 8 & 11: 15 min, 9 & 12: 30 min post-irradiation with or without IL1α treatment.  
Colo16 
Phospho-p38 
β-Actin 
Phospho-p38 
β-Actin 
Phospho-p38 
β-Actin 
A 
B 
C 
 
  1     2    3    4    5    6     7    8   9   10  11  12 
HaCaT 
HEK 
Control High Dose UVB 
  
 
- 104 - 
The level of phospho-p38 MAPK in sham-irradiated cells remained fairly constant in all 
three cell lines over a 30 min period as seen in Figure 3.16A. In Figure 3.17 the effect of 
IL1α on phospho-p38 levels in irradiated cells (HEK, HaCaT and Colo16) from 5 to 30 
min post-irradiation is seen. For reasons of clarity, it was decided to assign each  
sham-irradiated (control) time point (5, 15 and 30 min) a value of 100% (Figure 3.17). 
It can be seen from Figure 3.16A that the level of phospho-p38 over these time points 
were similar to each other, as well as to the 0 min control. Therefore, by assigning the 
value of 100% to these control time points (5, 15 and 30 min), the effects elicited by UV 
radiation and/or IL1α can be evaluated.  
 
 
Figure 3.16 The change in (A) phospho-p38, phospho-JNK1 and (B) phospho-IκB 
expression over time (5, 15, 30 & 120 min) in sham-irradiated HEK, HaCaT and Colo16 
cells. Results expressed as the means ± SD from triplicate samples. Data are 
representative of three independent experiments. 
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3.2.4.1.1 HEK cells 
In HEK cells, phospho-p38 levels were represented as 100% from 5 min to 30 min in 
sham-irradiated control (Figure 3.17A). The addition of IL1α caused a small but 
significant increase in the levels of phopsho-p38 in sham-irradiated control over this 30 
min time period (5, 15 and 30 min). Phospho-p38 levels were highest in sham-irradiated 
control at 15 min (154%) following the addition of IL1α.  
 
Following exposure to UVA radiation, there was a time-dependent decrease in the level 
of phospho-p38 from 5 min (271%) to 30 min (163%) post-irradiation (Figure 3.17A). 
The addition of IL1α to UVA-irradiated cells caused a decrease in phospho-p38 levels 
at 5 min (155%) which was significantly lower than that of UVA alone whereas that at 
15 min (310%) and 30 (226%) min post-irradiation the levels were significantly higher.  
 
After exposure to UVB radiation, phospho-p38 levels were the same at 5 min (309%) 
and 15 min, after which it fell to 224% at 30 min post-irradiation (Figure 3.17A). 
Phospho-p38 levels in UVB-irradiated cells treated with IL1α were similar to those 
exposed to only UVB radiation at 5 min but at 30 min (294%) they were significantly 
higher. 
  
In the case of UVA+B radiation, phospho-p38 levels peaked at 15 min (374%) before 
falling to 298% at 30 min post-irradiation (Figure 3.17A). When IL1α was added to the 
UVA+B-irradiated cells, phospho-p38 levels were significantly lower than that of cells 
exposed to UVA+B alone over this 30 min time period.  
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Figure 3.17 The effect of IL1α on the expression of phospho-p38 protein in (A) HEK, 
(B) HaCaT and (C) Colo16 cells after exposure to high dose UV radiation. Cell cultures 
were exposed to a high dose UV radiation and treated with or without 10 ng/ml of IL1α. 
Results expressed as the means ± SD from triplicate samples. Data are representative of 
three independent experiments. Comparisons were made between untreated sample and 
IL1α-treated sample using Student’s paired t-test where significance was recorded as p ≤ 
0.05 (*).  
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UVB+A radiation increased phospho-p38 levels from 5 min (315%) to 15 min (371%) 
and remained unchanged at 30 min (363%) post-irradiation (Figure 3.17A). In  
UVB+A-irradiated cells treated with IL1α, phospho-p38 levels were similar to those 
exposed to only UVB+A radiation except at 15 min (532%) where they were 
significantly higher.  
 
3.2.4.1.2 HaCaT cells 
In HaCaT cells, phospho-p38 levels were represented as 100% from 5 min to 30 min in 
sham-irradiated control (Figure 3.17B). The addition of IL1α caused a significant 
increase in these levels at the time points (5, 15 and 30 min) examined. Phospho-p38 
levels were highest in the sham-irradiated controls at 15 min (157%) following the 
addition of IL1α. 
 
UVA radiation increased phospho-p38 in a time-dependent manner from 5 min (380%) 
to 30 min (481%) post-irradiation (Figure 3.17B). Phospho-p38 levels in  
UVA-irradiated cells treated with IL1α were higher than those for UVA alone where 
only the 5 min (492%) and 15 min (679%) values were significant.  
 
After exposure to UVB radiation, there was a time-dependent decrease in the levels of 
phospho-p38 from 5 min (636%) to 30 min (275%) post-irradiation (Figure 3.17B). In 
UVB-irradiated cells treated with IL1α, although phospho-p38 levels increased at 5 min, 
they were only significantly higher than that of UVB alone at 15 min (447%) and 30 
min (481%) post-irradiation when compared to that seen for UVB alone. 
 
In the case of UVA+B radiation, phospho-p38 levels decreased from 5 min (525%) to 
30 min (388%) post-irradiation (Figure 3.17B). The addition of IL1α to  
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UVA+B-irradiated cells saw a similar time dependent decrease in phospho-p38 levels 
from 5 min (903%) to 30 min (529%) post-irradiation. However, when compared to 
those exposed to only UVA+B radiation, these levels were significantly higher at all 
time points. 
 
UVB+A radiation induced a time-dependent increase in the levels of phospho-p38 from 
5 min (574%) to 30 min (735%) post-irradiation (Figure 3.17B). In UVB+A-irradiated 
cells treated with IL1α, phospho-p38 levels were significantly higher than that of 
UVB+A alone from 5 min (668%) to 30 min (877%) post-irradiation. 
 
3.2.4.1.3 Colo16 cells 
In Colo16 cells, phospho-p38 levels were represented as 100% from 5 min to 30 min in 
sham-irradiated controls (Figure 3.17C). The addition of IL1α to sham-irradiated 
controls did not have a significant effect on phospho-p38 levels over the 30 min the 
time period.  
 
After exposure to UVA radiation, the level of phospho-p38 was slightly elevated to that 
seen in sham-irradiated cells (Figure 3.17C). The addition of IL1α to UVA-irradiated 
cells caused an increase in phospho-p38 levels at all time points. These levels were 
significantly higher only at 15 min (176%) and 30 min (173%) time points.  
 
In UVB-irradiated cells, the levels of phospho-p38 increased from 221% (5 min) to 
231% at 15 min before falling to 143% at 30 min post-irradiation (Figure 3.17C). 
Phospho-p38 levels in UVB-irradiated cells treated with IL1α decreased in a  
time-dependent manner from 5 to 30 min but these levels were only significantly lower 
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than that of cells exposed to UVB alone at the 5 min (162%) and 15 min (155%) time 
points. 
 
UVA+B radiation increased phospho-p38 levels in a time-dependent fashion from 5 min 
(233%) to 30 min (457%) post-irradiation (Figure 3.17C). The addition of IL1α to 
UVA+B-irradiated cells induced a significant decrease in phospho-p38 levels at 5 min 
(197%) and 15 min (280%) but was significantly higher at 30 min (580%)  
post-irradiation compared to the UVA+B irradiated cells.  
 
After exposure to UVB+A radiation, the levels of phospho-p38 increased from 5 min 
(367%) to 30 min (491%) post-irradiation (Figure 3.17C). The addition of IL1α to 
UVB+A-irradiated cells caused a time-dependent increase in phospho-p38 levels but 
these levels were only significantly higher at 15 min (474%) and 30 min (537%)  
time points.  
 
3.2.4.2 JNK pathway 
The polyclonal phospho-JNK1/2 antibody was used to probe for phospho-JNK1 protein 
on western blots (Figure 3.18). In this part of the study, the expression of  
phospho-JNK1 was taken into account as earlier experiments showed that  
phospho-JNK2 protein was mostly expressed in low levels in HEK, HaCaT and Colo16 
cells (Figures 3.7-3.9). Although phospho-JNK1 expression was only observed in this 
section, the levels of UV-induced phospho-JNK1 was calculated as a percentage of total 
phospho-JNK1 and -JNK2 in sham-irradiated control to maintain consistency with 
calculations performed in section 3.2.2.2 (Appendix A.5). Therefore, as seen in Figure 
3.16A, at 0 min the level of phospho-JNK1 was 61%, 60% and 59% for sham-irradiated 
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HEK, HaCaT and Colo16 cells, respectively and these levels were similar to those at 5, 
15 and 30 min.  
 
 
 
3.2.4.2.1 HEK cells 
In HEK cells, phospho-JNK1 levels in sham-irradiated controls were 55%, 57% and 
52% at 5, 15 and 30 min, respectively (Figure 3.19A). The addition of IL1α caused a 
significant increase in these levels at the time points (5, 15 and 30 min)
Figure 3.18 A representative western blot probed for phospho-JNK1 in (A) HEK,  
(B) HaCaT and (C) Colo16 cells exposed to high dose UVB radiation with IL1α 
treatment. The samples from lanes 4-6 and 10-12 in blots (A-C) were treated with 10 
ng/ml IL1α in sham-irradiated control (lanes 1-6) or after high dose UVB radiation 
(lanes 7-12). The lanes marked from 1 to 12 in blots (A-C) represents Lane 1 & 4: 5 
min, 2 & 5: 15 min, 3 & 6: 30 min after treatment in sham-irradiated control, 7 & 10: 5 
min, 8 & 11: 15 min, 9 & 12: 30 min post-irradiation with or without IL1α treatment.  
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Figure 3.19 The effect of IL1α on the expression of phospho-JNK1 protein in (A) HEK, 
(B) HaCaT and (C) Colo16 cells after exposure to high dose UV radiation. Cell cultures 
were exposed to a high dose UV radiation and treated with or without 10 ng/ml of IL1α. 
Results expressed as the means ± SD from triplicate samples. Data are representative of 
three independent experiments.  Comparisons were made between untreated sample and 
IL1α-treated sample using Student’s paired t-test where significance was recorded as p ≤ 
0.05 (*).  
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examined here. These levels were highest in sham-irradiated control at 15 min (90%) 
following the addition of IL1α. 
 
After exposure to UVA radiation, phospho-JNK1 levels peaked at 15 min (186%) 
before falling to 126% at 30 min post-irradiation (Figure 3.19A). The addition of IL1α 
to UVA-irradiated cells only caused a significant increase in phospho-JNK1 levels at 30 
min (183%) post-irradiation when compared to the UVA-irradiated cells. 
 
In response to UVB radiation, there was a time-dependent decrease in phospho-JNK1 
levels from 5 min (213%) to 30 min (107%) post-irradiation (Figure 3.19A). When IL1α 
was added to UVB-irradiated cells there was a time-dependent decrease in  
phospho-JNK1 levels from 5 to 30 min but the levels were only significant at the 15 
min (181%) and 30 min (177%) time points.    
 
In UVA+B-irradiated cells, phospho-JNK1 levels decreased in a time dependent manner 
from 5 min (132%) to 30 min (98%) post-irradiation (Figure 3.19A). The addition of 
IL1α to UVA+B-irradiated cells had no significant effect on phospho-JNK1 from 5 min 
(124%) to 30 min (108%) post-irradiation.  
 
After exposure to UVB+A radiation, phospho-JNK1 levels increased to 186% at 5 min 
after which it remained fairly constant until 30 min (194%) post-irradiation (Figure 
3.19A). In UVB+A-irradiated cell treated with IL1α, phospho-JNK1 levels remained 
fairly constant between 5 min (187%) and 30 min (204%) and was similar to that seen 
for UVB+A-irradiated cells post-irradiation.  
 
 
  
 
- 113 - 
3.2.4.2.2 HaCaT cells 
In HaCaT cells, phospho-JNK1 levels in sham-irradiated controls were 56%, 63% and 
64% at 5 min, 15 min and 30 min, respectively (Figure 3.19C). The addition of IL1α 
resulted in higher phospho-JNK1 levels but they were only significant at the 5 min 
(92%) and 30 min (91%) time points.  
 
After exposure to UVA radiation, phospho-JNK1 levels peaked at 15 min (560%) 
before falling to 415% at 30 min post-irradiation (Figure 3.19B). The addition of IL1α 
to UVA-irradiated cells caused a gradual increase in phospho-JNK1 levels from 5 min 
(600%) to 30 min (686%) post-irradiation which were all significantly higher than that 
stimulated by UVA alone.  
 
UVB radiation caused a time-dependent increase in phospho-JNK1 levels from 5 min 
(137%) to 30 min (268%) post-irradiation (Figure 3.19B). In UVB-irradiated cells 
treated with IL1α, phospho-JNK1 levels were elevated with those at 15 min (348%) and 
30 min (452%) which were significantly higher than those seen for UVB alone.  
 
In UVA+B-irradiated cells, phospho-JNK1 levels decreased from 5 min (676%) to 30 
min (443%) post-irradiation (Figure 3.19B). The addition of IL1α to irradiated cells 
induced a peak of phospho-JNK1 at 5 min (942%) before declining at 30 min (798%) 
post-irradiation and the levels were significantly higher than that of UVA+B alone at 
these time points.   
 
Following exposure to UVB+A radiation, phospho-JNK1 levels increased in a time 
dependent manner over the 30 min (793%) time period (Figure 3.19B). In  
UVB+A-irradiated cells treated with IL1α, phospho-JNK1 levels were significantly 
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increased at 15 min (905%) and 30 min (975%) post-irradiation compared to cells 
exposed to UVB+A alone. 
 
3.2.4.2.3 Colo16 cells 
In Colo16 cells, phospho-JNK1 levels in sham-irradiated controls were 52%, 57% and 
61% at 5 min, 15 min and 30 min, respectively (Figure 3.19C). The addition of IL1α 
caused a significant increase in these levels at the time points (5, 15 and 30 min) 
examined. The levels were highest in sham-irradiated control at 15 min (80%) following 
the addition of IL1α. 
 
After exposure to UVA radiation, phospho-JNK1 levels increased to 573% at 5 min 
after which it fell to 481% at 15 min before rising to 667% at 30 min post-irradiation 
(Figure 3.19C). In UVA-irradiated cells treated with IL1α, phospho-JNK1 levels were 
similar to the irradiated cells, except at 30 min (593%) where it was significantly lower. 
 
UVB radiation induced an increase in phospho-JNK1 levels to 168% at 5 min which 
continued to rise to 700% at 15 min before falling to 678% at 30 min  
post-irradiation (Figure 3.19C). The addition of IL1α to UVB-irradiated cells 
significantly increased phospho-JNK1 levels at 15 min (742%) and 30 min (773%)  
post-irradiation than that of cells exposed to UVB alone.  
 
Following exposure to UVA+B radiation, the levels of phospho-JNK1 decreased from 5 
min (600%) to 30 min (517%) post-irradiation (Figure 3.19C). The addition of IL1α to 
UVA+B-irradiated cells induced similar levels of phospho-JNK1 to those exposed to 
UVA+B alone except at 15 min (554%) where the level was significantly lower.  
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UVB+A radiation increased phospho-JNK1 levels in a time dependent manner from 5 
min (301%) to 30 min (793%) post-irradiation (Figure 3.19C). When IL1α was added to 
UVB+A-irradiated cells, the levels of phospho-JNK1 were similar at 5 and 15 min 
except at 30 min (678%) where it was significantly lower.  
 
3.2.4.3 NFκB pathway 
The monoclonal phospho-IκBα antibody was used to probe for phospho-IκBα protein 
on western blots (Figure 3.20). The expression of the phospho-IκBα at 120 min  
post-irradiation was calculated as a ratio of UV-irradiated sample over sham-irradiated 
controls (control = 100%). The level of phospho-IκBα in sham-irradiated cells at 120 
min was similar to that seen at 0 min (Figure 3.16B). In Figure 3.21 the effect of IL1α 
on phospho-IκBα levels in irradiated cells (HEK, HaCaT and Colo16) at 120 min  
post-irradiation is seen. For reasons of clarity, it was decided to assign the  
sham-irradiated (control) at 120 min a value of 100% (Figure 3.21). Therefore, by 
assigning the value of 100%, the effects elicited by UV radiation and/or IL1α can be 
evaluated.  
 
3.2.4.3.1 HEK cells 
In HEK cells, the level of phospho-IκBα was expressed as 100% at 120 min in  
sham-irradiated control (Figure 3.21A). The addition of IL1α caused a slight increase in 
this level in sham-irradiated control (123%).  
 
After exposure to UVA radiation, phospho-IκBα levels increased to 184% at 120 min 
post-irradiation (Figure 3.21A). When IL1α was added to UVA-irradiated cells, there 
was a significant decrease in phospho-IκBα levels (172%) when compared to that of 
UVA alone.  
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UVB radiation increased the levels of phospho-IκBα to 195% at 120 min 
post-irradiation (Figure 3.21A). The addition of IL1α to UVB-irradiated cells caused a 
significant decrease in phospho-IκBα levels (175%) when compared to that of UVB 
alone. 
 
Following exposure to UVA+B radiation, phospho-IκBα levels rose to 162% at 120 min 
post-irradiation (Figure 3.21A). In UVA+B-irradiated cells treated with IL1α, 
phospho-IκBα levels (172%) were significantly higher than those exposed to only 
UVA+B.  
Figure 3.20 A representative western blot probed for phospho-IκBα in (A) HEK,  
(B) HaCaT and (C) Colo16 cells exposed to high dose UVB radiation with IL1α 
treatment. The samples from lanes 2 & 4 in blots (A-C) were treated with 10 ng/ml IL1α 
in sham-irradiated control (lanes 1 & 2) or after high dose UVB radiation (lanes 3 & 4). 
The lanes marked from 1 to 4 in blots (A-C) represents Lane 1 & 2: 120 min after 
treatment in sham-irradiated control, 3 & 4: 120 min post-irradiation with or without 
IL1α treatment.  
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Figure 3.21 The effect of IL1α on the expression of phospho-IκBα protein in (A) HEK, 
(B) HaCaT and (C) Colo16 cells at 120 min following exposure to high dose UV 
radiation. Cell cultures were exposed to a high dose UV radiation and treated with or 
without 10 ng/ml of IL1α. Results expressed as the means ± SD from triplicate samples. 
Data are representative of three independent experiments.  Comparisons were made 
between untreated sample and IL1α-treated sample using Student’s paired t-test where 
significance was recorded as p ≤ 0.05 (*).  
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In UVB+A-irradiated cells, phospho-IκBα levels rose to 121% at 120 min 
post-irradiation (Figure 3.21A). The addition of IL1α to UVB+A-irradiated cells 
slightly elevated phospho-IκBα levels (137%) but this was not significant. 
 
3.2.4.3.2 HaCaT cells 
In HaCaT cells, the level of phospho-IκBα was expressed as 100% at 120 min in  
sham-irradiated control (Figure 3.21B). The addition of IL1α caused a significant 
increase in these levels (135%) when compared to the sham-irradiated controls.  
 
UVA radiation increased phospho-IκBα levels to 130% at 120 min post-irradiation 
(Figure 3.21B). The addition of IL1α to UVA-irradiated cells did not have a significant 
effect on phospho-IκBα levels at this time point 121%. 
 
In UVB radiation-irradiated cells, the levels of phospho-IκBα decreased below control 
levels (100%) to 93% at 120 min post-irradiation (Figure 3.21B). Phospho-IκBα levels 
after addition of IL1α to irradiated cells was significantly higher (90%) than those 
exposed to only UVB radiation. 
 
After exposure to UVA+B radiation, the levels of phospho-IκBα rose to 151% at 120 
min post-irradiation (Figure 3.21B). In UVA+B-irradiated cells treated with IL1α, 
phospho-IκBα levels were significantly higher (213%) than that induced by UVA+B 
alone.   
 
UVB+A radiation caused the levels of phospho-IκBα to remain the same as control 
levels (100%) at 120 min (101%) post-irradiation (Figure 3.21B). The addition of IL1α 
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to irradiated cells increased the phospho-IκBα levels (152%) but this was not 
significant. 
 
3.2.4.3.3 Colo16 cells 
In Colo16 cells, the level of phospho-IκBα was expressed as 100% at 120 min in  
sham-irradiated controls (Figure 3.21C). The addition of IL1α significantly increased 
these levels (154%) when compared to only the sham-irradiated controls.  
 
Following exposure to UVA radiation, phospho-IκBα levels increased to 138% at 120 
min post-irradiation (Figure 3.21C). The addition of IL1α to UVA-irradiated cells 
significantly reduced these levels (124%) below that seen in UVA-irradiate cells.   
 
In the case of UVB radiation, the levels of phospho-IκBα decreased below control 
levels (100%) to 90% at 120 min post-irradiation (Figure 3.21C). The addition of IL1α 
to UVB-irradiated cells did not have a significant effect on phospho-IκBα levels (83%).  
 
After exposure to UVA+B radiation, phospho-IκBα levels remained the same as control 
levels (100%) at 120 min (105%) post-irradiation (Figure 3.21C). In UVA+B-irradiated 
cells treated with IL1α, phospho-IκBα levels were significantly higher (132%) than that 
of cells exposed to only UVA+B radiation.   
 
In UVB+A-irradiated cells, the levels of phospho-IκBα fell below control levels (100%) 
at 120 min (84%) post-irradiation (Figure 3.21C). The addition of IL1α to  
UVB+A-irradiated cells significantly increased the levels of phospho-IκBα (119%) 
when compared to that of cells exposed to only UVB+A radiation.  
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3.3 Discussion 
3.3.1 Choice of cell types and UV radiation 
Three different human keratinocyte-derived cell types used in this study; HEK (Human 
Epidermal Keratinocytes), HaCaT (Immortalised Keratinocytes) and Colo16 (Squamous 
Cell Carcinoma) cells. The HEK and Colo16 cells were used to observe UV-induced 
responses between a normal and cancerous skin cell type. HaCaT cells were examined 
to confirm if they are an appropriate substitute for primary epidermal keratinocytes in 
terms of studying cell signal transduction pathways [187, 190-192].  These cells are 
often used in studies as they are easier to culture than primary keratinocytes [185, 190]. 
 
Four different UV types (UVA, UVB, UVA+B and UVB+A) were used in this study 
(Table 2.1). The UV component of sunlight which reaches the earth’s surface is made 
up of both UVA and UVB radiation. The source of UV radiation for this study was 
provided by banks of UVA and UVB lamps, but it was not possible to simultaneously 
irradiate these cell cultures. Therefore, the cells were exposed to UVA immediately 
followed by UVB (UVA+B) radiation or vice versa (UVB+A). The dose received from 
sunlight (UVA and UVB) that is equivalent to 1 MED is approximately 40-50 kJ/m2 
[87, 193, 194]. Sunlight that reaches the surface of earth is composed of 95% UVA and 
5% UVB [5]. Therefore, a dose of 42 kJ/m2 was used in this study where high dose 
UVA is 40 kJ/m2 and UVB is 2 kJ/m2 which is equivalent to 1 MED while the low 
doses corresponded to the UV components seen in 0.1 MED [87]. In this study, a low 
and a high dose of each UV type were used to observe dose-dependent effects on 
keratinocyte-derived cells. It should be noted that the highest dose used in this study did 
not induce more than 50% cell death (Figure 3.1).    
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3.3.2 The effect of UV radiation on the viability of keratinocyte-derived 
cells  
The viability of HEK, HaCaT and Colo16 cells 24 h post-irradiation was measured 
using the trypan blue exclusion method (Section 2.5). The HEK, HaCaT and Colo16 
cells displayed varying responses to UV radiation which suggests that this response may 
be cell-type dependent. In general, high UV doses caused a greater decrease in cell 
viability than did lower doses (Figure 3.1). This suggests that low UV doses either 
induced less damage and/or triggered DNA repair mechanisms whereas higher doses 
inflicted greater cellular damage resulting in cell death [195]. Latonen et al. [196] found 
that the low UVB doses caused p21cip1/waf1 (cell cycle arrest) and transient p53 induction 
whereas high doses led to a prolonged p53 expression and induction of Bax (apoptosis). 
High UV doses may mediate apoptosis as a result of a high level of cellular injury and 
upregulation of proapoptotic factors while low UV doses induce less cell damage which 
may upregulate DNA repair genes (Figure 3.1).  
 
HaCaT cells had a higher percentage of detached dead cells compared to HEK cells 
exposed to the same UV doses (Figure 3.1). Chouinard et al. [88] found that UVB 
radiation stabilized p53 in the cytoplasm of normal keratinocytes whereas it was 
localised in the nucleus for HaCaT cells. Since p53 induction at high doses is linked to 
upregulation of apoptosis, HEK cells may have been less sensitive to high dose  
UV-mediated cell death due to the postulated mechanism of p53 cytoplasmic 
localisation and its resulting inability to stimulate the expression of pro-apoptotic Bax in 
the nucleus. In this study, high dose UVB radiation was more cytotoxic than UVA in all 
three cell lines (Figure 3.1). The viability of cells exposed to high dose UVA+B and 
UVB+A radiation mirrored that seen for high UVB alone, which suggests that UVB has 
a dominant effect over UVA.  
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High UV doses induced greater cell death in Colo16 cells than in HEK or HaCaT cells 
(Figure 3.1). Colo16 cells at 24 h post-irradiation had a low percentage of attached 
viable cells and a high percentage of attached and detached dead cells. Dazard et al. 
[197] observed that SCC12B2 cells (squamous carcinoma cell line) were more 
susceptible to UVB radiation (0.4 kJ/m2) than were HEK cells. Furthermore, it was 
shown that survival factors, DNA repair-related proteins and anti-apoptotic genes were 
upregulated in NHEKs while some pro-apoptotic genes were found to be constitutively 
activated in SCC12B2 cells following UVB exposure [197]. Therefore, it is possible 
that Colo16 cells, which is derived from a SCC may also upregulate pro-apoptotic genes 
to induce cell death following UV radiation.   
 
3.3.3 The effect of UV radiation on the activation of the p38 MAPK, 
JNK and NFκB pathways in keratinocyte-derived cells 
In this study, the effect of UV radiation on the activation of the p38 MAPK, JNK and 
NFκB pathways was observed in HEK, HaCaT and Colo16 cells (Section 3.2.2). These 
three pathways were chosen as it has been suggested that they are involved in TNFα 
production [79, 110, 111, 128, 147]. The p38 MAPK and JNK proteins are stress-
activated protein kinases and are activated by stress stimuli like UV radiation, ionizing 
radiation, osmotic shock and hypoxia [129, 198]. These kinases are phosphorylated 
upon activation by the three-tiered MAPK cascade and share a few upstream activators 
like MEK 4, MEKK 4 [198]. The phosphorylated forms (phospho-p38 and phospho-
JNK1/2) of these proteins were chosen as targets to signify the activation of their 
respective pathways by UV radiation. ERK1/2 is also a well known protein of the 
MAPK family but unlike p38 MAPK or JNK there was little evidence to suggest a link 
between ERK1/2 pathway and TNFα production in response to UV radiation [79, 110, 
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Figure 3.22 The effect of MG115 on proteasomal inhibition and preservation of  
phospho-IκBα in HaCaT cells. HaCaT cells were incubated with MG115 (0.05 mM) for 
1 h prior to irradiation with high dose UVB (2 kJ/m2). Cell protein lysates were 
extracted at 60 min and 120 min post-irradiation with and without MG115. In each lane, 
30 µg of cell lysate was used to perform western blot which was probed with 
monoclonal phospho-IκBα antibody. Lanes 1 & 2: 60 min post-irradiation and lanes 3 & 
4: 120 min post-irradiation. β-Actin was used as an internal loading control. 
Lane 
UVB 
MG115 
 
Phospho- IκBα 
 
β-Actin 
+ + + + 
- - + + 
4 3 2 1 
111, 128]. This does not mean that ERK1/2 is not important or is unaffected by UV 
radiation but because there has been no evidence to show its involvement in TNFα 
production, it was not examined in this study. A study on ERK1/2 may yield useful 
information and should be included in any further studies on this topic.  
 
NFκB is a transcription factor that can be activated in a canonical, non-canonical  and 
atypical fashion [176]. The NFκB complex is inactive when bound to IκBα and is 
usually localised in the cytoplasm. In the canonical or classical pathway, IKK is 
phosphorylated by a series of upstream activators and inturn phosphorylates IκBα [176]. 
The phosphorylated IκBα is ubiquitinated and degraded by a proteasome. The NFκB 
complex is freed and translocates into the nucleus [137]. In this study, phosphorylated 
IκBα (phospho-IκBα) was used to identify the activation of the NFκB pathway [188]. 
As phospho-IκBα is degraded by the proteasome, MG115 (proteasome inhibitor) was 
added to the cells to block the activity of this enzyme to preserve phospho-IκBα levels 
within the cell (Figure 3.22) [188].  
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In order to observe the expression of the three proteins (phospho-p38, -JNK and -IκBα) 
of interest, western blots were used to separate the proteins in the cell protein lysates. 
However, as shown in Figure 3.23, the resolution of the phospho-proteins is dependent 
on the blocking agent used. If skim milk powder is used as a blocking agent,  
phospho-p38 is poorly resolved (Figures 3.23A & B), and is most likely due to the 
interference of phospho-proteins present in milk powder [199]. Only when 5% BSA and 
not 2% BSA was added to the blocking buffer were the phospho-proteins able to be 
clearly resolved (Figure 3.23C & D).  
 
 
Figure 3.23 The effect of different proteins as blocking reagents in Western blot 
analysis. HaCaT cells were irradiated with high dose UVA (40 kJ/m2). Cell protein 
lysates were extracted at 5 to 120 min post-irradiation. In each lane 30 µg of cell lysate 
was added. The migrated proteins were transferred onto a nitrocellulose membrane and 
blocked with (A) 5% skim milk powder, (B) 2% skim milk powder, (C) 2% BSA and 
(D) 5% BSA which were probed with polyclonal phospho-p38 MAPK antibody. Lane 1: 
sham-irradiated control, 2: 5 min, 3: 15 min, 4: 30 min, 5: 60 min and 6: 120 min post-
irradiation.  
1         2         3       4        5        6 Lane 
 
5% Skim Milk 
2% Skim Milk 
 
2% BSA 
 
5% BSA 
 
A 
B 
C 
D 
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In this study, the four different UV types (UVA, UVB, UVA+B and UVB+A) evoked 
varying phospho-p38 levels within HEK, HaCaT and Colo16 cells (Figures 3.3-3.5). 
The same observations were also seen for phospho-JNK and -IκBα levels as well  
(Figures 3.7-3.9 & 3.11-3.13). The results of which suggests that UVA and UVB 
radiation activated these pathways differently to each other. The combination of 
UVA+B or UVB+A activated the pathways differently to that of either UVA or UVB 
alone. In support, Schieke et al. [89] reported that UVA (300 kJ/m2), UVB (0.1 kJ/m2) 
radiation and its combination induced different responses of the p38 MAPK and JNK 
pathways in keratinocytes. They concluded that the distinct stress responses brought 
about by UVA or UVB may interact, when a combination of radiation is used to create a 
“third” response that resembles neither UVA nor UVB alone.  
 
Low dose UV elicited low levels of phospho-p38 while elevated levels of this protein 
were observed at high dose UV in all three cell lines (Figures 3.3-3.5). This indicated 
that the p38 MAPK pathway was activated to a greater extent following exposure to 
high UV dose than to a low dose. A similar response was also observed for UV  
dose-induced phospho-JNK expression (Figures 3.7-3.9). It is possible that the high UV 
doses induced higher levels of ROS and DNA damage which can further activate the 
p38 MAPK and JNK pathways as they are linked to the ATM/ATR and p53 DNA 
damage response signalling [150, 200-208]. However, in HEK cells the phospho-p38 
levels after low dose UVA exposure was higher at 5 min post-irradiation compared to 
high dose (Figure 3.3). The same was observed for JNK in HEK cells where following 
low dose  UVA, UVA+B or UVB+A radiation the level of phospho-JNK1 was higher 
than that induced by high dose of the same UV types (Figure 3.7). In HaCaT and 
Colo16 cells, low dose UV radiation induced a greater activation of the NFκB pathway 
than did the corresponding higher dose (Figures 3.12 & 3.13). The reasons for which are 
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unclear but the downstream effects elicited by these pathways might be different. An 
examination of downstream pathway intermediates may give a better understanding of 
how these pathways are affected by the high and low dose UV radiation.  
 
In this study, irrespective of the doses, UV or cell types, phospho-JNK1 expression was 
higher than that of phospho-JNK2 following exposure to UV radiation which suggests 
that JNK1 was the one preferentially activated in this pathway (JNK) (Figures 3.7-3.9). 
Katagiri et al. [209] observed that in UVB-irradiated (0.5 kJ/m2) keratinocytes, JNK1 
mRNA was upregulated while the JNK2 mRNA expression was suppressed and the 
JNK1 isoform translocated to the nucleus while the JNK2 isoform remained in the 
cytoplasm. Therefore, the activation of JNK1 in these cells may be a specific  
UV-induced response. The pattern of JNK (JNK1 and JNK2) pathway activation was 
different in HEK cells compared to HaCaT and Colo16 cells (Figures 3.7-3.9). In HEK 
cells, JNK pathway activation was immediate and transient while in HaCaT and Colo16 
cells it was immediate and sustained. Christmann et al. [210] found that an immediate 
and transient activation of the JNK/c-Fos pathway in wild-type MEF led to DNA repair 
but sustained JNK induction in c-Fos-/- MEF was less capable in removing CPDs 
(cyclobutane pyrimidine dimers) suggesting a role for c-Fos in nucleotide excision 
repair. It is possible that in HaCaT and Colo16 cells, sustained activation of the JNK 
pathway may lead to reduced DNA repair/more cell death whereas transient activation 
in the HEK cells may be responsible for greater DNA repair/less cell death via 
regulation of c-Fos.  
 
Phospho-IκBα levels fell below control levels and the pattern of expression was similar 
after exposure to high dose UVA and UVA+B radiation in HaCaT and Colo16 cells 
(Figures 3.12 & 3.13). This suggests a suppression of the NFκB pathway activity 
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following high dose UV radiation. A similar result was seen when these cells were 
exposed to high dose UVB and UVB+A but was less than that induced by high dose 
UVA and UVA+B (Figures 3.12 & 3.13). Of interest was the observation that all forms 
of low dose UV radiation induced activation of the NFκB pathway in HaCaT and 
Colo16 cells. This result differed to that seen in HEK cells where both low and high UV 
doses activated NFκB pathway activity (Figure 3.11). This suggests that HaCaT and 
Colo16 cells may possess similar mechanism or molecular alterations that regulate 
NFκB signalling distinct from those of primary keratinocytes (HEK cells). It is 
interesting to note that following exposure to high dose UV radiation, NFκB was the 
only pathway that was suppressed in the immortalised keratinocyte and squamous 
carcinoma cell lines. This suggests that the NFκB pathway could be a potential target in 
skin tumorigenesis as its suppression may inhibit or activate certain functions that are 
necessary for carcinogenesis and/or cancer progression. UVA+B and UVB+A radiation 
were shown to induce a distinct response compared to that of either UVA or UVB 
radiation. However, in HaCaT and Colo16 cells, the pattern of phospho-IκBα 
expression was similar following exposure to UVA and UVA+B radiation (Figures 3.12 
& 3.13). Likewise, phospho-IκBα expression following exposure to UVB and UVB+A 
radiation was similar in both the cell lines (Figures 3.12 & 3.13).  This suggests that in 
the combination of UV radiation (UVA+B or UVB+A) used, the first UV type 
dominated over the second thereby eliciting a response similar to that of the first type. It 
would be of interest to observe the response of these cells when exposed to a solar 
simulator where both UVA and UVB radiation are emitted simultaneously. 
 
HaCaT cells have been used as an immortalized substitute for primary keratinocytes 
since the mid-1990s [187, 190-192]. Boukamp et al. [185] stated that HaCaT cells 
exhibited a similar cellular morphology to keratinocytes and are able to differentiate 
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normally and were an appropriate model to study the differentiation of these cells. 
PI3K, IKKα, MMPs and E2F transcription factor-1 are some molecules which regulate 
keratinocyte differentiation and are either upstream or downstream of the pathways (p38 
MAPK, JNK and NFκB) used in this study [211-214]. Therefore, it is highly likely that 
these pathways may be involved in keratinocyte differentiation [9, 132, 214]. Although, 
HaCaT cells have been reported to possess normal differentiation, the difference in the 
activation of signalling pathways found in this study may inducate that different 
mechanisms may be responsible for differentiation in HaCaT and HEK cells (Figure 
3.24). As a result using HaCaT cells to understand differentiation processes in primary 
keratinocytes may not be appropriate.  
 
HaCaT cells also lack intact p53 alleles, p16 protein, and possess alterations in the  
c-myc oncogene when compared to HEK cells [186, 187, 215]. These mutations are also 
observed in squamous cell carcinomas [215, 216]. However, it is not known if Colo16 
cells in particular possess such mutations. In this study, despite the variations in the 
levels of phospho-p38, -JNK and -IκBα, the pattern of expression in HaCaT cells are 
similar to that of Colo16 (squamous cell carcinoma) and not HEK cells following 
exposure to high dose UV (Figure 3.24). These findings suggest that both HaCaT and 
Colo16 cells may possess similar molecular alterations or share common upstream 
activators of these signalling pathways (Figure 3.24).  
 
3.3.4 The effects of UV radiation and IL1α on TNFα release in 
keratinocyte-derived cells  
TNFα has been implicated in skin carcinogenesis and can mediate the blockade of cell 
cycle arrest thus allowing cells harbouring mutations to continue through the cell cycle 
[83, 182]. Therefore, it is imperative to observe the effect of UV radiation on TNFα 
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Figure 3.24 A comparison of the activation of (Row 1) p38 MAPK, (Row 2) JNK and  
(Row 3) NFκB pathways between (Column A) HEK, (Column B) HaCaT and  
(Column C) Colo16 cells exposed to high dose UV radiation. For further information 
on each figure please see Figures 3.3-3.5, 3.7-3.9 and 3.11-3.13. 
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release from HEK, HaCaT and Colo16 cells. Furthermore, it is of interest to observe the 
effect of tumorigenesis on TNFα release in irradiated cancer cell types (Colo16). ELISA 
were performed on media samples collected from cell cultures 24 h post-irradiation. 
Media samples were used as (a) whole cell lysates did not have detectable amounts of 
TNFα and (b) the low UV doses were omitted as they did not stimulate TNFα release 
from these cells.  
 
Cells exposed to UVB radiation released greater levels of TNFα than those exposed to 
UVA (Figure 3.14). UVA+B radiation induced similar levels of TNFα to that of UVB 
radiation, while that seen following UVB+A radiation was lower only in HaCaT and 
Colo16 cells but not HEK cells (Figure 3.14B &C). This suggests that in HaCaT and 
Colo16 cells, the initial UV type as a dominant effect over the second one used, where 
UVB+A elicited similar effects to UVB, while that of UVA+B was similar to UVA as 
seen by the release of TNFα from these cells. In support of this suggestion, Clingen et 
al. [217] found that in HEK cells, UVB radiation (0.1-0.5 kJ/m2) significantly increased 
TNFα levels in a dose-dependent manner. When the same cells were exposed to tanning 
lamps (250-500 kJ/m2) which emit higher levels of UVA radiation, lower levels of 
TNFα were secreted irrespective of the increasing UV doses. This decrease in TNFα 
levels were observed in the irradiated cells which suggested that UVA radiation has a 
suppressive effect on the release of this cytokine [217].  
 
Clingen et al. [217] found that when HEK cells were exposed to UVB prior to UVA 
radiation there was a fall in TNFα levels. However, in this present study, UVB+A 
radiation did not suppress TNFα release from HEK cells to that seen for UVB radiation 
alone (Figure 3.14A). It would be interesting to observe the effect of UVA-irradiation 
on TNFα release from 24 h post UVB-irradiated cells. Djavaheri-Mergny et al. [218] 
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found that UVA radiation decreased NFκB DNA binding activity in NCTC 2544 
keratinocytes, and suggested that this was due to UVA-induced degradation of NFκB 
subunits p50 and p65. Since NFκB is involved in the transcription of several cytokines 
including TNFα, it is possible that inactivation of NFκB could have reduced the levels 
released from the cells following UVA radiation [218].  
 
In this present study, the UVA and UVB+A mediated activation of NFκB pathway in 
HEK cells (Figure 3.24) was different to that seen previously [218]. Activation of the 
NFκB pathway may have increased the transcription and production of TNFα following 
UVA or UVB+A radiation in HEK cells. However, in HaCaT and Colo16 cells, UVA 
radiation suppressed NFκB activation which could have decreased transcription and 
production of TNFα (Figure 3.24). UVA+B radiation also suppressed activation of the 
NFκB pathway but this suppression did not inhibit TNFα release in both these cells 
lines (Figure 3.24). UVB+A and UVB radiation displayed a similar pattern of activation 
of the NFκB pathway but this was not reflected in the level of TNFα released, as 
UVB+A induced lower levels than did UVB (Figure 3.14B & C). These discrepancies 
could be due to the fact that the NFκB activation was only monitored over 120 min. It is 
possible that the activation of NFκB pathway may have varied between 2 to 24 h  
post-irradiation and observation of NFκB activation over a 24 h period may give a 
better indication of its relationship with TNFα release. In addition, silencing NFκB 
using siRNA or keratinocytes expressing dominant negative forms of NFκB would be 
useful in elucidating the role of this signalling molecule in TNFα release. Time and 
funding constraints did not allow for these to be examined in this study. 
 
In all three keratinocyte-derived cells UV radiation alone did not induce TNFα but when 
IL1α was added immediately post-irradiation (Figure 3.14) these levels were enhanced 
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[164, 219, 220]. It is possible that these two cytokines may promote or antagonize skin 
carcinogenesis as IL1α had a profound effect on augmenting TNFα levels in HaCaT 
cells followed by Colo16 cells and had the least effect on HEK cells (Figure 3.14). It 
can be speculated that as HEK produces high levels of TNFα in the absence of IL1α, the 
addition of this cytokine did not have a greater impact on these levels compared to that 
seen in HaCaT or Colo16 cells. La et al. [221] found that SCC tumour cell lines and 
neoplastic papilloma cell lines in the early stages of skin neoplasia expressed high levels 
of IL1α. In contrast, IL1Rα (IL1α receptor antagonist) was expressed to a lesser extent 
in papilloma and SCC cell lines than in keratinocytes. These findings suggest that IL1α 
is required for skin tumour progression as its signalling is enhanced by a corresponding 
reduction in IL1α receptor antagonist in pre-cancerous (papilloma) and cancerous 
(SCC) cells. This may explain the results seen in this study (Figure 3.14). It is also 
possible that the expression of IL1α receptor antagonist may be higher in HEK cells 
than in HaCaT or Colo16 cells, thereby resulting in a weaker response to IL1α in these 
cells which should be investigated further.  
 
IL1α downregulated DNA repair, cell cycle and pro-apoptotic genes while upregulating 
anti-apoptotic genes and other transcription factors in epidermal keratinocytes [222]. 
This suggests that IL1α signalling may be involved in promoting cell survival and 
inhibition of DNA repair whilst causing growth arrest. However, the dynamics of IL1α 
transcriptional regulation may be altered in UV irradiated keratinocytes as 
transcriptional regulation was only seen in unirradiated keratinocytes [222]. It will be 
interesting to observe if exogenous TNFα can also stimulate TNFα release to the same 
extent as IL1α. Apart from TNFα, keratinocytes and fibroblasts can also produce IL1α 
in response to UV radiation [189]. Therefore, it will be interesting to perform co-culture 
experiments with keratinocytes and fibroblasts using milliwell inserts to observe the 
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interaction of two cell types when exposed to UV radiation in the absence of exogenous 
mediators. 
 
3.3.5 The effect of UV radiation and IL1α on the activation of the p38 
MAPK, JNK and NFκB pathways in keratinocyte-derived cells 
IL1α  increased TNFα levels in UV-irradiated keratinocyte-derived cells (Section 3.2.3) 
and this may be mediated by an elevation in cell signalling pathway activity (Figure 
3.25). IL1α (section 3.2.4) induced a slight but not significant increase in the activation 
of the p38 MAPK, JNK and NFκB pathways in sham-irradiated controls (Figures 3.17, 
3.19 & 3.21). In irradiated HaCaT cells, IL1α enhanced the activation of the p38 MAPK 
pathway across all UV types. However, the upregulation of this pathway did not 
Figure 3.25 A postulated mechanism of UV+IL1α-mediated TNFα release in  
keratinocyte-derived cells. UV+IL1α may lead to an increase in the activation of the p38 
MAPK. JNK and NFκB pathways and may result in an increase in TNFα levels. It is 
possible that either one or all of these pathways may be regulated by UV+IL1α 
treatment. 
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correspond to the increase in TNFα levels induced by IL1α (Figure 3.14 & 3.17). In 
irradiated HEK and Colo16 cells, IL1α either upregulated or downregulated the p38 
MAPK pathway at different time points and UV types. In irradiated HEK and HaCaT 
cells, IL1α activated the JNK pathway to different degrees at the various time points and 
UV types (Figure 3.19). In Colo16 cells following UV radiation, IL1α had a minimal 
effect on activating the JNK pathway. In all three cell types, the NFκB pathway was 
either upregulated or downregulated at different time points and UV types after IL1α 
supplementation but the observed effect was minimal (Figure 3.21).  
 
On the whole, IL1α did not significantly affect the activation of the pathways compared 
to its effect on TNFα release from the UV-irradiated cells (Figures 3.14, 3.17, 3.19 & 
3.21). The effect of IL1α appeared to be cell- and UV- type dependent and it is possible 
that its effects may be evident at later time points than during the first 30 min  
post-irradiation. However, due to time constraints, this was not investigated. The 
observation of UV+IL1α-mediated activation of the p38 MAPK, JNK and NFκB 
pathways did not clearly show which one(s) played a significant role in TNFα release. 
The use of specific cell signalling pathway inhibitors will help delineate the role that 
these pathways will play in UV+IL1α-mediated TNFα release in keratinocyte-derived 
cells and as such further studies to investigate this process are warranted.  
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MELANOCYTE-DERIVED CELLS 
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4.1 Introduction 
Melanocytes are derived from the neural crest and migrate into the epidermis where 
they are distributed among the keratinocytes [173]. Melanocytes together with the other 
non-keratinocyte cells form 5-10% of the cells in the epidermis [173]. They produce 
melanin which is stored in melanosomes. These melanosomes (which contain melanin) 
are transferred to the keratinocytes and are known to confer protection to their nuclei 
[173]. Melanocytes transformed by a carcinogenic stimulus like UV radiation can form 
melanoma which is an aggressive and malignant type of skin cancer [174]. Both UVA 
and UVB radiation can penetrate into the epidermis which initiates molecular 
interactions leading to UV-induced responses such as skin carcinogenesis. Some of 
these molecular interactions can give rise to genetic alteration, activation of cell 
signalling pathways and either upregulation or downregulation of cytokines.  
 
As mentioned earlier (Section 3.1), this study investigates the involvement of MAPK 
(p38 MAPK and JNK) and the NFκB pathways in UV-specific signalling. These 
pathways have been suggested to play a role in malignant transformation of 
melanocytes and the progression of melanoma although its anti-tumorigenic activities 
have also been reported [223-226]. Denkert et al. [224] found that the p38 inhibitor, 
SB203580 caused a 60% reduction in the invasion of MeWo melanoma cells through a 
matrigel membrane which may correlate with SB203580-mediated inhibition of MMP-2 
proteolytic activity. Estrada et al. [225] showed that the p38 MAPK/IL8 pathway was 
involved in melanoma cell migration and growth. Through the use of small interfering 
RNAs (siRNA) which reduced p38 MAPK activity, a decrease in IL8 expression was 
observed along with reduced migration of melanoma cells in a modified Boyden 
chamber. This inhibition was overcome by the addition of exogenous IL8 which 
confirms that this cytokine must be downstream of the p38 MAPK pathway [225]. JNK 
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inhibition was also shown to induce G2/M cycle arrest and render the melanoma cells 
susceptible to cell death [223]. Taken together, these findings suggest that the p38 
MAPK and JNK pathways may be involved in melanoma progression and metastasis.  
 
Rel A is a subunit of the NFκB complex [137]. A comparison of Rel A expression in 
normal melanocytes, benign nevi and metastatic melanomas revealed that there were 
high levels of Rel A in the nucleus of melanomas whereas it was mostly localised in the 
cytoplasm of benign naevus and only low levels were detected in normal melanocytes 
[227]. In addition, McNulty et al. [228] found that Rel A played an important role in 
melanoma cell survival as antisense Rel A phosphorothioate oligonucleotides abrogated 
its protective effects.  
 
The effect of UV radiation on TNFα release in melanocyte-derived cells is also of 
interest as this cytokine may be involved in anti- or pro-tumour activities in melanoma 
development [226, 229]. Ivanov et al. [229] found that TNFα promoted cell survival of 
LU125 melanoma cells as ATF 2-mediated suppression of TNFα expression led to 
UVC-induced (0.06 kJ/m2) susceptibility to apoptosis. In support of this finding, 
exogenous TNFα was found to inhibit apoptosis in melanoma cells with abrogated  
B-Raf signalling [230]. The inhibition of B-Raf signalling in melanoma cell lines that 
contained mutant B-Raf induced cell cycle arrest and apoptosis. The addition of TNFα, 
attenuated apoptosis and led to survival of the melanoma cells through the activation of 
the NFκB pathway [230]. This was confirmed by depleting NFκB subunits, p65 and p50 
which inhibited TNFα-mediated cell survival. Therefore, it is possible that TNFα 
present in the tumour microenvironment may provide an added advantage for melanoma 
progression. 
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However, TNFα has also been implicated in anti-tumour activities. TNFα was used as 
an anti-vascular agent in melanoma cells where a virus phage vector was used that 
targets tumour endothelium in a melanoma xenograft in mice to express TNFα [231]. 
The expression of TNFα in the tumour endothelium led to a breakdown of tumour 
vasculature and inhibition of tumour growth [231]. On the whole, TNFα seems to 
possess both pro- and anti-tumour activities and the role TNFα undertakes may depend 
on molecular interactions within the compromised cells.  
 
In this chapter, UV-mediated cell signal transduction (p38 MAPK, JNK and NFκB) and 
cytokine (TNFα) regulatory studies performed on keratinocyte-derived cells (Chapter 3) 
were repeated using the melanocyte-derived cells; HEM and MM96L cells. In addition, 
the effect of the pathway specific inhibitors like SB202190 (p38 MAPK inhibitor), 
SP600125 (JNK inhibitor) and sulfasalazine (NFκB inhibitor) on UV-induced TNFα 
release from melanocyte-derived cells was investigated.   
 
4.2 Results 
4.2.1 The effect of UV radiation on the viability of melanocyte-derived 
cells 
The effect of UV radiation on the viability of HEM and MM96L cells was measured  
24 h post-irradiation using trypan blue exclusion (Figure 4.1). The ‘detached cells’ are 
those cells which had dissociated from the surface of the culture vessel, while ‘attached 
cells’ referred to those which had not. 
 
HEM cells do not appear to be susceptible to UV radiation as they had a high 
percentage of attached viable cells after exposure to low dose UV radiation similar to 
that of sham-irradiated control (Sham-irradiated control: 88%, low dose UVA: 82%, 
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Cell Viability of HEM and MM96L cells 
Legend:  Attached Viable Cells  Attached Dead Cells 
 Detached Viable Cells  Detached Dead Cells 
Figure 4.1 The viability of (A) HEM and (B) MM96L cell cultures at 24 h post  
UV-irradiation. Cell viability was performed using trypan blue solution. Results 
expressed as the means ± SD from triplicate samples. Data are representative of three 
independent experiments. Comparisons were made between sham-irradiated control and 
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*). 
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UVB: 80%, UVA+B: 83%, UVB+A: 82%) (Figure 4.1A). A similar result was seen 
when the cells were exposed to high dose of UV radiation (Sham-irradiated control: 
88%, high dose UVA: 82%, UVB: 85%, UVA+B: 86%, UVB+A: 85%) (Figure 4.1A). 
There were a small percentage of detached dead cells present in all UV-irradiated 
groups which was lower than that of attached dead cells. 
 
The viability of MM96L cells seemed dependent on the different UV types and doses. 
The low UV doses induced lesser cell death than the high dose (Figure 4.1). Cultures 
exposed to high dose UVA had a higher percentage of attached viable cells when 
compared to those exposed to the other UV types (Sham-irradiated control: 82%, high 
dose UVA: 70%, UVB: 40%, UVA+B: 39% UVB+A: 36%). As expected, the 
percentage of detached viable cells were lower in UVA-irradiated cultures compared to 
the other UV types (Sham-irradiated control: 1.6%, high dose UVA: 13.8%, UVB: 38%, 
UVA+B: 40%, UVB+A: 30%). High dose UVB+A radiation was the most cytotoxic of 
all the UV types. It can be seen that MM96L cells were more susceptible to UV 
radiation than HEM cells when these cultures were exposed to high UV doses (Figure 
4.1).  
 
4.2.2 The effect of UV radiation on the activation of p38 MAPK, JNK 
and NFκB pathways in melanocyte-derived cells  
The activation of the p38 MAPK, JNK and NFκB pathways in HEM and MM96L cells 
was observed over the first 120 min following UV radiation. These cells were exposed 
to either a low or a high dose of UVA, UVB, UVA+B or UVB+A radiation (Table 2.1). 
Once irradiated the cell cultures were left to incubate at various time points and the cell 
protein lysates were used for western blots (Section 2.7). The blots were probed with 
either polyclonal phospho-p38, phospho-JNK1/2 or monoclonal phospho-IκBα 
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antibodies. The phosphorylated forms of p38 MAPK, JNK1/2 and IκBα proteins were 
used as targets to signify the activation of the p38 MAPK, JNK1/2 and NFκB pathways 
respectively. The β-actin antibody was used as a loading control to ensure that a 
constant mass of cell protein lysate was loaded into each lane. 
 
4.2.2.1 p38 MAPK pathway 
A polyclonal phospho-p38 MAPK antibody was used to probe for phospho-p38 MAPK 
protein (43 kDa) on the western blots (Figure 4.2). The expression of phospho-p38 was 
calculated as a ratio of UV-irradiated sample over sham-irradiated control (control  
= 100%). 
 
 
Figure 4.2 A representative western blot probed for phospho-p38 MAPK in (A) HEM 
and (B) MM96L cells. The samples from lanes 2 to 5 in blot (A) and lanes 2 to 6 in blot 
(B) were exposed to low dose UVB radiation (0.2 kJ/m2). The samples from lanes 6 to 9 
in blot (A) and lanes 7 to 11 in blot (B) were exposed to high dose UVB radiation  
(2 kJ/m2). The lanes marked from 1 to 9 in blot (A) represents Lane 1: Sham-irradiated 
control, 2 & 6: 5 min, 3 & 7: 15 min, 4 & 8: 30 min, 5 & 9: 120 min post-irradiation. 
The lanes marked from 1 to 11 in blot (B) represents Lane 1: Sham-irradiated control, 2 
& 7: 5 min, 3 & 8: 15 min, 4 & 9: 30 min, 5 & 10: 60 min, 6 & 11: 120 min  
post-irradiation.  
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4.2.2.1.1 HEM cells 
In HEM cells, low dose UVA caused phospho-p38 levels to increase from 100% (0 
min) to 258% by 5 min, before falling to 143% at 120 min post-irradiation (Figure 
4.3A). After high dose UVA exposure, phospho-p38 levels also peaked at 5 min 
(286%), before falling to 187% by 15 min and remained fairly constant until 120 min 
(175%) post-irradiation. In response to low and high dose UVA radiation, the pattern of 
phospho-p38 expression was immediate and transient.  
 
In the case of low dose UVB radiation, the level of phospho-p38 peaked at 307% after 5 
min and immediately fell to 191% at 15 min, before declining to 136% at 120 min  
post-irradiation (Figure 4.3B). High dose UVB induced higher levels of phospho-p38 
than did low dose radiation. After high dose UVB radiation, phospho-p38 levels peaked 
at 5 min (339%), then fell to 296% at 30 min before declining gradually to 204% at 120 
min post-irradiation. The expression of phospho-38 following high dose UVB was more 
sustained than that after low dose exposure. 
 
After low dose UVA+B exposure, phospho-p38 levels rapidly increased to 267% at 5 
min, before falling to 164% at 15 min and gradually decreasing to 131% at 120 min 
post-irradiation (Figure 4.3C). High dose UVA+B radiation increased phospho-p38 
levels to 296% at 5 min which remained elevated at 30 min (308%) before declining to 
178% at 120 min post-irradiation. High dose UVA+B radiation induced a greater 
expression of phospho-p38 which was more prolonged than that of low dose radiation. 
 
Low dose UVB+A radiation stimulated an increase in phospho-p38 levels at 5 min 
(222%) which dropped to 186% at 30 min and remained constant until 120 min  
post-irradiation (Figure 4.3D). Following high dose UVB+A radiation, phospho-p38 
  
 
- 143 - 
  
* 
* † 
† 
Figure 4.3 The effect of UV radiation on the expression of phospho-p38 protein in 
HEM cells. Cell cultures were irradiated with either a low (0.1 MED) or high (1 MED) 
UV dose of (A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation and proteins 
were extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of 
cell lysate was used to perform western blotting. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (0 min) and UV-irradiated 
cultures using Student’s paired t-test where significance was recorded as p ≤ 0.05 (*,†). 
[High dose UV (*); Low dose UV (†)]. 
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levels peaked at 5 min (377%) and dropped to 275% at 30 min which further decreased 
to 200% at 120 min post-irradiation. The pattern of phospho-p38 expression was the 
same after low or high dose UVB+A radiation where activation was immediate and 
transient except that the higher dose was more stimulatory.  
 
4.2.2.1.2 MM96L cells 
In MM96L cells, low dose UVA caused a slight increase in phospho-p38 levels which 
remained constant over the 120 min (~120%) time period (Figure 4.4A). High dose 
UVA exposure resulted in a biphasic expression of phospho-p38. These levels peaked at 
880% by 5 min and then fell at 30 min (363%), after which they increased to 725% at 
60 min before falling to 145% at 120 min post-irradiation. 
 
After low dose UVB exposure, there was minimal activation of the p38 MAPK pathway 
(Figure 4.4B). Phospho-p38 levels increased to 203% at 5 min, falling to 148% at 15 
min and remaining constant until 120 min (187%) post-irradiation. High dose UVB 
exposure caused an increase in phospho-p38 levels at 5 min (198%) which decreased to 
145% at 15 min before increasing again to 207% at 30 min, and then declining to 187% 
at 120 min post-irradiation. 
 
Similar to that seen for UVA, the low dose UVA+B radiation caused a slight increase in 
phospho-p38 levels which remained constant (~145%) over the 120 min time period 
(Figure 4.4C). High dose UVA+B radiation stimulated a greater increase in  
phospho-p38 levels than did low dose radiation. The expression of phospho-p38 was 
biphasic where there was a peak at 5 min (1022%) which dropped to 309% at 15 min 
and increased again to 667% at 30 min, before finally dropping to 224% at 120 min 
post-irradiation.   
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Figure 4.4 The effect of UV radiation on the expression of phospho-p38 protein in 
MM96L cells. Cell cultures were irradiated with either a low (0.1 MED) or high  
(1 MED) UV dose of (A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation and 
proteins were extracted at various time points (0-120 min) post-irradiation. In each lane 
30 µg of cell lysate was used to perform western blotting. Results expressed as the 
means ± SD from triplicate samples. Data are representative of three independent 
experiments. Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*,†). [High dose UV (*); Low dose UV (†)]. 
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Low dose UVB+A radiation also induced minimal expression of phospho-p38 which 
remained constant (~150%) over the 120 min time period (Figure 4.4D). In comparison, 
high dose UVB+A radiation induced a greater expression of phospho-p38 where these 
levels rose to 375% at 5 min, peaking at 15 min (428%) before falling to 285% at 120 
min post-irradiation. The stimulation induced by UVA+B radiation was much greater 
and more sustained than that seen for UVB+A radiation. 
 
4.2.2.2 JNK pathway 
In order to detect phospho-JNK1/2 protein, a polyclonal phospho-JNK1/2 antibody was 
utilised in western blots (Figure 4.5). The expression of UV-induced phospho-JNK1 (46 
kDa) or -JNK2 (54 kDa) was calculated as a percentage of total phospho-JNK1 and 
JNK2 levels in sham-irradiated control (Appendix A.5). 
 
4.2.2.2.1 HEM cells 
Irrespective of the dose and type of UV radiation, phospho-JNK2 levels did not increase 
in the cells over the 120 min time period following irradiation (Figure 4.6). This 
suggests that JNK2 is not activated by UV radiation in these cells. 
 
In HEM cells, the phospho-JNK1/2 levels were similar irrespective of wether the cells 
were exposed to low or high dose UVA radiation. Low dose UVA radiation increased 
phospho-JNK1 levels from 54% (0 min) to 362% at 5 min which remained constant 
until 30 min (357%) before falling to 147% at 120 min post-irradiation (Figure 4.6A). 
Following high dose UVA exposure, phospho-JNK1 levels increased from 54% (0 min) 
to 395% at 15 min, after which it fell to 145% at 120 min post-irradiation.  
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Low dose UVB exposure induced high levels of phospho-JNK1 which increased rapidly 
from 51% (0 min) to 558% at 5 min before peaking at 15 min (593%), and then falling 
to 179% at 120 min post-irradiation (Figure 4.6B). After high dose UVB radiation, 
phospho-JNK1 levels rose from 51% (0 min) to 542% at 15 min, before falling to 418% 
at 120 post-irradiation. The activation of phospho-JNK1 following high dose UVB was 
more prolonged than that of low dose radiation. 
 
 
 
 
Figure 4.5 A representative western blot probed for phospho-JNK1/2 in (A) HEM and 
(B) MM96L cells. The samples from lanes 2 to 5 in blot (A) and lanes 2 to 6 in blot (B) 
were exposed to low dose UVB radiation (0.2 kJ/m2). The samples from lanes 6 to 9 in 
blot (A) and lanes 7 to 11 in blot (B) were exposed to high dose UVB radiation (2 
kJ/m2). The lanes marked from 1 to 9 in blot (A) represents Lane 1: Sham-irradiated 
control, 2 & 6: 5 min, 3 & 7: 15 min, 4 & 8: 30 min, 5 & 9: 120 min post-irradiation. 
The lanes marked from 1 to 11 in blot (B) represents Lane 1: Sham-irradiated control, 2 
& 7: 5 min, 3 & 8: 15 min, 4 & 9: 30 min, 5 & 10: 60 min, 6 & 11: 120 min  
post-irradiation.  
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Figure 4.6 The effect of UV radiation on the expression of phospho-JNK1/2 protein in 
HEM cells. Cell cultures were irradiated with either a low or high UV dose of (A) UVA, 
(B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins were 
extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of cell 
lysate was used to perform western blotting. Results expressed as the means ± SD from 
triplicate samples. Data are representative of three independent experiments. 
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †, §, θ). [High dose UV: phospho-JNK1(*), -JNK2 (†); Low dose UV:  
phospho-JNK1(§), -JNK2 (θ)]. 
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In the case of low dose UVA+B radiation, phospho-JNK1 levels rose rapidly from 52% 
(0 min) to 507% (5 min) which was maintained until 30 min (501%) before falling to 
197% at 120 min post-irradiation (Figure 4.6C). Following high dose UVA+B radiation, 
phospho-JNK1 levels rose from 52% (0 min) to a peak of 483% at 15 min, after which 
they fell to 404% at 30 min and continued to decrease to 277% at 120 min  
post-irradiation.  
 
After exposure to low dose UVB+A radiation, phospho-JNK1 levels rose from 53% (0 
min) to a peak of 373% at 5 min, after which it slowly decreased to 307% (15 min) 
before falling to 160% at 120 min post-irradiation (Figure 4.6D). High dose UVB+A 
radiation caused the phospho-JNK1 levels to rise from 53% (0 min), peaking at 15 min 
(483%) before decreasing to 193% at 120 min post-irradiation. The expression of 
phospho-JNK1 was higher following high dose UVB+A than low dose radiation.  
 
4.2.2.2.2 MM96L cells 
In MM96L cells, following exposure to low dose UVA, phospho-JNK1 levels was low 
over the 120 min time period (Figure 4.7A). These levels rose from 77% (0 min) 
peaking at 95% by 5 min and remaining constant for the next 10 min, before declining 
to 58% at 120 min post-irradiation. Phospho-JNK2 levels were also low and remained 
constant around control levels (0 min = 23%) over this same period of time. The 
activation of phospho-JNK1 was immediate and sustained after high dose UVA 
radiation, increasing from 68% (0 min) to 239% at 5 min, then gradually increasing to 
344% at 60 min before falling to 96% at 120 min post-irradiation. Phospho-JNK2 levels 
on the other hand increased from 32% (0 min) to 181% (30 min) before declining to 
48% at 120 min post-irradiation.  
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Figure 4.7 The effect of UV radiation on the expression of phospho-JNK1/2 protein in 
MM96L cells. Cell cultures were irradiated with either a low or high UV dose of  
(A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation (Table 2.1) and proteins 
were extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of 
cell lysate was used to perform western blotting. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †, §, θ). [High dose UV: phospho-JNK1(*), -JNK2 (†); Low dose UV:  
phospho-JNK1(§), -JNK2 (θ)]. 
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Low dose UVB exposure increased phospho-JNK1 levels from 66% (0 min) to 125% at 
15 min before falling to 80% at 120 min post-irradiation (Figure 4.7B). Phospho-JNK2 
levels on the other hand remained consistent (~35%) over this time period. After high 
dose UVB radiation, phospho-JNK1 levels rose from 80% (0 min) peaking at 120% 
after 5 min before gradually falling to 96% at 120 min post-irradiation. Phospho-JNK2 
levels remained around control levels (0 min = 20%) over the 120 min time period. It 
can be seen from the results that low or high dose UVB radiation induced minimal 
activation of the JNK pathway in MM96L cells. 
 
Low dose UVA+B radiation induced an increase in phospho-JNK1 levels from 81% (0 
min) to 117% at 5 min, before it fell to 70% at 120 min post-irradiation (Figure 4.7C). 
Phospho-JNK2 levels were unaffected and remained fairly constant at control levels (0 
min = 19%) over this time period. High dose UVA+B radiation stimulated higher levels 
of phospho-JNK1 than did low dose radiation. High dose UVA+B radiation increased 
phospho-JNK1 levels from 91% (0 min) to a peak of 394% at 5 min, after which it fell 
to 80% at 120 min post-irradiation. The phospho-JNK2 levels rapidly rose from 8% (0 
min) to 177% at 15 min before falling to 16% at 120 min post-irradiation. The 
expression of phospho-JNK1 and -JNK2 was immediate and prolonged following high 
dose UVA+B radiation compared to that for low dose radiation. 
 
In response to low dose UVB+A radiation there was an increase in phospho-JNK1 
levels from 78% (0 min) to 155% by 5 min, after which it dropped to 82% at 120 min 
post-irradiation (Figure 4.7D). Phospho-JNK2 levels increased from 22% (0 min) to a 
peak of 54% (15 min) before falling back to control levels (0 min) at 120 min  
post-irradiation. Following high dose UVB+A radiation, the levels of phospho-JNK1 
rapidly increased from 78% (0 min) to 580% at 15 min, before dropping to 123% at 120 
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min post-irradiation. Likewise phospho-JNK2 levels also rose from 22% (0 min), 
peaking at 15 min (188%) before decreasing to 58% at 120 min post-irradiation. The 
activation of JNK1 was short-lived following low dose UVB+A radiation but was 
sustained after high dose radiation in MM96L cells.  
 
4.2.2.3 NFκB pathway 
Phospho-IκBα protein (41 kDa) was used to observe the activation of the NFκB 
pathway by using monoclonal phospho-IκBα antibody in western blots (Figure 4.8). 
The expression of phospho-IκBα was calculated as a ratio of UV-irradiated sample over 
sham-irradiated control (control = 100%). 
 
 
 
 
Figure 4.8 A representative western blot probed for phospho-IκBα in (A) HEM and  
(B) MM96L cells. The samples from lanes 2 to 5 in blot (A) and lanes 2 to 6 in blot (B) 
were exposed to low dose UVB radiation (0.2 kJ/m2). The samples from lanes 6 to 9 in 
blot (A) and lanes 7 to 11 in blot (B) were exposed to high dose UVB radiation  
(2 kJ/m2). The lanes marked from 1 to 9 in blot (A) represents Lane 1: Sham-irradiated 
control, 2 & 6: 5 min, 3 & 7: 15 min, 4 & 8: 30 min, 5 & 9: 120 min post-irradiation. 
The lanes marked from 1 to 11 in blot (B) represents Lane 1: Sham-irradiated control, 2 
& 7: 5 min, 3 & 8: 15 min, 4 & 9: 30 min, 5 & 10: 60 min, 6 & 11: 120 min  
post-irradiation.  
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4.2.2.3.1 HEM cells 
In HEM cells, following exposure to low and high dose UVA radiation, phospho-IκBα 
expression was low and did not significantly change throughout the 120 min time period 
except for the 120 min time-point following UV radiation  (Figure 4.9A).  
 
Low dose UVB radiation increased phospho-IκBα levels to 140% at 5 min after which 
they fell to 116% at 15 min, before increasing to 130% (30 min) and then remained 
fairly constant for the next 90 min (Figure 4.9B). The activation of phospho-IκBα was 
immediate but transient following low dose UVB radiation in these cells. On the other 
hand, high dose UVB exposure caused a drop in phospho-IκBα levels below that of 
control levels (0 min = 100%) falling to 92% at 5 min and remained fairly constant until 
120 min post-irradiation.  
 
In the case of low dose UVA+B radiation, phospho-IκBα levels rose slightly from 100% 
(0 min) to 113% (5 min) before falling to 84% at 120 min post-irradiation (Figure 
4.9C). In response to high dose UVA+B exposure, phospho-IκBα levels fell to 64% (30 
min) before rising to 82% at 120 min post-irradiation. This observed suppression was 
immediate and prolonged over the 120 min time period. 
 
Following exposure to either low or high dose UVB+A radiation, phospho-IκBα levels 
were fell to ~70-75% and remained constant until 120 min post-irradiation (Figure 
4.9D).  
 
4.2.2.3.2 MM96L cells 
In MM96L cells, low dose UVA radiation caused phospho-IκBα levels to increase to 
121% at 5 min which then decreased to 105% at 30 min before increasing again to
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Figure 4.9 The effect of UV radiation on the expression of phospho-IκBα protein in 
HEM cells. Cell cultures were irradiated with either a low (0.1 MED) or high (1 MED) 
UV dose of (A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation and proteins 
were extracted at various time points (0-120 min) post-irradiation. In each lane 30 µg of 
cell lysate was used to perform western blotting. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (0 min) and UV-irradiated 
cultures using Student’s paired t-test where significance was recorded as p ≤ 0.05 (*, †). 
[High dose UV (*); Low dose UV (†)]. 
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124% at 120 min post-irradiation (Figure 4.10A). The expression of phospho-IκBα 
following high dose UVA radiation was less than that induced by low dose UVA 
radiation. After high dose UVA exposure, phospho-IκBα levels fell below control levels 
to 80% at 5 min before eventually reaching to 90% at 120 min post-irradiation.  
 
Low dose UVB exposure caused a slight increase in phospho-IκBα levels from 100% (0 
min) to 115% at 5 min, after which it fell to 86% at 30 min before rising to 124% at 120 
min post-irradiation (Figure 4.10B). High dose UVB radiation induced a gradual 
increase in phospho-IκBα levels from 0 min (100%) to 30 min (126%) after which it fell 
to 111% at 120 min post-irradiation.  
 
In the case of low dose UVA+B radiation, phospho-IκBα levels increased to 109% at 5 
min and remained constant until 15 min, after which it fell back to control levels at 30 
min (0 min = 100%) before increasing to 110% at 120 min post-irradiation (Figure 
4.10C). High dose UVA+B radiation induced a slight increase in phospho-IκBα levels 
at 5 min (110%), after which it decreased to 95% at 30 min and remained fairly constant 
over the next 90 min.  
 
Following exposure to low dose UVB+A radiation, phospho-IκBα levels dropped from 
100% (0 min) to 78% at 60 min before increasing to 90% at 120 min post-irradiation 
(Figure 4.10D). After high dose UVB+A radiation, the level of phospho-IκBα was also 
lower than controls (0 min= 100%). These levels decreased to 80% at 5 min and further 
dropped to 66% at 60 min and remained the same at 120 min (69%) post-irradiation. 
The pattern of phospho-IκBα expression was similar following low and high dose 
UVB+A radiation, where there was an initial drop in levels which did not recover for at 
least 60 min. 
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Figure 4.10 The effect of UV radiation on the expression of phospho-IκBα protein in 
MM96L cells. Cell cultures were irradiated with either a low (0.1 MED) or high  
(1 MED) UV dose of (A) UVA, (B) UVB, (C) UVA+B and (D) UVB+A radiation and 
proteins were extracted at various time points (0-120 min) post-irradiation. In each lane 
30 µg of cell lysate was used to perform western blotting. Results expressed as the 
means ± SD from triplicate samples. Data are representative of three independent 
experiments. Comparisons were made between sham-irradiated control (0 min) and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as 
p ≤ 0.05 (*, †). [High dose UV (*); Low dose UV (†)]. 
MM96L - Phosphorylated IκBα 
%
 
o
f C
o
n
tr
o
l 
Time (min) 
%
 
o
f C
o
n
tr
o
l 
A 
C 
UVA 
UVA+B 
200 
50 
100 
150 
0 
200 
50 
100 
150 
0 
20 100 60 40 80 120 
20 100 60 40 80 120 
Time (min) 
B 
D 
UVB 
UVB+A 
200 
50 
100 
150 
0 
200 
50 
100 
150 
0 
20 100 60 40 80 120 
20 100 60 40 80 120 
%
 
o
f C
o
n
tr
o
l 
Legend:    (High Dose UV)             (Low Dose UV)            
%
 
o
f C
o
n
tr
o
l 
* * 
* 
† † 
* † † 
* 
* * * 
† † 
* * 
* 
* * 
† 
† 
† 
  
 
- 157 - 
4.2.3 The effect of UV radiation and IL1α on TNFα release in 
melanocyte-derived cells  
The effect of UV radiation on TNFα release in HEM and MM96L cells were measured 
24 h post-irradiation using ELISA. In this study only high dose UV radiation was used 
as low dose UV did not stimulate detectable amounts of TNFα in irradiated media 
samples. There were two treatment groups in this study. In group (1) the cell cultures 
received high dose UV radiation (UVA, UVB, UVA+B or UVB+A) and in group (2) 
the cell cultures received the same UV dose plus IL1α (10 ng/ml) immediately after UV 
exposure. IL1α was added to the cells as it was shown that it stimulated TNFα release 
from irradiated keratinocytes (Section 3.2.3) [164]. These cell cultures were incubated 
for 24 h before media samples were collected and micro-concentrated. The cell lysates 
were also collected to measure its protein concentration using Bichinchoninic Assay 
(Section 2.7.2). ELISA was performed on micro-concentrated media samples to 
measure amount of TNFα present using an AccuKine Human TNFα ELISA Kit (Section 
2.8). The data was expressed as amount of TNFα protein released per culture of cell 
protein (pg/mg). 
 
TNFα is released at very low levels from sham-irradiated HEM and MM96L cells  
(7 pg/mg, and 2 pg/mg, respectively) (Figure 4.11). When HEM cells were exposed to 
UV radiation, there was a slight increase in TNFα released from the cells (UVA: 7 
pg/mg, UVB: 12 pg/mg, UVA+B: 13 pg/mg, UVB+A: 10 pg/mg) (Figure 4.11A). When 
IL1α was added immediately after UV-irradiation, TNFα levels were significantly 
increased (Control+IL1α: 67 pg/mg, UVA+IL1α: 122 pg/mg, UVB+IL1α: 1309 pg/mg, 
UVA+B+IL1α: 1339 pg/mg, UVB+A+IL1α: 1296 pg/mg) in the cells. UVA radiation 
induced low levels of TNFα than the other UV types. TNFα levels were similar in cells 
exposed to UVB, UVA+B and UVB+A radiation plus IL1α. 
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Figure 4.11 The effect of high dose UV radiation and IL1α on TNFα release in  
(A) HEM and (B) MM96L cells. Cell cultures were UV-irradiated with a high dose and 
treated with or without 10 ng/ml of IL1α. The media was collected 24 h post-irradiation 
and assayed for the presence of TNFα protein using an AccuKine Human TNFα ELISA 
Kit. Results expressed as the means ± SD from triplicate samples. Data are 
representative of three independent experiments. Statistical analysis was performed 
using a Student’s paired t-test where significance was recorded as  
p ≤ 0.05. (*) Significant difference between Control and UV-irradiated sample (with and 
without IL1α). (†) Significant difference between (Control + IL1α) and UV-irradiated 
sample (with IL1α). 
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All values are calculated as the fold increase of irradiated cell treated with IL1α 
compared to their corresponding irradiated counterparts. 
Similar to that seen in HEM cells, MM96L cells released low levels of TNFα following 
exposure to UV radiation which was slightly higher than that seen for sham-irradiated 
cells (UVA: 2 pg/mg, UVB: 6 pg/mg, UVA+B: 6 pg/mg, UVB+A: 6 pg/mg) (Figure 
4.11B). TNFα levels were significantly increased following the addition of IL1α to the 
UV-irradiated cells (Control+IL1α: 30 pg/mg, UVA+IL1α: 28 pg/mg, UVB+IL1α: 580 
pg/mg, UVA+B+IL1α: 525 pg/mg, UVB+A+IL1α: 192 pg/mg). UVA radiation did not 
seem to have an effect on TNFα release even if IL1α was present. TNFα levels were 
similar when the cells were exposed to either UVB or UVA+B radiation treated with 
IL1α. In contrast, TNFα levels fell to 70% in those cells irradiated with UVB+A 
compared to those irradiated with UVB in the presence of IL1α. 
 
Overall, HEM cells secreted higher levels of TNFα compared to MM96L cells. The 
addition of IL1α had a greater effect on TNFα secreted from irradiated HEM than 
MM96L cells, the reasons for which are not clear (Table 4.1). UVB+A and UVB 
radiation induced a higher fold increase in TNFα levels in the presence of IL1α in HEM 
and MM96L cells, respectively compared to the other UV types. This effect observed 
may be UV and cell type-dependent. In addition, the effect of IL1α was more 
pronounced in irradiated melanocyte- than keratinocyte-derived cells (Tables 3.1 & 
4.1).  
 
 
 
Cell Line Sham UVA UVB UVA+B UVB+A 
HEM 10 17 109 103 130 
MM96L 15 14 97 88 32 
Table 4.1 Effect of IL1α on the release of TNFα from UV-irradiated 
melanocyte-derived cell line. 
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4.2.4 The effect of UV radiation and IL1α on the activation of the p38 
MAPK, JNK and NFκB pathways in melanocyte-derived cells 
In section 4.2.3, IL1α was shown to stimulate TNFα production in UV-irradiated 
melanocyte-derived cells. It was of interest to observe if IL1α can positively regulate 
cell signalling pathways as well. Therefore, the activation of p38 MAPK, JNK and 
NFκB pathways was observed over the first 30 min following UV radiation of HEM 
and MM96L cells treated with 10 ng/ml IL1α. These cells were exposed to high dose 
UVA, UVB, UVA+B or UVB+A radiation (Table 2.1) and 10 ng/ml IL1α was added 
immediately post-exposure. western blots were performed to observe the activation of 
the pathways using either polyclonal phospho-p38, phospho-JNK1/2 or monoclonal 
phospho-IκBα antibodies to identify the phosphorylated forms of p38 MAPK, JNK1/2 
and IκBα proteins (Section 2.7). These phosphorylated proteins were used as targets to 
signify the activation of p38 MAPK, JNK1/2 and NFκB pathways respectively. 
Phospho-p38 and JNK1 expression was observed from 5-30 min while that of  
phospho-IκBα was observed at 120 min post-irradiation as earlier studies showed that 
expression of these proteins was mostly maximal at these time points (Figures 4.3, 4.4, 
4.6, 4.7, 4.9 & 4.10).  
 
4.2.4.1 p38 MAPK pathway 
The polyclonal phospho-p38 MAPK antibody was used to probe for phospho-p38 
MAPK protein (43 kDa) on the western blots (Figure 4.12). The expression of  
phospho-p38 was calculated as a ratio of UV-irradiated sample over sham-irradiated 
control (control = 100%). 
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The level of phospho-p38 MAPK in sham-irradiated cells remained fairly constant in all 
three cell lines over a 30 min period as seen in Figure 4.13A. In Figure 4.14 the effect of 
IL1α on phospho-p38 levels in irradiated cells (HEM and MM96L) from 5 to 30 min 
post-irradiation is seen. For reasons of clarity, it was decided to assign each  
sham-irradiated (control) time point (5, 15 and 30 min) a value of 100% (Figure 3.17). 
It can be seen from Figure 4.13A that the level of phospho-p38 over these time points 
are similar to each other as well as to the 0 min control. By assigning the value of 100% 
to these control time points (5, 15 and 30 min), the effects elicited by UV radiation 
and/or IL1α can be evaluated.  
 
 
 
Figure 4.12 A representative western blot probed for phospho-p38 MAPK in (A) HEM 
and (B) MM96L cells exposed to UVB radiation (2 kJ/m2) with IL1α treatment. The 
samples from lanes 4-6 and 10-12 in blots (A & B) were treated with 10 ng/ml IL1α in  
sham-irradiated control (lanes 1-6) or after high dose UVB radiation (lanes 7-12). The 
lanes marked from 1 to 12 in blots (A & B) represents Lane 1 & 4: 5 min, 2 & 5: 15 
min, 3 & 6: 30 min after treatment in sham-irradiated control, 7 & 10: 5 min, 8 & 11: 15 
min, 9 & 12: 30 min post-irradiation with or without IL1α treatment.  
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4.2.4.1.1 HEM cells 
In HEM cells, phospho-p38 levels were represented as 100% from 5 min to 30 min in 
sham-irradiated controls (Figure 4.14A). The addition of IL1α caused a significant 
increase in the levels of phospho-p38 in sham-irradiated control during this 30 min time 
period (5, 15 and 30 min). Phospho-p38 levels were highest in sham-irradiated control 
at 15 min (143%) following the addition of IL1α.  
 
After exposure to only UVA radiation, there was an immediate increase in  
phospho-p38 levels at 5 min (255%) after which they fell to 186% at 30 min  
Figure 4.13 The change in (A) phospho-p38, phospho-JNK1 and (B) phospho-IκBα 
expression over time (5, 15, 30 & 120 min) in sham-irradiated HEM and MM96L cells. 
Results expressed as the means ± SD from triplicate samples. Data are representative of 
three independent experiments. 
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Figure 4.14 The effect of IL1α on the expression of phospho-p38 protein in (A) HEM 
and (B) MM96L cells after exposure to high dose UV radiation. Cell cultures were 
exposed to a high dose UV radiation and treated with or without 10 ng/ml of IL1α. 
Results expressed as the means ± SD from triplicate samples. Data are representative of 
three independent experiments. Comparisons were made between UV-irradiated 
samples and UV-irradiated samples with IL1α treatment using Student’s paired t-test 
where significance was recorded as p ≤ 0.05 (*).  
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post-irradiation (Figure 4.14A). The addition of IL1α to UVA-irradiated cells induced 
an increase in phospho-p38 levels to 583% at 15 min before decreasing to 529% at 30 
min post-irradiation and all of these levels were significantly higher than that of UVA 
radiation alone. 
 
In the case of UVB radiation, phospho-p38 levels rose to 333% at 5 min after which 
they fell to 253% at 15 min before increasing to 307% at 30 min post-irradiation (Figure 
4.14A). The addition of IL1α to UVB-irradiated cells caused a peak in phospho-p38 
levels at 15 min (681%) before declining to 356% at 30 min post-irradiation which was 
significantly higher than that of UVB radiation alone.  
 
After exposure to UVA+B radiation, there was a time-dependent increase in  
phospho-p38 levels from 5 min (269%) to 30 min (309%) post-irradiation (Figure 
4.14A). The addition of IL1α to UVA+B-irradiated cells induced a significant decrease 
in phospho-p38 levels at 5 min (248%) but these levels were significantly higher at 15 
min (497%) and 30 min (431%) when compared to that of cells exposed to UVA+B 
alone.  
 
After exposure to UVB+A radiation, phospho-p38 levels increased to 374% at 5 min 
after which they declined to 279% at 30 min post-irradiation (Figure 4.14A). The 
addition of IL1α to UVB+A-irradiated cells significantly increased the phospho-p38 
levels to  at 15 min (482%) and  30 min (330%) post-irradiation compared to those of 
UVA+B radiation alone.  
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4.2.4.1.2 MM96L cells 
In MM96L cells, phospho-p38 levels were represented as 100% from 5 min to 30 min in 
sham-irradiated control (Figure 4.14B). The addition of IL1α caused a significant 
increase in the levels of phopsho-p38 in sham-irradiated control at 5 min (142%) and 30 
min (173%) in these cells. 
 
In response to UVA radiation, there was a time-dependent decrease in phospho-p38 
levels from 5 min (847%) to 30 min (417%) post-irradiation (Figure 4.14B). The 
addition of IL1α to UVA-irradiated cells did not affect these levels except at 30 min 
(527%) where it was significantly higher. 
 
After exposure to UVB radiation, phospho-p38 levels were slightly elevated to that of 
unirradiated cells over the 30 min period (Figure 4.14B). The addition of IL1α to  
UVB-irradiated cells significantly increased phospho-p38 levels at 5 min (244%) and 15 
min (206%) when compared to those exposed to UVB alone. 
 
In the case of UVA+B radiation, the phospho-p38 levels increased at 5 min (998%) 
after which it fell to 290% (15 min) before increasing again at 30 min (652%)  
post-irradiation (Figure 4.14B). The addition of IL1α to UVA+B-irradiated cells 
significantly increased the levels of phospho-p38 at all these time points (1107%, 418% 
and 813%, respectively) in these cells.  
 
After exposure to UVB+A radiation, the levels of phospho-p38 peaked at 432% by 15 
min before decreasing to 264% at 30 min post-irradiation (Figure 4.14B). The addition 
of IL1α to UVB+A-irradiated cells significantly increased phospho-p38 levels at all 
these time points (474%, 618% and 461%, respectively) examined in these cells.  
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Figure 4.15 A representative western blot probed for phospho-JNK1 in (A) HEM and 
(B) MM96L cells exposed to UVB radiation (2 kJ/m2) with IL1α treatment. The samples 
from lanes 4-6 and 10-12 in blots (A & B) were treated with 10 ng/ml IL1α in  
sham-irradiated control (lanes 1-6) or after high dose UVB radiation (lanes 7-12). The 
lanes marked from 1 to 12 in blots (A & B) represents Lane 1 & 4: 5 min, 2 & 5: 15 
min, 3 & 6: 30 min after treatment in sham-irradiated control, 7 & 10: 5 min, 8 & 11: 15 
min, 9 & 12: 30 min post-irradiation with or without IL1α treatment.  
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4.2.4.2 JNK pathway 
The polyclonal phospho-JNK1/2 antibody was used to probe for phospho-JNK1 protein 
(46kDa) on the western blots (Figure 4.15). In this part of the study, only the expression 
of phospho-JNK1 was taken into account. Earlier experiments showed that  
phospho-JNK2 was expressed at much lower levels compared to phospho-JNK1 in 
HEM and MM96L cells (Figures 4.6 & 4.7). In HEM cells, phospho-JNK2 was not 
activated in UV-irradiated cells irrespective of the type used (Figure 4.6) and as a result 
phospho-JNK2 levels were not measured. Although phospho-JNK1 expression was only 
observed in this section, the levels of UV-induced phospho-JNK1 was calculated as a 
percentage of total phospho-JNK1 and -JNK2 in sham-irradiated control to maintain 
consistency with calculations performed in section 4.2.2.2 (Appendix A.5). Therefore, 
as seen in Figure 4.13A, at 0 min the level of phospho-JNK1 was 63% and 64% for 
sham-irradiated HEM and MM96L cells, respectively and these levels were similar to 
those at 5, 15 and 30 min.  
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4.2.4.2.1 HEM cells 
In HEM cells, phospho-JNK1 levels in sham-irradiated controls were fairly constant  
(~65%) over the 30 min time period (Figure 4.16A). The addition of IL1α caused a 
significant increase in these levels at the time points (5, 15 and 30 min) examined here. 
These levels were highest in sham-irradiated control at 15 min (96%) following the 
addition of IL1α. 
 
In response to UVA radiation, phospho-JNK1 levels peaked at 15 min (413%) after 
which they fell to 350% at 30 min post-irradiation (Figure 4.16A). The addition of IL1α 
to UVA-irradiated cells did not have a effect on phospho-JNK1 levels except at 15 min 
(486%) which was significantly higher. 
 
 Following exposure to UVB radiation, phospho-JNK1 levels increased from 5 min 
(495%) to 15 min (547%) before declining back to 495% at 30 min post-irradiation 
(Figure 4.16A). When IL1α was added to UVB-irradiated cells the levels of  
phospho-JNK1 was similar to those exposed to UVB alone except at 30 min (487%) 
which was significantly lower.  
 
UVA+B radiation alone increased phospho-JNK1 levels from 411% (5 min) to 493% 
(15 min) after which it dropped to 419% at 30 min post-irradiation (Figure 4.16A). The 
addition of IL1α to UVA+B-irradiated cells caused an increase at all time points with 
that at 30 min (445%) being significant.   
 
Following exposure to UVB+A radiation, phospho-JNK1 levels increased from 431% 
(5 min) to 499% (15 min) which declined at 30 min (379%) post-irradiation (Figure 
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Figure 4.16 The effect of IL1α on the expression of phospho-JNK1 protein in (A) HEM 
and (B) MM96L cells after exposure to high dose UV radiation. Cell cultures were 
exposed to a high dose UV radiation and treated with or without 10 ng/ml of IL1α. 
Results expressed as the means ± SD from triplicate samples. Data are representative of 
three independent experiments. Comparisons were made between UV-irradiated 
samples and UV-irradiated samples with IL1α treatment using Student’s paired t-test 
where significance was recorded as p ≤ 0.05 (*). 
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4.16A). The addition of IL1α to UVB+A-irradiated cells caused a slight reduction in 
phospho-JNK1 levels except at 15 min (517%) where it was significantly higher.  
 
4.2.4.2.2 MM96L cells 
In MM96L cells, phospho-JNK1 levels in sham-irradiated controls were fairly constant 
(~70%) over the 30 min time period (Figure 4.16B). The addition of IL1α increased the 
phospho-JNK1 levels in these cells but it was only significant at the 15 min (92%) and 
30 min (85%) time points. 
 
After exposure to UVA radiation alone, phospho-JNK1 levels increased to 238% at 5 
min after which they fell to 193% at 15 min before increasing again to 247% at 30 min 
post-irradiation (Figure 4.16B). The addition of IL1α to UVA-irradiated cells increased 
phospho-JNK1 expression with those at 5 min (282%) and 30 min (281%) being 
significant.  
 
In response to UVB radiation alone, phospho-JNK1 levels were elevated and remained 
fairly constant over the 30 min (104%) time period (Figure 4.16B). The addition of 
IL1α to UVB-irradiated cells induced a significant increase in the phospho-JNK1 levels 
at all time points with the greatest increase seen at 30 min (183%) post-irradiation. 
 
In UVA+B-irradiated cells, there was a time-dependent decrease in phospho-JNK1 
levels from 5 min (403%) to 30 min (297%) post-irradiation (Figure 4.16B). The 
addition of IL1α to UVA+B-irradiated cells caused an increase in these levels but only 
those at 5 min (446%) and 30 min (323%) were significant.  
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Following exposure to UVB+A radiation, phospho-JNK1 levels peaked to 567% at 15 
min after which it declined to 504% at 30 min post-irradiation (Figure 4.16B). The 
addition of IL1α to UVB+A-irradiated cells slightly increased these levels but this was 
not significant.   
 
4.2.4.3 NFκB pathway 
The expression of phospho-IκBα was observed at 120 min post-irradiation as expression 
of the protein was mostly maximal at this time point (Figures 4.9 & 4.10). The 
monoclonal phospho-IκBα antibody was used to probe for phospho-IκBα protein (41 
kDa) on the western blots (Figure 4.17). The expression of phospho-IκBα was 
calculated as a ratio of UV-irradiated sample over sham-irradiated control (control  
= 100%). The level of phospho-IκBα in sham-irradiated cells at 120 min was similar to 
that seen at 0 min (Figure 4.13B). In Figure 4.18, the effect of IL1α on  
phospho-IκBα levels in irradiated cells (HEM and MM96L) at 120 min post-irradiation 
is seen. For reasons of clarity, it was decided to assign the sham-irradiated (control) at 
120 min a value of 100% (Figure 4.18). By assigning the value of 100%, the effects 
elicited by UV radiation and/or IL1α can be evaluated.  
 
4.2.4.3.1 HEM cells 
In HEM cells, the level of phospho-IκBα was expressed as 100% at 120 min in  
sham-irradiated control (Figure 4.18A). The addition of IL1α did not have a significant 
effect on these levels in sham-irradiated control (112%).  
 
UVA radiation reduced phospho-IκBα levels below control levels (100%) to 89%. 
However, the addition of ILα to UVA-irradiated cells had no effect on phospho-IκBα 
levels (86%) in these cells (Figure 4.18A). 
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Phospho-IκBα levels (95%) in UVB-irradiated cells were similar to unirradiated 
controls at 120 min  post-irradiation (Figure 4.18A). The addition of IL1α to these 
irradiated cells had no effect on phospho-IκBα levels (98%) in these cells.  
 
UVA+B radiation caused phospho-IκBα levels to fall below control levels (100%) at 
120 min (80%) post-irradiation (Figure 4.18A). These levels were slightly increased 
(90%) when IL1α was added to UVA+B-irradiated cells.  
 
UVB+A radiation also caused phospho-IκBα levels to fall below control levels (100%) 
at 120 min (72%) post-irradiation (Figure 4.18A). Adding IL1α to these irradiated cells 
caused a slight increase in phospho-IκBα levels (81%) but this was not significant.  
Figure 4.17 A representative western blot probed for phospho-IκBα in (A) HEM and 
(B) MM96L cells exposed to UVB radiation (2 kJ/m2) with IL1α treatment. The samples 
from lanes 2 & 4 in blots (A & B) were treated with 10 ng/ml IL1α in sham-irradiated 
control (lanes 1 & 2) or after high dose UVB radiation (lanes 3 & 4). The lanes marked 
from 1 to 4 in blots (A & B) represents Lane 1 & 2: 120 min after treatment in  
sham-irradiated control, 3 & 4: 120 min post-irradiation with or without IL1α treatment.  
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Figure 4.18 The effect of IL1α on the expression of phospho-IκBα protein in (A) HEM 
and (B) MM96L cells at 120 min following exposure to high dose UV radiation. Cell 
cultures were exposed to a high dose UV radiation and treated with or without 10 ng/ml 
of IL1α. Results expressed as the means ± SD from triplicate samples. Data are 
representative of three independent experiments. Comparisons were made between UV-
irradiated samples and UV-irradiated samples with IL1α treatment using Student’s 
paired t-test where significance was recorded as p ≤ 0.05 (*).  
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4.2.4.3.2 MM96L cells 
In MM96L cells, the level of phospho-IκBα was expressed as 100% at 120 min in 
sham-irradiated control (Figure 4.18B). The addition of IL1α caused a slight decrease in 
this level in sham-irradiated control (94%) which was not significant.  
 
The phospho-IκBα levels in UVA-irradiated cells (96%) were similar to those in 
unirradiated cells remained at 120 min post-irradiation (Figure 4.18B). These levels 
were unchanged following the addition of IL1α to UVA-irradiated cells. 
 
Phospho-IκBα levels increased to 111% in UVB-irradiated cells at 120 min  
post-irradiation (Figure 4.18B). The addition of IL1α to these irradiated cells caused a 
significant reduction in phospho-IκBα levels (96%) in these cells. 
 
At 120 min following UVA+B-irradiation, the phospho-IκBα levels (91%)  fell below 
that of unirradiated control levels (Figure 4.18B). When IL1α was added to  
UVA+B-irradiated cells, the phospho-IκBα levels fell to 77% which was significantly 
lower than that seen in cell exposed to only UVA+B radiation.  
 
UVB+A radiation, had no effect on phospho-IκBα levels in the irradiated cells at 120 
min (99%) post-irradiation (Figure 4.18B). When IL1α was added to UVB+A-irradiated 
cells the phospho-IκBα levels significantly fell (94%) when compared to that seen in 
those exposed to UVB+A alone. 
 
In general IL1α had no effect on the phospho-IκBα levels in the HEM and MM96L cells 
(Figure 4.18). 
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4.2.5 The effect of pathway specific inhibitors on UV-induced TNFα 
release in melanocyte-derived cells 
The changes in the level of phosphorylated intermediates of the p38 MAPK, JNK and 
NFκB pathways were not sufficient to elucidate which pathway/s is/are involved in  
UV-induced TNFα release in these melanocyte-derived cells (Section 4.2.4). Therefore, 
pathway specific inhibitors were utilised to inhibit the activity of the pathways and 
observe the effects they had on UV-mediated TNFα release. Since high dose UVB 
radiation induced the highest level of TNFα release in HEM and MM96L cells (Figure 
4.11), this study was performed using cells exposed to high dose UVB radiation.  
 
4.2.5.1 Inhibitor study 
4.2.5.1.1 Cell viability assay  
Cell viability was determined at 24 h post UVB-irradiation to ensure that the inhibitor 
doses used in this study were not cytotoxic (Table 4.2). Due to the difficulty to grow 
large numbers of HEM cells in culture, the MM96L melanoma  cell line was used to test 
the cytotoxicity of the inhibitors at different doses. The melanocyte-derived cells were 
both treated with specific inhibitors for 1 h prior to exposure to high dose UVB 
radiation. Following UVB exposure, the cells were then exposed to the inhibitor for  
24 h. As the inhibitors (SB202190, SP600125 and sulfasalazine) were dissolved in 
DMSO, the cytotoxicity of the solvent was also tested.  
 
The solvent DMSO did not induce cell death in sham- and UVB-irradiated MM96L 
cells (Figures 4.19-4.21). In MM96L cells, SB202190 (2.5-20 µM) (p38 inhibitor) was 
not cytotoxic in sham-irradiated controls (Figure 4.19). At low doses (2.5 and 5 µM), 
SB202190 did not decrease the number of attached viable cells following  
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UVB-irradiation in the presence or absence of IL1α. However, at higher doses (10 and 
20 µM) SB202190 induced cell death (23% and 41%, respectively) in the  
UVB-irradiated cultures (15%).  
 
In sham-irradiated controls, the increasing doses of SP600125 (2.5-20 µM) (JNK 
inhibitor) were not cytotoxic to MM96L cells (Figure 4.20). However in irradiated cells 
treated with SP600125, the lower doses (2.5 and 5 µM) caused an increase in the levels 
of dead cells (attached and detached) (71% and 69%, respectively) whereas the higher 
doses (10 and 20 µM) induced a greater increase in cell death (91% and 96%, 
respectively) when compared to those exposed to only UVB radiation (21%).  
 
Sulfasalazine (NFκB inhibitor) was not cytotoxic at low doses (0.625 and 1.25 mM) in 
sham-irradiated controls (Figure 4.21). However, at higher doses (2.5 and 5 mM) (21%) 
it reduced the levels of attached viable cells (67% and 21%, respectively) in 
Pathway Specific Inhibitor Doses 
2.5 µM 
5 µM 
10 µM 
P38 MAPK SB202190 
20 µM 
2.5 µM 
5 µM 
10 µM 
JNK SP600125 
20 µM 
0.625 mM 
1.25 mM 
2.5 mM 
NFκB Sulfasalazine 
5 mM 
Table 4.2 The pathway specific inhibitors and doses used in 
this study.  
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Figure 4.19 The effect of SB202190 on the viability of MM96L cell cultures at 24 h post UVB-irradiation (2 kJ/m2). The cells were incubated with 
SB202190 for 1 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with SB202190 before cell viability was determined 
using trypan blue solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments. 
Comparisons were made between sham-irradiated control (Control) and UV-irradiated cultures using Student’s paired t-test where significance was 
recorded as p ≤ 0.05 (*). 
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Figure 4.20 The effect of SP600125 on the viability of MM96L cell cultures at 24 h post UVB-irradiation (2 kJ/m2). The cells were incubated with 
SP600125 for 1 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with SP600125 before cell viability was determined 
using trypan blue solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (Control) and UV-irradiated cultures using Student’s paired t-test where significance was 
recorded as p ≤ 0.05 (*). 
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Figure 4.21 The effect of sulfasalazine on the viability of MM96L cell cultures at 24 h post UVB-irradiation (2 kJ/m2). The cells were incubated with 
sulfasalazine for 1 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with sulfasalazine before cell viability was determined 
using trypan blue solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments. 
Comparisons were made between sham-irradiated control (Control) and UV-irradiated cultures using Student’s paired t-test where significance was 
recorded as p ≤ 0.05 (*). 
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sham-irradiated control. After UVB radiation, low dose sulfasalazine (0.625 and 1.25 
mM) had no effect on the viability of cells in the presence or absence of IL1α. In 
irradiated cells treated with higher doses (2.5 and 5 mM) of sulfasalazine there was a 
fall in the percentage of attached viable cells (34% and 0%, respectively). As a result of 
this study, the two lowest inhibitor doses (SB202190 and SP600125: 2.5 µM and 5 µM; 
sulfasalazine: 0.625 mM and 1.25mM) which were the least cytotoxic in MM96L cells 
were chosen and tested for their effect on HEM cell viability. 
 
In HEM cells, SB202190, SP600125, sulfasalazine and the solvent DMSO were shown 
to be non-cytotoxic as the percentage of attached viable cells was similar in treated or 
non-treated cultures (Figures 4.22-4.24). Irradiated HEM cells treated with SB202190 
or SP600125 (2.5 µM or 5 µM) displayed similar viability to those cells exposed to only 
UVB (Figures 4.22-4.23). The addition of IL1α had no effect on the viability of 
irradiated cells treated with inhibitors.  
 
Sulfasalazine treatment resulted in increased levels of cell death in UVB-irradiated 
HEM cells in the presence or absence of IL1α (Figure 4.24). At 0.625 mM and 1.25 mM 
sulfasalazine, the percentage of attached viable cells was 73% and 72%, respectively 
which was less than that seen in UVB-irradiated cells (83%). In irradiated HEM cells 
treated with IL1α, 0.625 mM and 1.25 mM sulfasalazine caused a drop in the 
percentage of attached viable cells to 72% and 70% compared to cells exposed to just 
UVB+IL1α alone (80%). 
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Figure 4.22 The effect of SB202190 on the viability of HEM cell cultures at 24 h post UVB-irradiation (2 kJ/m2). The cells were incubated with 
SB202190 for 1 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with SB202190 before cell viability was determined 
using trypan blue solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (Control) and UV-irradiated cultures using Student’s paired t-test where significance was 
recorded as p ≤ 0.05 (*). 
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Figure 4.23 The effect of SP600125 on the viability of HEM cell cultures at 24 h post UVB-irradiation (2 kJ/m2). The cells were incubated with 
SP600125 for 1 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with SP600125 before cell viability was determined 
using trypan blue solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments. 
Comparisons were made between sham-irradiated control (Control) and UV-irradiated cultures using Student’s paired t-test where significance was 
recorded as p ≤ 0.05 (*). 
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Figure 4.24 The effect of sulfasalazine on the viability of HEM cell cultures at 24 h post UVB-irradiation (2 kJ/m2). The cells were incubated with 
sulfasalazine for 1 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with sulfasalazine before cell viability was determined 
using trypan blue solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments.  
Comparisons were made between sham-irradiated control (Control) and UV-irradiated cultures using Student’s paired t-test where significance was 
recorded as p ≤ 0.05 (*). 
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In general, cell viability decreased as the doses of the inhibitors increased. Therefore, 
inhibitor doses which were least cytotoxic were chosen to investigate their effects on 
TNFα release from UVB-irradiated HEM and MM96L cells (Table 4.3).  
 
 
 
Pathway Specific Inhibitor Doses 
2.5 µM P38 MAPK SB202190 
5 µM 
2.5 µM JNK SP600125 
5 µM 
0.625 mM NFκB Sulfasalazine 
1.25 mM 
 
 
 
4.2.5.1.2 ELISA  
In order to observe which signalling pathway was involved in UV-induced TNFα 
release, ELISAs were performed to quantify the level of TNFα released from HEM and 
MM96L cells treated with either SB202190, SP600125 or sulfasalazine (Table 4.3). The 
cell cultures were treated with the respective doses of each inhibitor for 1 h prior to 
receiving 2 kJ/m2 UVB-irradiation. After UVB exposure, the cell cultures were 
incubated with the specific inhibitors for 24 h in the presence or absence of IL1α (10 
ng/ml). The level of TNFα released from the cultures was expressed as amount of TNFα 
protein released per mg cell protein (pg/mg), as described previously in sections 2.7.2 
and 2.8. 
 
In HEM cells, unirradiated cultures treated with either SB202190 (p38 inhibitor), 
SP600125 (JNK inhibitor) or sulfasalazine (NFκB inhibitor) released similar amounts of 
Table 4.3 The doses of pathway inhibitors used in measuring 
TNFα release from irradiated cells.   
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TNFα compared to untreated controls (Figure 4.25). The amounts of TNFα released 
from UVB-irradiated cells treated with 2.5 and 5 µM SB202190 were 11 and 9 pg/mg, 
respectively which was less than that seen in irradiated cells (16 pg/mg). This degree of 
inhibition was more pronounced when the UVB-irradiated cells were stimulated with 
IL1α. The irradiated cells released 1343 pg/mg TNFα after 24 h, however when these 
cultures were treated with 2.5 and 5 µM SB202190, only 89 and 113 pg/mg TNFα, 
respectively was released. Neither SP600125 (2.5 and 5 µM) nor sulfasalazine (0.625 
and 1.25 µM) inhibited TNFα release from the UVB-irradiated HEM cells either in the 
presence or absence of IL1α. 
 
In MM96L cells, sham-irradiated cells treated with either SB202190, SP600125 or 
sulfasalazine released similar levels of TNFα to untreated controls (Figure 4.26).  
UVB-irradiated MM96L cells released 20 pg/mg TNFα, while those cells treated with 
either 2.5 or 5 µM SB202190 (p38 inhibitor) only released 9 pg/mg TNFα. When  
UVB-irradiated MM96L cells were incubated in the presence of IL1α, 539 pg/mg TNFα 
was released from the cells over 24 h. However, when SB202190 (2.5 and 5 µM) was 
added to these cells, there was a significant reduction in the level of TNFα released (244 
pg/mg and 234 pg/mg TNFα, respectively). SP600125 (JNK inhibitor) did not inhibit 
the release of TNFα from UVB-irradiated MM96L cells in the presence or absence of 
IL1α (Figure 4.26).  
 
Sulfasalazine (0.625 or 1.25 mM) was shown to slightly reduce the TNFα levels (15 
pg/mg) released from UVB-irradiated MM96L cells compared to untreated irradiated 
cells (20 pg/mg). When the irradiated cells were treated with IL1α, sulfasalazine (0.625 
and 1.25 mM) was shown to inhibit TNFα levels from 539 pg/mg to 279 and 282 
pg/mg, respectively. There was a slight additive effect observed when SB202190 
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SB202190 2.5 µM 
SP600125 5 µM 
SP600125 2.5 µM 
Sulfasalazine 0.625 mM 
SB202190 5 µM 
Sulfasalazine 1.25 mM 
Figure 4.25 The effect of pathway specific inhibitors on TNFα release from HEM cells at 24 h post UVB-irradiation (2 kJ/m2). The cells were 
incubated with the specific inhibitors for 1 h prior to high dose UVB exposure. After UVB exposure, the cells were incubated for 24 h with the specific 
inhibitors and treated with or without 10 ng/ml of IL1α. Results expressed as the means ± SD from triplicate samples. Data are representative of three 
independent experiments. Statistical analysis was performed using a Student’s paired t-test where significance was recorded as p ≤ 0.05. (†) Significant 
difference between untreated control and inhibitor treated sample in the presence of IL1α. 
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Legend:             No treatment          IL1α treatment
 
SB202190 2.5 µM 
SP600125 5 µM 
SP600125 2.5 µM 
Sulfasalazine 0.625 mM 
SB202190 5 µM 
Sulfasalazine 1.25 mM 
Figure 4.26 The effect of pathway specific inhibitors on TNFα release from MM96L cells at 24 h post UVB-irradiation (2 kJ/m2). The cells were 
incubated with the specific inhibitors for 1 h prior to high dose UVB exposure. After UVB exposure, the cells were incubated for 24 h with the specific 
inhibitors and treated with or without 10 ng/ml of IL1α. Results expressed as the means ± SD from triplicate samples. Data are representative of three 
independent experiments. Statistical analysis was performed using a Student’s paired t-test where significance was recorded as p ≤ 0.05. Significant 
difference between untreated control and inhibitor treated sample in the (*) absence of IL1α or (†) presence of IL1α. 
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and sulfasalazine were both added to the irradiated cells treated with IL1α, where the 
levels fell to 224 pg/mg. In summary it appears that the p38 MAPK pathway seems to 
be involved in UVB-mediated TNFα release in both HEM and MM96L cells. However 
NFκB and other pathways may also be involved in TNFα release from the MM96L 
melanoma cells as well.  
 
4.2.5.2 Anisomycin study 
4.2.5.2.1 Western blot 
The results obtained from using signalling pathway inhibitors showed that the  
UVB-activated p38 MAPK pathway appears to be involved in TNFα release from both 
HEM and MM96L cells (Figures 4.25 & 4.26). Anisomycin is known to activate the 
p38 MAPK pathway [177]. Therefore, anisomycin was used to confirm if the p38  
MAPK-mediated TNFα release is a UV specific response or not. Firstly both HEM and 
MM96L cells were incubated with anisomycin (20-100 µM) to observe if the p38 
MAPK pathway was activated in these cells (Figure 4.27). In HEM cells, anisomycin 
(20-100 µM) increased the phospho-p38 levels by 2.6 to 3.5-fold compared to that of 
untreated controls (Figure 4.28A). When IL1α was added to the cultures there was a 
greater increase (5 to 7.5-fold) in phospho-p38 levels than that of untreated control. In 
UVB-irradiated HEM cells, there was a 2.5-fold increase in phospho-p38 levels 
compared to that of sham-irradiated controls. When anisomycin (20-100 µM) was added 
to UVB-irradiated cells, phospho-p38 levels were 1.5 to 1.7-fold higher than that of 
UVB-irradiated cells. A similar result was also seen when anisomycin was added to 
UVB-irradiated cells treated with IL1α (Figure 4.28B).  
 
In untreated MM96L cells, low dose anisomycin (20 µM) increased phospho-p38 levels 
by 2.4-fold compared to that of untreated controls (Figure 4.29A). However, when the
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Figure 4.27 A representative western blot probed for phospho-p38 in HEM and 
MM96L cells treated with anisomycin. Cell cultures were either incubated with 
anisomycin in sham-irradiated or UVB-irradiated (2 kJ/m2) cell cultures with or without 
IL1α supplementation (10 ng/ml). All cell lysates were extracted at 15 min  
post-incubation of anisomycin. In blots (A & B) the lanes represent, Lanes 3 & 8: 20 
µM anisomycin, 4 & 9: 40 µM anisomycin, 5 & 10: 60 µM anisomycin, 6 & 11: 80 µM 
anisomycin and 7 & 12: 100 µM anisomycin. In blots (C & D) the lanes represent, 
Lanes 5 & 8: 20 µM anisomycin, 6 & 9: 40 µM anisomycin and 7 & 10: 100 µM 
anisomycin.  
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Figure 4.28 The effect of anisomycin on the expression of phospho-p38 protein in  
(A) sham-irradiated and (B) UVB-irradiated HEM cells. Sham and UVB-irradiated  
(2 kJ/m2) cell cultures which were treated with or without 10 ng/ml of IL1α were 
incubated with anisomycin for 15 min. Data Results expressed as the means ± SD from 
triplicate samples. Data are representative of three independent experiments. Statistical 
analysis was performed using a Student’s paired t-test where significance was recorded 
as p ≤ 0.05. Significant difference between untreated control and anisomycin treated 
sample in the (*) absence of IL1α or (θ) presence of IL1α. Significant difference 
between UVB-irradiated untreated sample and anisomycin treated irradiated sample in 
the (†) absence of IL1α or (§) presence of IL1α.  
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Figure 4.29 The effect of anisomycin on the expression of phospho-p38 protein in  
(A) sham-irradiated and (B) UVB-irradiated MM96L cells. Sham and UVB-irradiated  
(2 kJ/m2) cell cultures which were treated with or without 10 ng/ml of IL1α were 
incubated with anisomycin for 15 min. Results expressed as the means ± SD from 
triplicate samples. Data are representative of three independent experiments. Statistical 
analysis was performed using a Student’s paired t-test where significance was recorded 
as p ≤ 0.05. Significant difference between untreated control and anisomycin treated 
sample in the (*) absence of IL1α or (θ) presence of IL1α. Significant difference 
between UVB-irradiated untreated sample and anisomycin treated irradiated sample in 
the (†) absence of IL1α or (§) presence of IL1α.  
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concentration of anisomycin was increased the phospho-p38 level in fell in these cells 
(Figure 4.29A). When IL1α was added to the unirradiated cells, phospho-p38 levels 
were only higher in cells treated with 20 and 60 µM anisomycin (Figure 4.29A). In 
UVB-irradiated MM96L cells exposed to anisomycin (20-100 µM), phospho-p38 levels 
increased by 2.4 to 3.5-fold compared to that of untreated irradiated cells without 
anisomycin (Figure 4.29B). Phospho-p38 levels fell when IL1α was added to irradiated 
cells treated with anisomycin (Figure 4.29B).   
 
4.2.5.2.2 Cell viability  
In order to confirm that anisomycin used in the above study (Section 4.2.5.2.1) was not 
cytotoxic, its effect on cell viability was determined. anisomycin was dissolved in 
DMSO and this solvent had no effect on untreated HEM cell cultures (Figure 4.30). 
Increasing concentrations of anisomycin (20-100 µM) resulted in a dose-dependent 
decrease in percentage of attached viable cells from ~80% to ~42% in sham-irradiated 
cells. In UVB-irradiated HEM cells in the presence or absence of IL1α, anisomycin  
(20-100 µM) elicited a similar effect with the percentage of attached viable cells falling 
from 79% to 25%.  
 
Similar observations were seen in MM96L cells treated with increasing concentrations 
of anisomycin. As with that seen in HEM cells, DMSO had no effect on the viability of 
unirradiated MM96L cells (Figure 4.31). Increasing doses of anisomycin (20-100 µM) 
reduced the percentage of attached viable cells in both sham- or UVB-irradiated 
MM96L cells in the presence or absence of IL1α. The percentage of attached viable 
cells in sham- or UVB-irradiated MM96L cells treated with 100 µM anisomycin was 
between 7-13%. 
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Figure 4.30 The effect of anisomycin on the viability of HEM cell cultures at 24 h post UVB-irradiation (2 kJ/m2). After UV exposure, the cells were 
incubated for 24 h with anisomycin before cell viability was determined using trypan blue solution. Results expressed as the means ± SD from 
triplicate samples. Data are representative of three independent experiments. Comparisons were made between sham-irradiated control and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as p ≤ 0.05 (*). 
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Figure 4.31 The effect of anisomycin on the viability of MM96L cell cultures at 24 h post UVB-irradiation (2 kJ/m2). After UV exposure, the cells 
were incubated for 24 h with anisomycin before cell viability was determined using trypan blue solution. Results expressed as the means ± SD from 
triplicate samples. Data are representative of three independent experiments. Comparisons were made between sham-irradiated control and  
UV-irradiated cultures using Student’s paired t-test where significance was recorded as p ≤ 0.05 (*). 
Effect of anisomycin on viability of MM96L cells  
Control Control Control Control Control Control 
100 
90 
80 
70 
60 
50 
40 
30 
20 
10 
0 
UVB 
High 
%
 
C
e
l
l
 
P
o
p
u
l
a
t
i
o
n
 
Control Control Control Control UVB 
High 
UVB 
High 
UVB 
High 
UVB 
High 
UVB 
High 
UVB 
High 
UVB 
High 
Legend:  Attached Viable Cells  Attached Dead Cells          Detached Viable Cells                      Detached Dead Cells 
* 
* 
* * 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* * 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* * 
* 
* * 
* 
* 
* 
* 
* 
* 
* * 
* 
* 
* 
* 
* 
* 
* 
* 
Anisomycin 20 µM 
Anisomycin 40 µM 
Anisomycin 100 µM 
Treatment Groups 
+ - 
- 
- 
+ + - - 
- 
- - - + 
- - 
- 
- 
- 
IL1α (10ng/ml) 
0.5% DMSO 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
+ 
+ 
- - 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
+ 
+ 
+ 
- 
- 
- 
- 
- 
+ + + + 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ + 
+ - 
- - 
- 
- 
- 
- 
+ + 
+ 
UVB 
High 
UVB 
High 
* 
* 
* 
* 
* 
* 
* 
* 
  
 
- 194 - 
4.2.5.2.3 ELISA  
The effect of anisomycin on UV-mediated TNFα release in HEM and MM96L cells was 
measured using ELISA. Two doses of anisomycin (20 and 40 µM) were used in this 
study as they were less toxic to the cells than 100 µM anisomycin (Figures 4.30 & 
4.31). In sham-irradiated HEM and MM96L cells, anisomycin induced low levels of 
TNFα in the presence or absence of IL1α (Figure 4.32). A similar observation was seen 
in UVB-irradiated HEM and MM96L cells in the presence or absence of IL1α where 
anisomycin treatment inhibited TNFα release (< 29 pg/mg) when compared to that seen 
in cells exposed to UVB or UVB+IL1α. 
 
In general, anisomycin did not enhance TNFα release from UVB-irradiated HEM and 
MM96L cells in the presence or absence of IL1α. In section 4.2.5, SB202190 (p38 
MAPK inhibitor) caused a dose-dependent decrease in percentage of attached viable 
MM96L cells and inhibited TNFα release from melanocyte-derived cells (Sections 4.19, 
4.25 & 4.26). This suggests that the p38 MAPK pathway maybe involved in  
UVB-mediated cell survival and TNFα release. Although, in this section anisomycin 
was shown to be a potent activator of the p38 MAPK pathway (Figures 4.28 & 4.29) it 
did not confer protection to either UVB-irradiated cells or increased TNFα release 
(Figures 4.30, 4.31 & 4.32). Therefore, this may suggest that other signalling pathways 
maybe involved in this process.  
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Figure 4.32 The effect of anisomycin on TNFα release in (A) HEM and (B) MM96L 
cells. Cell cultures were treated with either 20 µM or 40 µM anisomycin in  
sham-irradiated or UVB-irradiated (2 kJ/m2) cells in the presence or absence of 10 
ng/ml of IL1α. Results expressed as the means ± SD from triplicate samples. Data are 
representative of three independent experiments. Statistical analysis was performed 
using a Student’s paired t-test where significance was recorded as p≤0.05. Significant 
difference between untreated control and anisomycin treated sample in the (*) absence 
of IL1α or (†) presence of IL1α. Significant difference between UVB-irradiated 
untreated sample and anisomycin treated irradiated sample in  the (θ) absence of IL1α or 
(§) presence of IL1α.  
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4.3 Discussion  
4.3.1 Choice of cell types and UV radiation 
Two different human melanocyte-derived cell types, HEM (Human Epidermal 
Melanocytes) and MM96L (Malignant Melanoma) cells were used in this study. The 
HEM and MM96L cells were used to observe how normal and cancerous melanocytes 
responded to UV radiation. These cells were exposed to the same low and a high dose 
of UVA, UVB, UVA+B and UVB+A radiation that was used to irradiate  
keratinocyte-derived cell lines (Chapter 3).  
 
4.3.2 The effect of UV radiation on the viability of melanocyte-derived 
cells  
HEM cells were less susceptible to different UV types or doses than were MM96L cells. 
The percentage of attached viable cells following UV radiation was higher in HEM cells 
than in MM96L cells (Figure 4.1). This suggests that HEM cells either have a more 
efficient DNA repair mechanism or certain factor(s) that render(s) them less susceptible 
to UV radiation. This factor is most likely to be melanin, which is a UV-absorbing 
pigment that is synthesized in melanocytes (HEM) and is present at a much higher level 
than found in keratinocytes [232, 233]. Kobayashi et al. [234] observed that melanin 
forms supranuclear caps around the nucleus protecting the DNA from harmful UV 
radiation. Epidermal cells containing melanin acquired less CPDs than did cells lacking 
melanin. The accumulation of DNA photoproducts was inversely related with the 
concentration of melanin within these epidermal cells [234]. Melanocytes possess a 
weaker antioxidant defence mechanism than do keratinocytes, but are less sensitive to 
UV-induced damage [235]. UV radiation can produce ROS which can inflict oxidative 
damage to the cells leading to apoptosis [65-67, 157, 159].  
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In this study, the MM96L cells had a greater percentage of detached viable cells than 
HEM cells following exposure to high UV doses (Figure 4.1). The highest levels were 
observed in cells exposed to high dose UVB, UVA+B and UVB+A radiation. The 
cellular morphology of detached viable MM96L cells differed to that of attached viable 
cells and may be due to UV-induced membrane damage (Figure 4.33).  
 
 
 
In Figure 4.34 it can be seen that these cells may be in the early stages of apoptosis 
where the plasma membrane was intact and excluded the trypan blue dye [236]. In 
MM96L cells, 24 h following exposure to either high dose UVB, UVA+B or UVB+A 
radiation, there were almost as many attached and detached viable cells (Figure 4.1). 
However, following high dose UVA radiation, the values were 70% and 14%,  
Detached MM96L Cells Attached MM96L Cells 
Figure 4.33 Phase contrast images of detached and attached MM96L cells after trypan 
blue exclusion. The MM96L cells were exposed to high dose UVB (2 kJ/m2) radiation 
and incubated for 24 h. After incubation, the detached cells were collected from media 
and attached cells were dissociated by trypsin from the base of the petri dish. These 
groups of cells were centrifuged and the cell pellet was resuspended in PBS. These cells 
were treated with trypan blue and viewed under an inverted microscope. The red arrow 
indicates a dead cell and the black arrow indicates a viable cell.  
250 µm 250 µm 
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Figure 4.34 Phase contrast images of (A) detached and (B) attached MM96L cells 
seeded onto petri dishes 24 h after high dose UVB exposure. The MM96L cells were 
exposed to high dose UVB (2 kJ/m2) radiation and incubated for 24 h. After incubation, 
the detached cells were collected from media and attached cells were dissociated by 
trypsin from the base of the petri dish. These groups of cells were centrifuged and the 
cell pellet was resuspended in PBS. The resuspended detached and attached cells were 
seeded onto petri dishes and observed for cell adhesion and growth at (C) 0 h (D) 24 h 
and (E) 72 h. 
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respectively (Figure 4.1). This suggests that when the cells were exposed to a 
combination of UVA+B or UVB+A radiation, the effect of UVB component was 
predominant over that of UVA. Koch-Paiz et al. [237] found that the genetic response 
triggered by UVA (50 kJ/m2) in MCF-7 cells was weaker than that of UVB (0.1 kJ/m2) 
radiation. In mouse embryonic fibroblast cells, UVB (0.8 kJ/m2) radiation produced 
more CPDs while UVA (180 kJ/m2) radiation formed mainly oxidized purines [238]. In 
these cells the UVB-induced DNA lesions were repaired after 24 h while the  
UVA-induced oxidized purines were repaired within 30 min. 
  
4.3.3 The effect of UV radiation on the activation of the p38 MAPK, 
JNK and NFκB pathways in melanocyte-derived cells 
In response to UV radiation, the p38 MAPK, JNK and NFκB pathways were activated 
differently to each other in the HEM and MM96L cells (Figure 4.35). The HEM cells 
exhibited a uniformed activation of all three pathways following each type of UV 
radiation whereas in MM96L cells the activation of this pathway was  UV type 
dependent. This suggests that the activation of the pathways in response to UV radiation 
is also cell type dependent. In the HEM cells, although there was a difference in the 
levels of phospho-p38, the pathway was activated in a similar pattern irrespective of the 
UV types and doses used (Figure 4.3). The p38 MAPK pathway was activated 
immediately with increased levels evident within 5 min post-irradiation (Figure 4.3). 
The activation of the p38 MAPK pathway decreased after 30 min post-irradiation all 
UV types and doses which suggests a brief and transient signal. In MM96L cells, a 
minimal p38 MAPK pathway activation was seen when the cells were exposed to low 
dose UV irrespective of the type used (Figure 4.4). High dose UVA and UVA+B 
radiation induced a biphasic increase in p38 MAPK activation with peaks at 5 and 60 
min after UVA exposure and 5 and 30 min following UVA+B radiation (Figure 4.4).
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250 µm 250 µm 
250 µm 250 µm 
250 µm 250 µm 
Figure 4.35 A comparison of the activation of (Row 1) p38 MAPK, (Row 2) JNK and  
(Row 3) NFκB pathways between (Column A) HEM and (Column B) MM96L cells 
exposed to high dose UV radiation. For further information on each figure please see 
Figures 4.3, 4.4, 4.6, 4.7, 4.9 & 4.10. 
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The UVB and UVB+A radiation stimulated a low and transient activation of the p38 
MAPK pathway. In MM96L cells, this pathway appeared to be both UV wavelength 
and dose-dependent.  
 
In HEM cells, the JNK pathway was activated  irrespective of UV type or dose. In 
general, phospho-JNK1 levels peaked 5 min following exposure to high or low UV 
doses (Figures 4.6). Like that seen with the p38 MAPK pathway, phospho-JNK1 levels 
fell after 30 min post-irradiation for all UV types. Of interest was that phospho-JNK2 
levels were minimal and largely unaffected following exposure to all UV types. In 
MM96L cells phospho-JNK1 levels peaked at different time-points depending on the 
types of UV radiation (Figure 4.7). The phospho-JNK2 isoform was activated to higher 
levels in MM96L cells after high dose UV radiation and this activation was both 
immediate and transient (Figure 4.35). In MM96L cells, low dose of the different UV 
types initiated low activation of the JNK pathway which was opposite to that observed 
in HEM cells (Figure 4.35). 
 
As the p38 MAPK and JNK pathways are regulated differently in HEM and MM96L 
cells, it provides evidence that the functions performed by both pathways in normal 
melanocytes may not be the same in melanoma cells. Cohen et al. [239] found that 
radial growth melanoma cells have constitutive activation of MAPK whereas primary 
melanocytes had minimal activation. These pathways are known to be involved in a 
plethora of functions like proliferation, inflammation, apoptosis, differentiation, cell 
cycle regulation among others [175, 240]. Therefore, mutations incurred in the upstream 
activators of these pathways that can lead to deleterious events within normal 
melanocytes and altered signalling in melanoma cells. Melanoma cells possessing  
B-Raf and N-Ras mutations have an increased activation of MEK/ERK [241]. When 
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melanoma cells were treated with CI1040, the MEK inhibitor, cell proliferation and 
increased cell death were observed in mutant Ras/B-Raf cells but not in wild type cells 
[242]. This suggested that mutant Ras and B-Raf are necessary for melanoma growth 
and MEK is required for MAPK activation in these cells. B-Raf mutations were shown 
not to correlate with ERK activation in melanocytic nevi [243]. Apart from B-Raf 
mutations other factors like B-Raf overexpression and regulation by MAPK 
phosphatases may also activate ERK [243].  
 
The ERK pathway has been suggested to be  the main pathway involved in melanoma 
formation and progression [241, 242, 244]. Less is known about the role of the p38 
MAPK and JNK pathways in this process.  Apart from ERK, Ras and Raf are also 
located upstream of the p38 MAPK and JNK pathways and any mutations present in 
these upstream proteins will affect the ERK1/2, p38 MAPK and JNK pathways. Estrada 
et al. [225] have shown that both high levels of ERK and p38 MAPK activity are 
required for melanoma development. These authors also found that inhibition of high 
p38 MAPK activity alone can inhibit migration of melanoma cells [225]. The JNK 
pathway is activated by ERK in a feedback loop in melanoma cells [245]. Through the 
use of specific inhibitors, the ERK pathway was shown to upregulate c-Jun expression, 
RACK 1 and JNK activity. Activated JNK can induce the transcriptional regulation of 
c-Jun which feedbacks to increase RACK 1 and JNK activity thereby constantly 
maintaining an active JNK pathway. Of interest was that ERK or c-Jun inhibition 
attenuated cyclin D1 expression in melanoma cells. This cyclin is a positive regulator of 
cell cycle progression which suggests that the ERK/JNK pathways are involved in 
melanomagenesis [245, 246]. Therefore, further research into the involvement of p38 
MAPK and JNK pathways in melanoma formation is warranted. 
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In this study, both cells predominantly expressed higher levels of JNK1 compared to 
JNK2 (Figures 4.6 & 4.7). This suggests that the JNK1 isoform is selectively activated 
in response to stress induced by UV. Melanoma cell lines were shown to express JNK1 
and JNK2 isoforms at different levels [223]. Some (1205Lu, WM983B, sk28, WM852 
and WM 793) possess a high JNK1/JNK2 ratio while others have a low ratio (888mel, 
Gerlach and WM983A). The exact role played by each JNK isoform in melanoma is 
unclear.  It was shown that JNK1 siRNA inhibited cell growth in melanoma cell lines 
expressing high levels of JNK1 whereas JNK2 siRNA had no effect [223]. However, in 
WM983B melanoma cells JNK inhibition had no effect on cell growth but induced 
apoptosis [223]. Although the JNK1 isoform was activated in both cell lines, MM96L 
cells had a higher level of phospho-JNK2 in response to UV radiation while in HEM 
cells its activity was almost negligible (Figures 4.6 & 4.7). Through the use of  
JNK2-deficient fibroblasts, the JNK2 isoform was identified as a negative regulator of 
cell proliferation [247]. As JNK2 is expressed in MM96L cells, its postulated role in 
apoptosis could have contributed to the sensitivity of these cells to  
UV-induced cell death (Figure 4.1). However, in vivo studies using JNK2 knockout 
mice showed that TPA-induced tumour growth was inhibited, which suggested that 
JNK2 was necessary for tumour proliferation [248]. Tao et al. [249] found that mice 
containing JNK2-/- CD8+T cells exhibited resistance to tumour proliferation and 
development when inoculated with B16F0 melanoma cells. This suggests that JNK2 has 
the potential to be involved in cell proliferation or cell death. Therefore, further 
functional studies need to be performed to confirm the role JNK1 and JNK2 plays in 
melanoma cell biology.  
 
The NFκB pathway was shown to be minimally activated in both HEM and MM96L 
cells in response to different UV types and doses (Figures 4.9 & 4.10). MM96L cells 
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were found to possess slightly higher levels of constitutively active phospho-IκBα than 
HEM cells (Figure 4.36). McNulty et al. [228] also found that normal melanocytes and 
melanoma cells express high constitutive levels of NFκB which were not augmented by 
UVB-irradiation. UVA radiation has been shown to have no effect on NFκB levels and 
activity in normal melanocytes [250]. These results suggest that UV radiation may not 
activate the NFκB pathway to the same extent as that seen in the p38 MAPK and JNK 
pathways. Bender et al. [6] found that the p65/p50 NFκB heterodimer was activated 
more than the p50/p50 homodimer in UVC-irradiated (0.04 kJ/m2) in HeLa cells. 
Campbell et al. [251] also found that the Rel A (p65)/p50 heterodimer was activated 
more than the Rel B, c-Rel and p52 subunits in UVC-irradiated  
(0.04 kJ/m2) MEF. Therefore, of the five NFκB subunits, only the p65/p50 complex 
seems to be specifically activated by UV radiation. A supershift electrophoretic 
mobility assay will enable for the detection of the subunits which are predominantly 
activated by UV radiation.  
 
4.3.4 The effects of UV radiation and IL1α on TNFα release in 
melanocyte-derived cells 
UVA radiation stimulated less TNFα release than did UVB radiation in both HEM and 
MM96L cells (Figure 4.11). This difference could be due to the ability of UVA 
Figure 4.36 Constitutive expression of phospho-IκBα in HEM and MM96L cells in  
sham-irradiated control at 120 min.  
HEM MM96L 
Control 
Phospho-IκBα 
β-Actin 
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radiation to selectively regulate cytokines, promote protein degradation or inhibit 
protein synthesis [218, 252]. UVA has been shown to upregulate the transcription of 
IL12 but at the same time inhibit IL10 transcription suggesting that it may also 
selectively downregulate TNFα transcription in melanocyte-derived cells [164, 252]. 
Although, it is tempting to postulate that UVA may also increase production of specific 
proteases and regulate proteasomal activity which may have an effect on TNFα release, 
measuring TNFα levels in the presence and absence of protease/proteasome or protein 
synthesis inhibitors would need to be performed to confirm this. 
 
In melanocyte-derived cells, UVA+B radiation caused a similar increase in TNFα levels 
to that of UVB radiation. Intriguingly, UVB+A radiation on the other hand, decreased 
TNFα levels in MM96L cells but not in HEM cells (Figure 4.11). As UVA radiation 
induced less TNFα release than UVB, it is possible that in the combination of UVB+A 
radiation, the UVA component may have a suppressive effect on TNFα release in 
MM96L cells. In HEM cells this suppressive effect brought about by UVA may have 
been overshadowed by the molecular interaction induced by UVB radiation and this 
suggests that there is a cell type-dependent response to UV radiation. HEM cells 
produced more TNFα compared to MM96L cells in response to UV radiation (Figure 
4.11). MM96L cells do not contain large quantities of intracellular TNFα as determined 
by ELISA using cell lysates (results not shown). This suggests that the reduced levels of 
TNFα released from these cells is due to reduced synthesis rather than due to other 
mechanisms. When IL1α was added to the cells, a greater increase in TNFα levels was 
observed in UV-irradiated HEM cells than in MM96L cells (Figure 4.11). TNFα has 
been shown to have a pro-survival effect in different cell lines although anti-survival 
effects have also been reported [226, 229, 253, 254]. In this study, HEM cells were less 
susceptible to UV radiation than MM96L cells  and it is possible that high levels of 
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TNFα could have protected these cells from UV-induced cell death (Figure 4.1). Ivanov 
et al. [229] found that ATF2 downregulated TNFα expression in UVC-irradiated  
(0.06 kJ/m2) melanoma cells. Forced expression of ATF2 increased UVC-induced cell 
death in melanoma cells while the addition of exogenous TNFα restored cell survival. 
Antagonising antibodies for Fas and TNF receptor 1 (TNFR1) showed that the Fas 
receptor was involved in apoptosis while TNFR1 conferred cell survival. In order to 
delineate if TNFα release was suppressed in MM96L cells to promote UV-induced cell 
death, exogenous TNFα and neutralising TNFα antibodies should be used separately to 
observe the role this cytokine plays in cell survival following UV exposure 
  
While it is possible that TNFα is regulated in melanocyte-derived cells to support cell 
survival, this cytokine has also been implicated in apoptosis, growth inhibition and 
tumour development [69, 71, 83]. The tumour microenvironment has been shown to be 
important for tumour progression [255, 256]. TNFα may also regulate signalling 
molecules within the tumour cells leading to a different response to UV radiation [257]. 
Therefore the use of a reconstructed skin tissue containing keratinocytes, melanocytes 
and/or melanoma cells and fibroblasts may help elucidate how these cells interact with 
each other. In this present in vitro study, a monolayer culture of MM96L cells produced 
lower levels of TNFα than HEM cells in response to UV radiation. It is likely that a 
coculture with other skin cells may behave differently. TNFα levels were higher in the 
serum of metastatic melanoma patients compared to that present in patients with no 
melanoma recurrence [258]. The metastatic melanoma patients had higher serum levels 
of soluble TNFα receptor 55 (sTNF-R55). TNFα signalling is inhibited by the presence 
of sTNF-R55 as such the balance between the levels of TNFα and sTNF-R55 would 
determine activation or blockade of TNFα activity [258]. This suggests that melanomas 
in vivo may release high levels of TNFα which may be involved in pro-tumour activities 
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but its biological activity may be regulated by the presence of sTNF-R55. Therefore in 
vivo functional studies on TNFα and sTNF-R55 need to be undertaken to delineate the 
roles played by both in a tumour microenvironment.  
 
In section 4.2.3, IL1α was shown to stimulate an increase in the release of TNFα from 
UV-irradiated melanocyte-derived cells irrespective of the UV types used (Figure 4.11). 
The addition of IL1α to sham-irradiated cells activated the p38 MAPK and JNK 
pathways but this was not significant (Figures 4.14 & 4.16). The addition of IL1α to 
UV-irradiated HEM cells induced a significant increase in p38 MAPK activity 
compared to MM96L cells (Figure 4.14). In both irradiated HEM and MM96L cells, 
IL1α had no effect on the JNK and NFκB pathways (Figures 4.16 & 4.18). Overall, 
IL1α activation of the cell signalling pathways was unlike its effects on TNFα release 
(Figures 4.11, 4.14, 4.16 & 4.18). It was unclear as to which pathway is involved in 
UV+IL1α-induced TNFα release. In order to elucidate which pathway/s may be 
involved, specific cell signalling pathway inhibitors should be used, eg. SB202190 
inhibits p38 MAPK pathway activity [259, 260], SP600125 (JNK pathway) [261] and 
Sulfasalazine (NFκB pathway) [262]. 
 
SB202190, SP600125 and Sulfasalazine had no effect on sham- and UVB-irradiated 
HEM cell viability except for Sulfasalazine in irradiated HEM cells (Figure 4.37). This 
suggests that the NFκB pathway may confer some protection to the UV-irradaited HEM 
cells. In the sham-irradiated MM96L cells, SB202190 and SP600125 did not affect cell 
viability but when the cells were irradiated with UVB, they reduced the number of 
attached viable cells (Figure 4.37B). This suggests that the p38 MAPK and JNK 
pathways may protect MM96L cells from UVB-induced cell death. However, it is not 
clear if the pathways are entirely involved in mediating cell survival as this observation 
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Figure 4.37 The effect of pathway specific inhibitors on the viability of (A & C) HEM 
and (B & D) MM96L cell cultures at 24 h post UVB-irradiation (2 kJ/m2). The cells 
were incubated with (A & B) SB202190, (A & B) SP600125 and (C & D) sulfasalazine 
for 1 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with 
the specific inhibitors before cell viability was determined using trypan blue solution. 
Results expressed as the means ± SD from triplicate samples. Data are representative of 
three independent experiments. For further information on each figure please see 
Figures 4.18-4.20, and 4.21-4.23. 
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could be due the high inhibitor doses being cytotoxic as well. In both sham- and  
UVB-irradiated MM96L cells, sulfasalazine caused a dose dependent decrease in the 
percentage of attached viable cells (Figure 4.37D). As its carrier solvent DMSO did not 
affect cell viability, the results seen would be due to that of sulfasalazine (Figure 4.21). 
As the NFκB pathway was constitutively activated in MM96L cells in sham-irradiated 
control, it is not clear if the higher doses of sulfasalazine had a greater inhibitory effect 
on the NFκB pathway leading to cell death or whether it caused cytotoxicity by other 
means. The NFκB pathway seems to be necessary for cell survival in UVB-irradiated 
HEM cells whereas all three pathways were involved in MM96L cells.  
 
The doses of the signalling pathway inhibitors used in this study were not cytotoxic. 
Inhibition of the p38 MAPK pathway resulted in a complete abrogation of TNFα levels 
in UVB-irradiated HEM cells while inhibition of either the JNK or NFκB pathways had 
no effect (Figure 4.25). In the UVB-irradiated MM96L cells, inhibition of either the p38 
MAPK or NFκB pathways caused a partial decrease in TNFα levels (Figure 4.26). 
These results suggest that the p38 MAPK pathway is most likely the main pathway 
involved in regulating UV-induced release of TNFα from melanocyte-derived cells. 
Ivanov et al. [226] found that inhibition of p38 MAPK pathway led to a decrease in 
TNFα transcriptional activation. When both p38 MAPK and NFκB inhibitors were 
added to the cells, a partial decrease in UVB-induced TNFα release in MM96L cells 
was observed. This suggests that UV-mediated crosstalk may exist between the p38 
MAPK and NFκB pathways, as well as others (Figure 4.26). The p38 MAPK pathway  
has been shown to be upstream of the NFκB pathway in UVC-irradiated (0.25 kJ/m2) 
A2058 melanoma cells [150]. Caffeine inhibited the activation of the ATM/PKCδ/p38 
MAPK pathway which in turn inhibited the activation of the NFκB pathway [150]. As 
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such, caffeine may be a useful tool in inhibiting both pathways and observing the effect 
this has on TNFα release in UVB-irradiated MM96L cells. 
 
Since SB202190 inhibited UVB-induced TNFα release in both cell lines, it suggests that 
the release of this cytokine is regulated by UVB-activated p38 MAPK pathway. In order 
to confirm this observation, anisomycin, a potent stimulator of the p38 MAPK and JNK 
pathways was used (Figures 4.27 & 4.38) [177].  
 
 
Anisomycin upregulated phospho-JNK1 levels in melanocyte-derievd cells but it did 
not affect phospho-JNK2 levels in HEM cells, the reason for which is unclear (Figure 
4.38).It was shown to cause a dose dependent decrease in the population of attached 
Figure 4.38 A representative western blot probed for phospho-JNK1/2 in (A) HEM and 
(B) MM96L cells treated with anisomycin. Cell cultures were either incubated with 
anisomycin in sham-irradiated cell cultures with or without IL1α supplementation (10 
ng/ml). All cell lysates were extracted at 15 min post-incubation of anisomycin. In blots 
(A & B) the lanes represent, Lanes 3 & 8: 20 µM anisomycin, 4 & 9: 40 µM 
anisomycin, 5 & 10: 60 µM anisomycin, 6 & 11: 80 µM anisomycin and 7 & 12: 100 
µM anisomycin.  
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viable cells in sham- and UVB-irradiated HEM and MM96L cells (Figures 4.30 & 
4.31). Moreover, MM96L cells had a greater number of detached viable cells after 
anisomycin treatment and UV-irradiation compared to HEM cells (Figure 4.31). These 
anchorage-dependent MM96L cells are more sensitive to stress than HEM cells and 
anisomycin at a high concentration (100 µM) and/or UV radiation could have disrupted 
MM96L cell-to-cell adhesion leading to detachment of these cells which may undergo 
apoptosis eventually (Figures 4.33 & 4.34). As 100 µM anisomycin induced a high level 
of cell death, lower doses (20 and 40 µM) were used to observe its effect on TNFα 
release from HEM and MM96L cells (Figures 4.30-4.32).  
 
Anisomycin failed to stimulate TNFα release in the presence or absence of IL1α in these 
irradiated cells. This suggests that p38 MAPK-mediated TNFα release following  
UVB-irradiation may be a UV-specific response (Figure 4.32). However, when 
anisomycin was added to UVB-irradiated HEM and MM96L cells, TNFα release was 
not observed even if IL1α was present (Figure 4.32). This is an interesting observation 
as UVB radiation did not induce TNFα release in the presence of anisomycin. It is 
possible that UVB and anisomycin activate the p38 MAPK pathway via a different 
mechanism and the mode of activation might change when both stimuli are used 
together. In support, Ravi et al. [150] found that caffeine or rottlerin inhibited  
UV-induced p38 MAPK activation but it did not inhibit anisomycin-induced p38 
MAPK activation. This suggests that UV radiation may not share similar downstream 
intermediates to that of anisomycin. The type of UV radiation, doses of anisomycin and 
cell type may play a part in determining the mechanism of p38 MAPK activation.  
 
In summary, TNFα release by UV radiation seemed to be a UV specific response and 
the p38 MAPK pathway appears to be the main pathway involved in HEM cells while 
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both p38 MAPK/NFκB pathways may be involved in MM96L cells. Currently, the 
exact role of TNFα in skin carcinogenesis is not known. As highlighted in Section 4.1, 
previous studies have shown that TNFα has a role in executing either pro- or  
anti-tumour activities [226, 229, 231]. Despite its dual role, identifying the pathways 
regulating UV-induced TNFα release is of importance because if TNFα is an  
anti-tumour agent then pharmacological enhancers of the p38 MAPK pathway may 
increase its expression in targeted tumours. On the other hand, if it has a pro-tumour 
function, pharmacological inhibitors of the p38 MAPK pathway could be useful in 
reducing TNFα levels to eradicate skin tumours. Since the p38 MAPK pathway is also 
involved in normal homeostasis, the challenge would be to intervene in p38  
MAPK-mediated TNFα release without initiating any instability within the cell by 
disrupting other roles of this pathway which are responsible for normal cellular 
functioning.  It will be plausible to do so if key upstream effectors of the p38 MAPK 
pathway or substrates of this pathway which specifically control TNFα release in  
UV-irradiated skin cells are identified.  
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CHAPTER 5 
 
EFFECT OF MARINE LIPID 
EXTRACTS ON UV-INDUCED 
TNFα RELEASE IN 
MELANOCYTE-DERIVED CELLS 
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5.1 Introduction 
Free radicals can be defined as molecules or molecular fragments containing one or 
more unpaired electrons thereby increasing their reactivity and can be grouped into ROS 
(reactive oxygen species) and RNS (reactive nitrogen species) [263]. There is mounting 
evidence to suggest that UV radiation can induce ROS which can lead to cellular 
damage resulting in photoageing or skin carcinogenesis [65, 264-267]. ROS can be 
stabilised by antioxidants which are categorised into enzymatic and non-enzymatic 
molecules. Although endogenous antioxidants are regulated to maintain appropriate 
levels of free radicals within the cell, a high influx in free radicals caused by UV 
exposure may overwhelm the intracellular defence mechanisms. Exogenous 
antioxidants such as α-tocopherol have shown some promising effects on reducing 
UV/ROS-induced cell damage [157-159, 268]. Furthermore, relatively new compounds 
like mussel crude lipid extract (MCLE) and scymnol are still being investigated to 
identify their biological activities which may be beneficial in reducing the risk of UV 
exposure. 
 
α-Tocopherol is a form of vitamin E which is present in high levels in dietary 
supplements and serum (Figure 5.1) [269, 270]. It is also the most biologically active 
type among the eight forms of vitamin E, and its antioxidant property has been widely 
researched [66, 269-273]. Its antioxidant property is derived from the hydroxyl group in 
C16H33 
O 
HO 
α-tocopherol 
Figure 5.1 Structure of α-tocopherol. Adapted from [269]. 
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the aromatic ring where its hydrogen is donated to a free radical to form a stable product 
[273]. α-Tocopherol is converted into a free radical when it donates hydrogen but it can 
be returned to its reduced form by intracellular vitamin C and glutathione [269, 273].  
It has been shown to reduce cyclobutane pyrimidine photoproducts via application to 
UV exposed skin to reduce UV-induced tumours in mice [271, 272]  
 
MCLE is a lipid extract from Perna canaliculus (New Zealand green-lipped mussel) 
[166]. It contains several different lipid classes; sterol esters, triglycerides, free fatty 
acids, sterols and polar lipids [274]. Its anti-inflammatory activity is believed to be 
brought about by the presence of polyunsaturated fatty acids and natural antioxidants 
[170]. However, its antioxidant effect has not been well documented [169, 275].  
 
Scymnol is a shark bile sterol which has been shown to have hydroxyl radical 
scavenging property [167]. Its antioxidant activity can be attributed to the presence of 
hydroxyl groups in its structure [276]. Macrides et al. [167] found that the radical 
scavenging activity of 5β-scymnol decreased as its sulfation was increased and 
concluded that the tri-alcohol-substituted aliphatic side chain is responsible for its 
hydroxyl quenching property[167].  
 
In this chapter, the antioxidant effect of MCLE and scymnol will be investigated in  
UV-irradiated melanocyte-derived cells. As UV radiation can initiate the production of 
ROS which in turn can activate MAPK cascades, the effect of α-tocopherol, MCLE and 
scymnol on UV-induced TNFα release via p38 MAPK activation will also be 
investigated [64, 65].  
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5.2 Results 
5.2.1 The effect of test compounds in antioxidant assays 
In this study, two antioxidant assays; DPPH (2, 2-Diphenyl-1-picrylhydrazyl) (section 
5.2.1.1) and Fenton reaction (5.2.1.2) methods, were utilised to identify the antioxidant 
properties of test compounds (MCLE and scymnol). α-Tocopherol which is a well 
known antioxidant was used as a positive control [66, 270, 273].  
 
5.2.1.1 DPPH assay 
DPPH is a stable free radical which has a strong spectral absorbance at 517/490 nm 
[171]. Once it accepts an electron or hydrogen radical (from an antioxidant), the 
reduction of DPPH (violet colour) to DPPH2 (clear) forms a stable product which loses 
absorbance at 517/490 nm [171]. The absorbance of the reaction mixture (test 
compound and DPPH) was read at 3 h and later at 24 h to confirm that the reaction had 
gone to completion. Since the data obtained at 24 h was similar to that at 3 h, the later 
data was not presented in this thesis. The test compounds used in this study were 
dissolved in ethanol and as such this solvent was used as a control (0 mg/ml) for the test 
compounds (Figure 5.2). Ethanol did not react with the DPPH assay as its absorbance 
(~0.6) did not change during the reaction (results not shown). The addition of 0 to 0.6 
mg/ml α-tocopherol to DPPH caused a dose-dependent decrease in absorbance from 0.6 
to 0.1 after which it remained constant at this absorbance (~0.1) from 1.3 to 10 mg/ml 
concentrations. In comparison neither MCLE nor scymnol (0-10 mg/ml) were shown to 
reduce DPPH over a 3 h period (Figure 5.2).  
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5.2.1.2 Fenton reaction assay 
In the Fenton reaction assay, the iron-EDTA complex reacts with H2O2 in the presence 
of ascorbic acid to generate hydroxyl radicals [172]. These radicals can degrade 
deoxyribose to form a pink chromogen in the presence of thiobarbituric acid (TBA). 
The addition of antioxidants will compete with deoxyribose for hydroxyl radicals. 
Therefore the higher the scavenging capacity of the test compounds the lower the 
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Figure 5.2 DPPH radical scavenging assay. The test compounds (0-10 mg/ml) were 
added to 100 µM DPPH and absorbance was read at 490 nm after 3 h of incubation with  
the test compounds. Results expressed as the means ± SD from triplicate samples. Data 
are representative of three independent experiments.    
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degradation of deoxyribose. Since the compounds were dissolved in ethanol (which 
itself reacts with the assay), the solvent was evaporated by the introduction of air 
(Section 2.9.3). The control (blank) contained only ethanol which was evaporated and 
its deoxyribose degradation was set at 100% (Figure 5.3). In this assay, α-tocopherol 
(67%) caused the least degradation of deoxyribose followed by scymnol (77%) while 
MCLE (105%) did not cause any inhibition (Figure 5.3). Correspondingly,  
α-tocopherol had 33% hydroxyl scavenging capacity whereas scymnol had 23% and 
MCLE none.                  
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Figure 5.3 Fenton reaction assay. A comparison of the effect of α-tocopherol  
(10 mg/ml), MCLE (10 mg/ml) and scymnol (10 mg/ml) on the degradation of 
deoxyribose by a Fenton reaction. Absorbance was read at 532 nm. Results expressed as 
the means ± SD from triplicate samples. Data are representative of three independent 
experiments. 
Test Compounds 
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5.2.2 The effect of test compounds on the viability of  
melanocyte-derived cells 
The cell viability assay was performed to observe if the concentrations of compounds 
used in this study were cytotoxic. Initially, three different concentrations (0.625, 6.25 
and 62.5 µg/ml) of test compounds were examined and the two higher doses (6.25 and 
62.5 µg/ml) of MCLE and scymnol was found to be highly toxic as all the MM96L cells 
had died in culture (Figure 5.4). Therefore, the effects of lower concentrations (0-0.625 
µg/ml) of the test compounds on the viability of HEM and MM96L cells were tested 
(Figures 5.5-5.10). The effect of α-tocopherol, MCLE and scymnol (0-0.625 µg/ml) on 
the viability of HEM and MM96L cells was measured 24 h post UVB-irradiation (2 
kJ/m2) using trypan blue exclusion (Section 2.5) to ensure that these compounds were 
not cytotoxic. The ‘detached cells’ are those cells which had dissociated from the 
surface of the culture vessel, while ‘attached cells’ referred to those which had not.  
 
The compounds were reconstituted in ethanol and the solvent on its own had no effect 
on HEM cell viability (Figures 5.5 -5.7). In sham-irradiated controls, the addition of  
α-tocopherol, MCLE and scymnol had no effect on the number of attached viable cells 
(~86%) (Figures 5.5-5.7). In UVB-irradiated HEM cells, α-tocopherol had no 
significant effect on the percentage of attached viable cells even in the presence or 
absence of IL1α (Figure 5.5). When this experiment was repeated with either MCLE or 
scymnol, a similar result to that seen for α-tocopherol was observed (Figures 5.6 & 5.7).  
 
In MM96L cells, ethanol had no effect on the viability of sham-irradiated controls 
(Figures 5.8-5.10). The test compounds also had no cytotoxic effect when they were 
added to the sham-irradiated controls. The viability of UVB-irradiated MM96L cells 
was significantly less than that of unirradiated cells (Figures 5.8-5.10). When the test  
  
 
- 220 - 
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Figure 5.4 Phase contrast images of MM96L cells incubated with test compounds. The 
cultures of MM96L cells were incubated for 24 h with (Row 1) No treatment (Control), 
(Row 2) α-tocopherol, (Row 3) MCLE and (Row 4) scymnol at different concentrations 
(Column A) 0.625 µg/ml, (Column B) 6.25 µg/ml and (Column C) 62.5 µg/ml.  
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Figure 5.5 The effect of α-tocopherol on the viability of HEM cell cultures at 24 h post UV-irradiation. The cells were incubated with α-tocopherol for 
24 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with α-tocopherol before cell viability was determined using trypan 
blue solution. Results expressed as the means ± SD from triplicate samples. ata are representative of three independent experiments.  Comparisons 
were made between sham-irradiated control and UV-irradiated cultures using Student’s paired t-test where significance was recorded as p ≤ 0.05 (*). 
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Figure 5.6 The effect of MCLE on the viability of HEM cell cultures at 24 h post UV-irradiation. The cells were incubated with MCLE for 24 h prior 
to UV exposure. After UV exposure, the cells were incubated for 24 h with MCLE before cell viability was determined using trypan blue solution. 
Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments. Comparisons were made 
between sham-irradiated control and UV-irradiated cultures using Student’s paired t-test where significance was recorded as p ≤ 0.05 (*). 
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Figure 5.7 The effect of scymnol on the viability of HEM cell cultures at 24 h post UV-irradiation. The cells were incubated with scymnol for  
24 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with scymnol before cell viability was determined using trypan blue 
solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments. Comparisons were 
made between sham-irradiated control and UV-irradiated cultures using Student’s paired t-test where significance was recorded as p ≤ 0.05 (*). 
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Figure 5.8 The effect of α-tocopherol on the viability of MM96L cell cultures at 24 h post UV-irradiation. The cells were incubated with  
α-tocopherol for 24 h prior to UV exposure. After UV exposure, the cells were incubated for 24 h with α-tocopherol before cell viability was 
determined using trypan blue solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent 
experiments. Comparisons were made between sham-irradiated control and UV-irradiated cultures using Student’s paired t-test where significance was 
recorded as p ≤ 0.05 (*). 
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Figure 5.9 The effect of MCLE on the viability of MM96L cell cultures at 24 h post UV-irradiation. The cells were incubated with MCLE for 24 h 
prior to UV exposure. After UV exposure, the cells were incubated for 24 h with MCLE before cell viability was determined using trypan blue 
solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments. Comparisons were 
made between sham-irradiated control and UV-irradiated cultures using Student’s paired t-test where significance was recorded as p ≤ 0.05 (*). 
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Figure 5.10 The effect of scymnol on the viability of MM96L cell cultures at 24 h post UV-irradiation. The cells were incubated with scymnol for 24 h 
prior to UV exposure. After UV exposure, the cells were incubated for 24 h with scymnol before cell viability was determined using trypan blue 
solution. Results expressed as the means ± SD from triplicate samples. Data are representative of three independent experiments. Comparisons were 
made between sham-irradiated control and UV-irradiated cultures using Student’s paired t-test where significance was recorded as p ≤ 0.05 (*). 
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compounds (α-tocopherol, MCLE and scymnol) were added to the irradiated cells no 
differences in cell viability was observed (Figures 5.8-5.10). The addition of IL1α to the 
irradiated cells had no effect on cell viability. In general, the test compounds at the 
doses used in this study had no significant effect on the cell viability of HEM and 
MM96L cells.   
 
5.2.3 The effect of test compounds on UV-induced TNFα release in 
melanocyte-derived cells 
α-Tocopherol, MCLE and scymnol were added to HEM and MM96L cell cultures to 
observe their effect on UV-induced TNFα release. The dose for the test compounds 
chosen was 0.625 µg/ml because it was the highest dose which was not cytotoxic 
(Figures 5.5-5.10). HEM or MM96L cell cultures were incubated with these compounds 
for 24 h before and after UVB-irradiation (2 kJ/m2) and at the end of this period the 
media samples were collected to perform ELISA (Section 2.8) and the cell lysates were 
used to determine total protein concentration (Section 2.7.2).  
 
In sham-irradiated HEM cells, the test compounds had no effect on TNFα release when 
compared to the unirradiated controls (Figure 5.11A). In UVB-irradiated HEM cells, the 
level of TNFα released fell when 0.625 µg/ml α-tocopherol (9 pg/mg), MCLE (7 
pg/mg) and scymnol (5 pg/mg) was added to the cells when compared to untreated 
irradiated cells (11 pg/mg) (Figure 5.11A). This effect was more apparent when IL1α 
was added to UVB-irradiated cells. Here the levels of TNFα released from the cells fell 
from 1316 pg/mg to 621, 455 and 321 pg/mg when the cells were treated with  
α-tocopherol, MCLE and scymnol, respectively. 
 
  
 
- 228 - 
 
Figure 5.11 The effect of α-tocopherol, MCLE and scymnol on UVB-mediated TNFα 
release in (A) HEM and (B) MM96L cells. Cell cultures were incubated with  
0.625 µg/ml of test compounds prior to and after UVB-irradiation in the presence or 
absence of 10 ng/ml of IL1α. Results expressed as the means ± SD from triplicate 
samples. Data are representative of three independent experiments. Statistical analysis 
was performed using a Student’s paired t-test where significance was recorded as p ≤ 
0.05. Significant difference between UVB-irradiated untreated sample and test 
compound treated irradiated sample in the (*) absence of IL1α or (†) presence of IL1α. 
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In MM96L cells, the test compounds had no effect on TNFα release from the 
unirradiated cells (Figure 5.11.B). UVB-irradiated cells released 6 pg/mg TNFα which 
increased to 607 pg/mg when IL1α was added to the cells (Figure 5.11B). When the test 
compounds were added to the UVB-irradiated cells treated with IL1α there was no 
inhibition in the level of TNFα released from these cells (Figure 5.11B). It can be seen 
from this study that while the compounds inhibited TNFα release in HEM cells, they 
had no effect on MM96L cells.    
 
5.2.4 The effect of test compounds on the activation of p38 MAPK 
pathway in UV-irradiated melanocyte-derived cells 
It was shown from the results obtained from section 4.2.5, that the p38 MAPK pathway 
was involved in UV-mediated TNFα release in both HEM and MM96L cells. As a 
result an experiment was conducted to observe if α-tocopherol, MCLE and scymnol had  
an effect on UVB-induced (2 kJ/m2) activation of the p38 MAPK pathway in these cells 
(Figure 5.12). The expression of phospho-p38 was observed at 15 min post-irradiation 
as earlier experiments (Figure 4.35) showed that this protein was maximally expressed 
at this time point.  
 
In sham-irradiated HEM cells, none of the test compounds (0.625 µg/ml) had any effect 
on phospho-p38 expression as the levels remained fairly constant to that of unirradiated 
controls (100%) (Figure 5.13A). The addition of IL1α increased phopsho-p38 levels to 
146% in sham-irradiated cells which were similar to that seen in Figure 4.14A. 
However, when α-tocopherol and scymnol was added to these cells phospho-p38 levels 
increased slightly to 157% while MCLE had no effect (146%). The phopsho-p38 levels 
in UVB-irradiated cells were at 242% and the levels increased (640%) when IL1α was 
cells had no significant effect on the level of phospho-p38 in the cells (Figure 5.13A).  
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In sham-irradiated MM96L cells, phospho-p38 levels were at 100% and when they were 
treated with the test compounds, these levels (~99%) did not change significantly  
(Figure 5.13B). In sham-irradiated cells treated with IL1α, the phospho-p38 levels 
increased to 133% (Figures 5.13B & 4.14B). The addition of test compounds to these 
cells caused a slight but insignificant decrease (~127%) in the levels of phospho-p38. In 
UVB-irradiated cells, phospho-p38 levels were at 134% and the levels decreased to 
121% when Scymnol was added whereas α-tocopherol and MCLE had no effect (Figure 
5.13B). In the presence of IL1α, phospho-p38 levels increased to 213% in  
UVB-irradiated cells. The addition of MCLE caused a slight decrease in these levels 
(203%) while α-tocopherol and scymnol had no effect (Figure 5.13B). 
Figure 5.12 A representative western blot probed for phospho-p38 MAPK in (A) HEM 
and (B) MM96L cells incubated with either α-tocopherol, MCLE or scymnol prior to 
and after UVB-irradiation. The cell lysates were extracted at 15 min  
post-irradiation. The sham-irradiated control (lanes 1-8) or cell cultures exposed to high 
dose UVB radiation (lanes 9-16)  were treated with 10 ng/ml IL1α (lanes 2, 4, 6, 8, 10, 
12, 14 and 16). The lanes marked from 1 to 16 in blots (A & B) represents Lane 1, 2, 9, 
10: no test compound, lanes 3, 4, 11, 12: 0.625 µg/ml α-tocopherol, lanes 5, 6, 13, 14: 
0.625 µg/ml  MCLE, and lanes 7, 8, 15, 16: 0.625 µg/ml scymnol. 
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Figure 5.13 The effect of α-tocopherol, MCLE and scymnol on the expression of 
phospho-p38 protein in (A) HEM and (B) MM96L cells after exposure to high dose 
UVB radiation. Cell cultures were incubated with 0.625 µg/ml of test compounds for  
24 h prior to and 15 min after UVB-irradiation with or without of 10 ng/ml of IL1α. The 
proteins were extracted at 15 min post-irradiation. Results expressed as the means ± SD 
from triplicate samples. Data are representative of three independent experiments. 
Statistical analysis was performed using a Student’s paired t-test where significance was 
recorded as p ≤ 0.05. (*) Significant difference between untreated sample and test 
compound treated sample. 
Legend:             No treatment         IL1α treatment
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In general, the results suggest that the test compounds had no inhibitory effect on 
phospho-p38 expression in either sham- or UVB-irradiated HEM and MM96L cells. As 
a result, it is likely that the compounds may not inhibit TNFα release in HEM cells 
(Figure 5.11) via the suppression of p38 MAPK pathway unlike that seen in Figure 4.25 
where SB202190 (p38 inhibitor) inhibited TNFα release in irradiated HEM cells. As  
phospho-p38 expression was only observed at 15 min post-irradiation, the experiment 
should be repeated with an extended time period to confirm this finding. 
 
5.3 Discussion 
5.3.1 Test compounds 
In this study, the compounds α-tocopherol, MCLE and scymnol were used.  
α-Tocopherol is a well known antioxidant and as such was used as a positive control in 
this study [66, 277-279]. It is able to stabilise oxidants by donating its hydrogen which 
is derived from the hydroxyl group present in the aromatic ring [273]. The antioxidant 
effect of α-tocopherol was found to inhibit the loss of glutathione, activation of the 
NFκB pathway and apoptosis in irradiated human melanocytes [66]. Apart from  
α-tocopherol, MCLE [166] and scymnol [167] which are extracted from green-lipped 
mussel and shark bile, respectively were used in this study. MCLE may contain natural 
antioxidants whereas scymnol has hydroxyl groups present to donate hydrogen to free 
radicals [170, 276]. As free radicals have been shown to induce inflammation, it is 
possible that the antioxidant activity which may be present in MCLE could lead to its 
known anti-inflammatory property [166, 170, 280]. Little is known about the 
antioxidant properties of MCLE and scymnol. Therefore, in this study, the antioxidant 
properties of these lipids were tested as well as of their ability to inhibit TNFα release in  
UVB-irradiated melanocyte-derived cells to determine their capacity to reduce 
excessive inflammation. If UV-induced TNFα release is mediated by reactive oxygen 
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species, then compounds possessing antioxidant properties may be used to reduce the 
inflammation in the skin that is induced by UV radiation [280, 281].  
 
5.3.2 The effect of test compounds in antioxidant assays 
In the DPPH and Fenton reaction assays, α-tocopherol was able to reduce DPPH. and 
scavenge hydroxyl radicals whereas scymnol was only able to scavenge hydroxyl 
radicals which agrees with that seen previously [167]. On the other hand, MCLE did not 
react in any of these assays which suggests that this compound is unable to scavenge 
DPPH or hydroxyl radical. Whitehouse et al. [170] and Halpern et al. [282] have both 
reported that MCLE contains carotenoids which are antioxidants known to scavenge 
singlet oxygen and peroxyl radicals [283]. It is possible that the differences in 
scavenging properties of these compounds may be related to their structures. The 
vitamin E analogues differ in their biological properties due to the different groups 
present at their functional domains [270]. Furthermore, Macrides et al. [167] found that 
structural modifications to scymnol by increasing sulfation affected its oxidant 
scavenging capacity. Although, α-tocopherol may seem to be a versatile antioxidant as 
it scavenged both DPPH and hydroxyl radicals at a low dose unlike that seen for the 
other compounds, only two antioxidant assays were performed in this study  
(Figures 5.2 & 5.3). As such other scavenging capacity assays targeting hydrogen 
peroxide, singlet oxygen, peroxynitrite, peroxyl, nitric oxide and superoxide radical 
anions should be carried out to fully determine the antioxidant activity of MCLE  and 
scymnol [171]. In an instance where these compounds display specificity to different 
free radicals, a combination of which may prove to be beneficial in eliminating oxidants 
and their downstream effects. At the same time, the level of these compounds should 
not be cytotoxic to the skin cells.  
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5.3.3 The effect of test compounds on the viability of  
melanocyte-derived cells 
Neither α-tocopherol, MCLE nor scymnol had any significant effect on the percentage 
of attached viable HEM and MM96L cells (Figure 5.14). As these compounds did not 
confer significant protection from high dose UVB-induced cell death, it is highly likely 
that free radicals may not play a role in this process. UVA radiation has been shown to 
produce higher levels of ROS compared to UVB radiation and as such these compounds 
may be more effective in protecting the cells from UVA-induced cell death compared to 
that of UVB [284]. Time constraints did not allow investigation of the effect of these 
compounds in UVA-irradiated cells. 
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Figure 5.14 The effect of test compounds on the percentage of attached viable (A) HEM 
and (B) MM96L cell cultures at 24 h post UVB-irradiation. The cells were incubated 
with α-tocopherol, MCLE and scymnol for 24 h prior to UVB exposure. After UV 
exposure, the cells were incubated for 24 h with the test compounds before cell viability 
was determined using trypan blue solution. Results expressed as the means ± SD from 
triplicate samples. Data are representative of three independent experiments. For further 
information on each figure please see Figures 5.3-5.9. 
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5.3.4 The effect of test compounds on UV-induced TNFα release in 
melanocyte-derived cells 
In UVB-irradiated HEM cells treated with IL1α, the test compounds induced varying 
degrees of inhibition of TNFα release from the cells. Scymnol was the most effective in 
inhibiting UVB-induced TNFα release followed by MCLE and α-tocopherol. However, 
in UVB-irradiated MM96L cells, none of the three compounds had any significant 
effect on suppressing UVB-induced TNFα release. It is possible that different 
mechanisms may be involved in UV-induced TNFα release in the two cell lines and as 
such these test compounds may inhibit certain mechanisms but not others resulting in 
varying efficacy of inhibition. In support of this result, Pupe et al. [148] showed that in 
keratinocytes, the antioxidant BHA (Butylated hydroxyanisole) (200 µM) completely 
inhibited UVB-induced (0.3 kJ/m2) TNFα release; while 3 mM NAC (N-acetylcysteine) 
induced a 2.5-fold inhibition; both EGCG (Epigallocatechin gallate) (50 µM) and 
vitamin C (1 mM) had minimal effect; and vitamin E (50 µM) had no effect. This 
suggests that antioxidants may exhibit specificity in suppressing pathways involved in 
UV-induced TNFα release. The authors also found that the LOX (lipoxygenase) 
inhibitors, NDGA (Nordihydroguaiaretec acid) and MK-886 completely inhibited TNFα 
release in UVB-irradiated keratinocytes. LOX produce reactive oxygen intermediates 
like hydroperoxides which can form superoxide anions [148, 285]. It was also reported 
that BHA is a LOX inhibitor as well as a free radical scavenger and as such BHA could 
have caused a complete suppression of TNFα due to its free radical quenching capacity 
as well as inhibition of LOX which may be a mechanism distinct from that inhibited by 
the other antioxidants used.   
 
In this study, α-tocopherol and scymnol were shown to have antioxidant properties and 
inhibited TNFα release in UVB-irradiated HEM cells (Figures 5.2 & 5.3). This suggests 
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that UV-induced TNFα release could be mediated by free radicals. Pupe et al. [148] 
found that tBHP which produces hydroxyl and alkoxyl radicals caused an upregulation 
of TNFα mRNA in sham-irradiated keratinocytes. However, tBHP downregulated 
TNFα mRNA expression when incubated with keratinocytes prior to UVB-irradiation 
(0.3 kJ/m2) [148]. It is possible that the oxidants together with UVB-induced oxidative 
stress could have resulted in a higher output of endogenous antioxidants. This could 
have led to the effective scavenging of the oxidants present and therefore, prevented 
ROS-induced TNFα mRNA upregulation.  
 
MCLE used in this study did not exhibit any antioxidant properties but inhibited  
UVB-induced TNFα release in HEM cells (Figures 5.2 & 5.3). There is evidence to 
suggest that this extract may possess both antioxidant and anti-inflammatory properties 
as it contains polyunsaturated fatty acid and carotenoids [170, 282]. Since TNFα is a  
pro-inflammatory cytokine which is produced by the COX (cycloxygenase) pathway in 
response to UV, it is likely that MCLE may inhibit TNFα release via its  
anti-inflammatory property [148]. Sandoval et al. [286] found that cat’s claw inhibited 
lipopolysaccharide-induced TNFα release at doses lower than that required for its 
antioxidant activity in murine macrophages. Therefore, it is possible that MCLE needs 
to be added at a higher concentration to exhibit its antioxidant activity in these cells. On 
the whole, although α-tocopherol, MCLE and scymnol were able to inhibit TNFα 
release, it is not clear if this effect is due solely to their antioxidant or other inhibitory 
properties (anti-inflammatory). Moreover, the results of this current study do not 
confirm if free radicals are involved in UV-induced TNFα release. 
 
In order to elucidate if free radicals are involved in UVB-induced TNFα release, cellular 
antioxidants (catalase, superoxide dismutase and glutathione) can be added exogenously 
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after UVB-irradiation to deplete the cells of oxidants and then quantify TNFα release 
using ELISA. Once after adding exogenous cellular antioxidants, free radical detection 
systems like fluorescent probes (Hydroethidine, 2'-7'-dichlorofluorescin) which react 
with intracellular oxidants to produce fluorescent substrates can be performed to 
confirm that oxidants have been depleted from the cells [287]. In this way a comparison 
of TNFα release can be made between cells untreated and treated with exogenous 
cellular antioxidants. In order to elucidate if UVB-induced TNFα release is inhibited by 
scymnol and MCLE via its antioxidant property, the oxidant(s) it specifically scavenges 
should be identified and then a dose-dependent correlation study can be performed to 
observe specific oxidant scavenging and TNFα inhibition by the compound. In an 
instance when both the studies do not correlate, it can be ruled out that the compounds 
inhibit TNFα release via its antioxidant effect.  
 
5.3.5 The effect of test compounds on the activation of p38 MAPK 
pathway in UV-irradiated melanocyte-derived cells 
In chapter 4, SB202190 (p38 MAPK inhibitor) inhibited UVB-mediated TNFα release 
in HEM and MM96L cells (Figures 4.24 & 4.25). As α-tocopherol, MCLE and scymnol 
suppressed UV-induced TNFα release, it was of interest to observe if these compounds 
also inhibited the activities of the p38 MAPK pathway (Figure 5.11). In this study, the 
activation of the p38 MAPK pathway did not appear to be affected by the addition of 
any of the test compounds in UVB-irradiated HEM and MM96L cells (Figure 5.13). In 
contrast, previous studies have shown that the p38 MAPK pathway can be activated by 
free radicals and as such antioxidants targeting these oxidants should be able to inhibit 
the activation of this pathway as well [154, 268]. In this current study, phospho-p38 
expression was observed only at 15 min post-irradiation where expression was shown to 
be maximal. However, a time-point study (0-2 h) should be conducted to verify if the 
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test compounds have no effect on p38 MAPK activity in these irradiated cells (Figure 
5.13). A specific H2O2 antioxidant, catalase showed that H2O2 activated both the p38 
MAPK and JNK pathways in UVB (4 kJ/m2) or UVC-irradiated (0.06 kJ/m2) JB6 C141 
mouse epidermal cells [154]. Larsson et al. [66] reported that α-tocopherol prevented 
the loss of glutathione and the translocation of NFκB subunit into the nucleus in  
UVB- (0.6 kJ/m2) and UVA-irradiated (60 kJ/m2) melanocytes. However, little research 
has been undertaken on the effect of either MCLE or scymnol on signal transduction 
pathways. Since this was a preliminary study, other pathways like the JNK, NFκB and 
ERK should also be examined to see if these compounds have an effect on their activity.  
 
In general, the test compounds were effective in inhibiting TNFα release from HEM 
cells but had no effect on suppressing p38 MAPK pathway activity. This suggests that 
these compounds do not act through the p38 MAPK pathway to inhibit TNFα release in 
UVB-irradiated HEM cells. It is most likely that other mechanisms may also be 
involved in this process which should be investigated further. Moreover, as scymnol and 
MCLE exhibited potential anti-inflammatory and antioxidant properties, they may be 
useful supplements to add to sunscreens. This may help reduce the detrimental effects of 
penetrating UV radiation in the skin by protecting the cells from oxidative and/or 
inflammatory stress as a result of exposure to UV radiation. Therefore, further research 
into antioxidants and the effects of UV radiation on skin functions need to be 
investigated.  
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6.1 General Discussion 
6.1.1 Keratinocytes and SCC 
In Chapter 3, the effects of UV radiation on viability, cell signal transduction and 
cytokine release between normal keratinocyte (HEK) and their malignant counterpart 
(Colo16) were compared. The immortalised HaCaT cells were also used to determine if 
they are a suitable model to replace primary keratinocytes in regards to studying signal 
transduction pathways activated by UV radiation.  
 
Only UVA and UVB radiation were used in this study, as the skin is not exposed to 
UVC because it is blocked by the ozone layer [5]. However, previous studies have used 
UVC radiation in studying signal transduction which may only have relevance if the 
skin is exposed to germicidal lamps, arc welding lamps or lasers emitting UVC [6-10]. 
Furthermore, some studies have used excessively high UV doses to study the activation 
of cell signalling pathways in skin cells [99, 100, 104, 106, 131]. These high doses 
usually result in elevated levels of cell death and unless the aim of the study is to 
investigate cell death pathways or occupational hazards giving rise to high cumulative 
doses, the physiological relevance of such studies are questionable. Therefore, the aim 
of this current study was to investigate the activation of cell signalling pathways and 
cytokine release under physiological conditions. In this study, the UV doses and types 
(UVA and/or UVB) used were those which induced 1 MED in sun exposed skin 
(Section 2.4.2). The doses used for 0.1 MED were a tenth of that used for 1 MED.  
  
Colo16 cells were more susceptible to UV radiation than HaCaT and HEK cells (Figure 
3.1 & Table 6.1). Colo16 cells may possess defective DNA repair mechanisms resulting 
in unrepaired DNA damage and thus elimination through cell death pathways [288, 
289]. 
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In this study, the activation of the p38 MAPK, JNK and NFκB pathways in irradiated 
keratinocyte-derived cells were also investigated. We observed that the same UV types 
and doses stimulated completely different responses in triggering cell signalling 
pathways in normal and malignant keratinocytes (Figure 3.24 & Table 6.1). In irradiated 
Colo16 cells, the JNK and NFκB pathways were activated differently to that of HEK 
cells (Figure 3.24 & Table 6.1). Although, the pattern of activation of the p38 MAPK 
Cells HEK HaCaT Colo16 
Cell viability (Figure 3.1) + + + + + + 
UVA Prolonged  
UVB 
Transient 
Transient 
Transient 
UVA+B 
p38 pathway activation 
(Figure 3.24) 
UVB+A 
Prolonged  Prolonged  Prolonged  
UVA 
UVB 
UVA+B 
JNK pathway activation 
(Figure 3.24) 
UVB+A 
Transient Prolonged  Prolonged  
UVA Suppressed & delayed Suppressed & delayed 
UVB Transient No activation 
UVA+B Suppressed & delayed Suppressed & delayed 
NFκB pathway activation 
(Figure 3.24) 
UVB+A 
Transient 
No activation Transient 
TNFα release enhanced by IL1α   
(Figure 3.14) 
+ + + + + + + + + 
p38 pathway activated by IL1α  
(Figure 3.17) 
+  + + + 
JNK pathway activated by IL1α  
(Figure 3.18) 
+ + + + 
NFκB pathway activated by IL1α  
(Figure 3.19) 
+ + + 
Table 6.1 A summary of the effect of UV radiation on keratinocyte-derived cells. 
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pathway was similar in both Colo16 and HEK cells, the former had higher phospho-p38 
levels. This suggests that pathways like p38 MAPK, JNK and NFκB may be 
differentially regulated in malignant cells to sustain their malignancy. Exploiting these 
differences may give rise to possible therapeutic targets although more research in this 
area is warranted.  
 
It has been suggested that tumour development may require the presence of 
inflammatory mediators [290, 291]. The pro-inflammatory cytokine, TNFα’s role in 
promoting or antagonising carcinogenesis is controversial [5, 83]. HEK cells released 
greater levels of TNFα than Colo16 cells following UV-irradiation (Figure 3.14). Since 
inflammation is part of the immune response cascade, it is possible that cancer cells 
may downplay inflammation to suppress immunosurveillance [292]. In contrast,  
UV-induced inflammation has also been found to be necessary for skin carcinogenesis 
[290, 291, 293, 294]. It should be kept in mind that these in vitro studies using a single 
cell type may greatly differ to that seen in vivo where multiple cell types may interact 
with each other. In this present study, the addition of IL1α after UV-irradiation had a 
greater impact on enhancing TNFα levels in Colo 16 than in HEK cells (Figure 3.14). 
As suggested earlier, in section 3.3.4, primary keratinocytes possess higher levels of 
IL1α receptor antagonist than do SCC cells which may explain the effect this cytokine 
had on TNFα release in HEK and Colo16 cells [221]. IL1α did not appear to have an 
effect on the cell signalling pathways compared to its effect on TNFα release (Table 
6.1). While the results (Figures 3.17, 3.19 & 3.21) suggest that these pathways may not 
be involved in UV-induced TNFα release, it is possible that they do not need to be 
maximally activated as downstream amplification of their signals may occur. Therefore, 
the use of inhibitors of key pathway intermediates will aid in determining which 
pathway(s) is/are involved in UV-induced TNFα release in keratinocyte-derived cells. It 
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will be useful to identify the pathway(s) involved in UV-induced TNFα release and then 
perform functional studies to map out the path that UV radiation activates in normal and 
malignant cells.  
 
Apart from HEK and Colo16 cells, HaCaT cells were used in this study to investigate if 
they were a suitable model for HEK cells as they have been used as a substitute for 
primary keratinocytes in other studies [187, 190-192]. When exposed to UV radiation, 
HaCaT cells elicited different responses to that seen in HEK cells (Table 6.1). HaCaT 
cells possess genetic alterations which may affect their ability to behave similarly to 
HEK cells post-UV radiation. These cells lack intact p53 alleles as well as p16 proteins 
and both proteins are involved in activating cell signalling pathways and control cellular 
responses like DNA repair and apoptosis [186, 187], [150, 204, 295, 296]. Therefore, 
mutations in these proteins may result in malfunctioning of the cell. Squamous 
carcinomas have genetic alterations similar to that seen in HaCaT cells [215, 216]. 
However, it is unclear if Colo16 cells (squamous cell carcinoma) used in this study 
possess such mutations as they displayed similar UV responses to that of HaCaT cells. 
Since the UV-induced responses observed in HaCaT cells mirrored closely to that of 
Colo16 cells, these cells could be better suited as a model cell to study solar keratoses or 
similar precancerous skin lesions due to their molecular defects and altered signalling 
pathways. As a result, care should be taken when extrapolating results obtained using 
HaCaT to what may occur in HEK cells.  
 
6.1.2 Melanocytes and melanoma 
In Chapter 4, the effects of UV radiation on cell viability, cellular signalling pathways 
and TNFα release between normal melanocytes (HEM) and a melanoma cell line 
(MM96L) were investigated. The effects α-tocopherol, MCLE and scymnol had on the 
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same parameters in melanocyte-derived cells were also examined in Chapter 5. MM96L 
cells were more susceptible to UV radiation than were HEM cells (Figure 4.1 & Table 
6.2). It is possible that the melanin present in HEM cells absorbed the UV light, thereby 
preventing excessive UV damage leading to cell survival [233, 234]. The use of normal 
and malignant melanocytes containing different melanin levels and types (eumelanin 
and pheomelanin) should be examined to delineate its function in these cells. The cell 
signalling pathways in HEM and MM96L cells were activated differently in response to 
different types of UV radiation. In HEM cells, while the p38 MAPK, JNK and NFκB 
pathways were activated differently to each other, there was a similar pattern of 
activation within each pathway irrespective of the UV types used  (Figure 4.35 & Table 
6.2). MM96L cells on the other hand, exhibited erratic activation of these pathways 
following each UV type (Figure 4.35 & Table 6.2). This could be indicative of their 
malignant nature and suggests that these pathways may have functional significance in 
melanomagenesis. Since this present study profiled the UV-induced activation of p38 
MAPK, JNK and NFκB pathways, further studies to elucidate the roles of these 
pathways in melanoma development are warranted.  
 
The B-Raf/ERK1/2 signalling pathway has also been extensively researched in 
melanoma and melanocyte biology [55, 133, 135, 297-299]. As Ras and Raf mutations 
are prevalent in melanomas and are upstream of the MAPK pathway, it is likely that 
such mutations would affect the p38 MAPK and JNK pathways and their involvement 
in melanomagenesis [135, 300]. Although, there was little or no activation of the NFκB 
pathway in HEM and MM96L cells following UV radiation, this pathway was 
constitutively activated to a higher extent in sham-irradiated MM96L than in HEM cells 
(Figure 4.36). This is in accordance with some studies which suggest that constitutively 
active NFκB may provide an anti-apoptotic signal thereby enabling the development of
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Cells HEM MM96L 
Cell viability (Figure 3.1) + + + + 
UVA Biphasic 
UVB Transient  
UVA+B Biphasic 
p38 pathway activation 
(Figure 3.24) 
UVB+A 
Prolonged 
Transient  
UVA Prolonged 
UVB Transient  
UVA+B Transient 
JNK pathway activation 
(Figure 3.24) 
UVB+A 
Prolonged 
Prolonged 
UVA No activation 
UVB Transient 
UVA+B Transient 
NFκB pathway 
activation (Figure 3.24) 
UVB+A 
No activation 
No activation 
TNFα release enhanced by IL1α  (Figure 3.14) + + + + + + 
p38 pathway activated by IL1α (Figure 3.17) + + + + 
JNK pathway activated by IL1α (Figure 3.18) + + + 
NFκB pathway activation activated by IL1α  
(Figure 3.19) 
No change + 
SB 202190 (p38 inhibitor)-mediated inhibition of  
UV-induced TNFα release 
Complete inhibition 0.5-fold  inhibition 
SP600125 (JNK inhibitor)-mediated inhibition of  
UV-induced TNFα release 
No effect No effect 
Sulfasalazine (NFκB pathway)-mediated inhibition of 
UV-induced TNFα release 
No effect 0.5-fold  inhibition 
α-Tocopherol-mediated inhibition of UV-induced 
TNFα release 
0.5-fold  inhibition No effect 
MCLE-mediated inhibition of UV-induced  
TNFα release 
0.7-fold  inhibition No effect 
Scymnol-mediated inhibition of UV-induced  
TNFα release 
0.8-fold  inhibition No inhibition 
Table 6.2 A summary of the effects of UV radiation on melanocyte-derived cells. 
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melanoma [228, 250]. Therefore, these pathways (p38 MAPK, JNK and NFκB) may be 
targets for drug development to impede melanoma growth and metastasis. However, 
this may become complicated as such pathways have multi-faceted roles and crosstalk 
between cell signalling pathways exist. In addition, interactions between cell types 
mediated by these pathways form a complex network in vivo that is required for cellular 
homeostasis. As a result, functioning of normal cells will also be affected if these drugs 
are not specific to melanoma cells and this could result in detrimental side effects [301]. 
The challenge would be to develop drug delivery methods which only target these 
signalling intermediates which are specifically involved in melanoma development. 
 
Apart from cell signalling pathways, cytokines also play an important role in 
melanomagenesis. In this study, both MM96L and HEM cells released low levels of 
TNFα following UV radiation (Section 4.2.3). The addition of IL1α enhanced the TNFα 
levels but these were lower in MM96L than HEM cells. Moreti et al. [302] found that 
cytokine levels can vary at different stages of carcinogenic melanoma cells. 
Furthermore, the authors found that TNFα levels were low in nevi, primary and 
metastatic melanoma [302]. The significance of low TNFα levels in melanoma is 
unclear but the use of TNFα neutralising antibodies may help delineate its function. In 
this current study, the p38 MAPK pathway seemed to be the major pathway involved in 
UV-induced TNFα release in HEM cells while the NFκB pathway was also involved in 
the MM96L cells. In addition, the compounds α-tocopherol, MCLE (extract from  
green-lipped mussel) and scymnol (extract from shark bile) inhibited UV-induced TNFα 
release to varying degrees in HEM cells where scymnol was the most effective. These 
compounds had no effect on UV-induced TNFα release in MM96L cells (Figure 5.11). 
It is possible that in MM96L cells the mechanism involved in UV-induced TNFα 
release may differ from that in melanocytes. As a result, the compounds may be specific 
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in inhibiting some mechanisms but not others. These compounds did not have an effect 
on the p38 MAPK pathway which suggests that other pathways are utilised to inhibit 
TNFα release in melanocytes. As TNFα is a pro-inflammatory cytokine, excessive 
inflammation can be reduced using MCLE, scymnol or other antioxidants which may 
prove to be beneficial ingredients to be added to suncreens. Furthermore, scymnol was 
shown to have hydroxl scavenging property and may also serve as an effective 
antioxidant (Figure 5.3). Therefore, instead of sunscreens consisting of only physical 
blockers of UV light, addition of benefical compounds such as antioxidant and  
anti-inflammatory agents that aid in damage control should be investigated further.   
 
6.2 Conclusion 
In conclusion, UV radiation affected the viability, activity of cell signalling pathways 
and cytokine release of both the keratinocyte and melanocyte-derived cells. These 
effects of UV radiation was UV type, dose and cell type dependent. While the cells 
were exposed to the same UV type or dose, normal and malignant cell types exhibited 
different cellular responses. UVB radiation was the most cytotoxic and induced higher 
TNFα levels from keratinocyte and melanocyte-derived cells than the other UV types. 
Colo16 and MM96L cells were more susceptible than HEK and HEM cells to  
UVB-irradiation but the malignant cells released lower levels of TNFα than did their 
corresponding primary cell lines. The UVB-activated p38 MAPK pathway seemed to be 
the major pathway involved in TNFα release in HEM cells but in MM96L cells the 
NFκB pathway was also involved. These differences in UV responses of the cells may 
be attributed to the various molecular intermediates involved in these cells and possibly 
the presence of mutant proteins in malignant cells which alter its response. Therefore, 
the pathways and cytokines studied in this project may have therapeutic potential but 
their functional roles in malignancy will need to be further investigated. As HEM cells 
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released higher levels of TNFα than HEK cells, it is likely that both these cells together 
with other inflammatory (mast cells and macrophages) and resident cells (fibroblasts) 
would contribute to inflammation in skin exposed to UV radiation. It is unknown if 
HEM and HEK cells may synergistically increase TNFα levels or may act to negate the 
effect via a negative feedback loop. It will be of interest to test this using skin explants, 
biopsies or co-cultures containing keratinocytes, melanocytes and fibroblasts. 
 
It should be noted that although in vitro experiments provide an insight into these 
pathways and sometimes the possible crosstalk that occurs, a wide array of chemical 
reactions, different type of cells, communication between different organs, and the 
interaction between various systems (endocrine, lymphatic, nervous, cardiovascular etc) 
are involved in an organism. The results from in vivo studies may provide a sound 
understanding of the effects of UV radiation in humans as opposed to in vitro studies. 
Therefore, further research using suitable animal models could prove to be useful in 
delineating the effects of UV radiation on skin cell function and malignancy. In this 
current study, the cells were exposed to a single physiological dose of either UVA, 
UVB, UVA+B or UVB+A radiation. However, depending on the type of activity the 
human skin is exposed to cumulative doses of UV radiation, varying durations of 
exposure and varying interval periods before the next exposure which can influence the 
changes in cellular mechanisms [303, 304]. Therefore, as am extension of this project, 
the use of a solar simulator and the effects of different UV regimens on these skin cells 
should be investigated. The use of sunscreens and other forms of sun protection may 
also alter the dose of UV the skin receives. In a randomized trial in Queensland, it was 
found that less sunscreen was applied on the skin than the amount needed to achieve the 
labelled sun protection factor [305]. Inefficient application of sunscreens may allow 
excessive UV to penetrate the skin leading to the production of an array of biomolecules 
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like TNFα. There is evidence to suggest that TNFα may be involved in sunburn cell 
formation, depletion of Langerhans cells, blockade of cell cycle checkpoints and tumour 
development [81, 182, 183, 306]. Therefore, UV-induced inflammation can be both 
anti- and pro-tumorigenic and chronic inflammation has been found to induce 
carcinogenesis [280]. A dynamic interplay between inflammation and free radicals 
seems to exist and they may act together to create a positive feedback loop to increase 
inflammation [280]. This creates a favourable environment for the onset of skin cancer. 
Therefore, it is crucial to devise ways to inhibit the level of inflammation which may be 
harmful to the skin.   
 
On the whole, this study showed that the physiological doses used were found to induce 
high levels of the inflammatory mediator, TNFα in HEK and HEM cells. While the 
inhibition of p38 MAPK pathway led to an almost complete loss of TNFα released in 
HEM cells, the putative antioxidants (α-tocopherol, MCLE and scymnol) differed in 
their ability to suppress TNFα and this may not occur via inhibition of the p38 MAPK 
pathway. Therefore, this study highlights that there are different mechanisms/pathways 
involved in mediating UV-induced inflammation. The other pathways involved in  
UV-induced inflammation should be investigated and the activity of such pathways can 
be inhibited or enhanced to decrease the onset of inflammatory mediators. It will be 
plausible to do so if the level of inflammation required to initiate tumour development is 
determined and targeted without affecting immunosurveillance.  
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CHAPTER 7 
 
FUTURE DIRECTIONS 
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7.1 Future Directions 
As this project progressed and evolved, analysis of the results and discussions gave rise 
to more questions that needed to be addressed. However, in the given time frame only 
some of these were investigated. Therefore, in this section some further experiments 
that can be undertaken as an extension of this work are highlighted below.  
 
7.1.1 Receptors 
A preliminary study was conducted to observe if the activation of the MAPK signalling 
pathways were membrane receptor-dependent (Figure 7.1). In this preliminary study, 
the low temperature method used by Rosette et al. [54] was followed where the Colo16 
cells were either preincubated at 37°C or 10°C prior to UVB exposure. The low 
temperatures will prevent downstream signalling if membrane receptors are involved in  
UV-activated signal transduction. Figure 7.1 shows that Colo16 cells incubated at 10°C 
pre and post UVB-irradiation (2 kJ/m2) did not show p38 MAPK or JNK pathway 
activation compared to those cells incubated at 37°C. In addition, when the cells 
incubated at 10°C pre-irradiation were allowed to warm up (37°C for 15 min), 
activation of these pathways occurred post-irradiation. This suggests that UV radiation 
might signal through membrane receptors (e.g. cytokine and growth factor receptors) to 
activate downstream signalling. In order to confirm this finding and also delineate 
specific receptors involved, neutralising antibodies to receptors such as IL1α and TNFα 
receptors should be incubated with the cells to observe if the activation of the pathways 
are inhibited by inactivating these receptors. In addition, cytoplasmic aryl hydrocarbon 
receptors (AhR) were found to be activated by UVB radiation via the formation of AhR 
ligand thereby stimulating the expression of cytochrome P450 1A1 and COX-2 [57]. 
Therefore, as well as plasma membrane receptors, cytoplasmic receptors like AhR 
should be studied as they may also be involved in cell signal transduction as well.  
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7.1.2 ERK1/2 pathway 
Aside from p38 MAPK and JNK proteins, ERK1/2 proteins also belong to the MAPK 
family. ERK1/2 is involved in a plethora of functions including normal epidermal cell 
proliferation [307]. However, UV-induced mutations in BRAF and RAS results in 
deregulated signalling of the ERK1/2 pathway which has been widely implicated in 
melanoma progression, invasion and metastasis [241-243, 297, 308]. ERK1/2 was also 
found to be involved in UVB-induced immunosuppression in a mouse model and cell 
cycle progression in human melanoma [245, 309]. Therefore, studies performed on the 
p38 MAPK and JNK pathways in this project should be repeated for the ERK pathway 
due to its importance in skin carcinogenesis. The use of PD98059, an ERK1/2 pathway 
Figure 7.1 A temperature-dependent study on the activation of the p38 and JNK 
pathways in UVB-irradiated (2 kJ/m2) Colo16 cells. The cell cultures were incubated for 
30 min at either 10°C or 37°C pre-irradiation. After UVB exposure, the cell cultures 
were incubated for 15 min at either 10°C or 37°C post-irradiation and proteins were 
extracted from these cell cultures. In each lane 50 µg of cell lysate was used to perform 
western blotting. The lanes marked from 1 to 10 in the blots represent Lane 1 & 3: 
Sham-irradiated control, 2 & 4: Sham-irradiated control+IL1α (10 ng/ml), 5, 7 & 9: 
UVB radiation alone, 6, 8 & 10: UVB+IL1α. 
1   2   3  4   5   6   7   8  9  10 
Pre and Post-irradiation (10°C) 
Pre and Post-irradiation (37°C) 
Pre (10°C) and Post-irradiation (37°C) 
+ + 
+ + 
+ + 
+ + 
+ + 
Phospho-p38 
Phospho-JNK1/2 
β-Actin 
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inhibitor will assist in delineating the role of the ERK1/2 pathway in functional studies 
[309]. 
 
7.1.3 NFκB pathway and subunits 
In this study, the NFκB pathway was not activated to a great extent over the 120 min 
time period in irradiated keratinocyte or melanocyte-derived cells (Chapters 3 & 4). It is 
possible that the weak activation could be due to a stronger activation occurring at later 
time intervals. Bender et al. [6] reported that the NFκB pathway was activated between 
2-8 h post UVC-irradiation (0.1 kJ/m2) and Lewis et al. [187] found that both HaCaT 
and HEK cells displayed a time-dependent activation (2-8 h) of the NFκB pathway after 
UVB-irradiation (0.4-0.6 kJ/m2). In this current study, to observe the activation of the 
NFκB pathway, phospho-IκBα (Serines 32/36) was used as a target in western blots 
(Figure 2.1D). Perkins et al. [176] have outlined that the NFκB pathway can be 
activated in a canonical, non-canonical and atypical fashions. In this study, the focus 
was on the canonical NFκB pathway where IKK complex phosphorylates IκBα thereby 
activating the NFκB complex. It is possible that the pathway was activated through the 
other non-canonical or atypical mechanisms resulting in the detection of a weak  
phospho-IκBα expression in this study. Therefore, the non-canonical and atypical 
activation of the pathway should also be observed using different targets like  
NFκB-inducing kinase (non-canonical) and phospho-IκBα (C-terminal) (atypical) [176]. 
 
The NFκB complex is made up of heterodimers from the five different subunits which 
are Rel A, Rel B, c-Rel, p50 and p52 [176]. It will be interesting to observe which 
heterodimer is specifically activated by UV radiation by utilising supershift 
electrophoretic mobility assays with subunit specific antibodies. If the specific NFκB 
subunit/s activated by UV radiation is identified its functional role/s in mediating UV 
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responses in normal and malignant cells can be determined. Further studies on the role 
of NFκB in UV-induced cell signalling should be performed by specifically 
investigating these subunits. 
 
7.1.4 UV/IL1α signalling 
In this study, it was identified that the p38 MAPK and NFκB pathways were down 
stream of UV/IL1α-mediated TNFα release in MM96L cells. However, the p38 MAPK 
and NFκB pathway inhibitors only caused a partial inhibition of UV/IL1α-induced 
TNFα release which indicates that other mechanisms may be involved in stimulating 
TNFα release following UV and IL1α exposure. Wang et al. [310] found that TNFα 
expression can be regulated by the PI3K/AKT/mTOR (mammalian target of rapamycin) 
pathway in mouse melanoma B16 cells. The JAK/STAT signalling can also be involved 
in cytokine production as it is often associated with cytokine receptors [116]. Therefore, 
mTOR and JAK/STAT pathways should be investigated to see if UV/IL1α also signals 
through these pathways to induce TNFα release. Moreover, IL1α neutralising antibody 
can be used to negate the effects of intracellular IL1α which may be produced by 
keratinocytes post-irradaition. This may be useful in confirming the effects of 
recombinant IL1α used in this study as well as provide further information on its 
signalling events.  
 
7.1.5 TNFα functional study 
In this study, it has been shown that UV radiation with or without IL1α can induce 
TNFα production in keratinocyte and melanocyte-derived cells. It will be of interest to 
observe if exogenous TNFα also stimulates the production and release of endogenous 
TNFα from these cells. Studies should be undertaken to determine the role of the TNFα 
induced by UV radiation in tumorigenic cell lines. The effect of TNFα on the 
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proliferation rate and migration/metastasis of cancer cells needs to be performed. A 
clonogenic assay can be performed to test the potential of the cancer cells to form 
colonies in soft agar under anchorage-independent conditions with or without TNFα 
neutralising antibody [135]. A cell invasion assay can be performed using a matrigel 
invasion chamber where the cancer cells pre-treated with siRNA to silence TNFα are 
inserted into the chamber and allowed to migrate through the membrane and the number 
of cells can be counted to determine the cell’s ability to invade [311]. Moreover, 
TNFα’s role in immunosuppression, cell cycle and tumour microenvironment should 
also be observed in in vivo mouse models. These experiments will provide an insight 
into TNFα’s pro- or anti-tumorigenic effects in skin cells.   
 
7.1.6 UV-induced gene regulation  
In this study, it has been identified that the p38 MAPK and NFκB pathway is involved 
in TNFα release. There are many other genes that can be regulated by these pathways. 
Therefore, a DNA microarray analysis comparing UV-irradiated and sham-irradiated 
cell cultures should be performed. This will help identify groups of genes that are either 
specifically upregulated or downregulated by UV radiation. In addition, a microarray 
assay to compare UV-irradiated cell cultures with and without treatment with pathway 
specific inhibitors can be conducted as well. In this way the genes regulated by either 
p38 MAPK, JNK or NFκB pathways after UV radiation can be identified by comparing 
these results against those of irradiated cells without inhibitors. In this experiment two 
cultures can be set up where one is incubated with a pathway inhibitor and the other is 
not. These cultures are then exposed to UV radiation, after which the RNA is purified 
and amplified to perform a microarray.  
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7.1.7 Co-culture experiments 
In this study, exogenously added IL1α was shown to be a positive regulator of TNFα 
production in keratinocyte and melanocyte-derived cells (Chapters 3 & 4). Both 
keratinocytes and fibroblasts have been show to produce IL1α in response to UV 
radiation [114, 219, 312, 313]. It will be of interest to perform co-culture experiments 
with these cells and quantify the levels of endogenously produced IL1α and TNFα when 
these cells are irradiated. The keratinocytes can be grown over a scaffold embedded 
with fibroblast cells or milliwell inserts containing a monolayer of keratinocyte can be 
placed over a layer of fibroblast cells grown in a petri dish [314, 315]. The autocrine or 
paracrine signalling of these cytokines can also be studied using this co-culture method. 
This will allow for crosstalks between these cells which may result in a different 
outcome to that of adding IL1α exogenously. Moreover, these cells (keratinocytes and 
fibroblasts) should be tested for the production of endogenous IL1α following exposure 
to different UV types to observe if synergistic effects occur.   
 
On the whole, the above mentioned studies on UV-activated receptors, pathway 
intermediates and downstream targets will help narrow down the molecules involved in 
the UV response. The use of DNA microarray will further streamline the genes 
regulated by UV radiation and their probable involvement in initiating carcinogenesis. 
As inflammation is known to play a role in carcinogenesis, the functional studies of 
inflammatory mediators may help elucidate their roles in tumorigensis [290]. The  
co-culture experiments may provide useful information on which cell type/s are 
predominantly involved in regulating carcinogenesis. In the long-term, if the roles of 
each cell type and cell signalling pathway molecules in tumorigensis have been 
determined, they may prove to be potential therapeutic targets in combating skin cancer. 
Drugs may be designed to silence or enhance pathway intermediates to inhibit the 
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production of inflammatory mediators thereby reducing chronic inflammation. Genes 
can be knocked out to prevent the translation of detrimental proteins or inhibitors can be 
created to reduce the activity of such proteins. However, we have to keep in mind that 
these molecules are multi-faceted and can also be involved in maintaining cellular 
homeostasis as well. Therefore, the key is to increase specificity by means of either a) 
targeting a specific isoform/epitope of a protein involved in tumorigensis or b) selecting 
biomarkers to target tumour cells in order to devise ways to prevent or treat skin cancer.  
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A.1 Solutions 
A.1.1 Cell culture solutions (Chapter 2, Section 2.3) 
• 1% (v/v) Penicillin-Streptomycin-Glutamine 
 5,000 units/ml penicillin G sodium, 5,000 µg/ml streptomycin sulfate and 1.46 
mg/ml L-glutamine 
• Trypsin-EDTA solution  
 0.5 g/l trypsin, 0.2 g/l EDTA•4Na, 0.85 g/l NaCl 
• 1% (v/v) Trypsin Neutraliser or  5% (v/v) Trypsin Neutraliser 
[1% (v/v) FBS in PBS] or [5% (v/v) FBS in PBS] 
 
A.1.2 Cell protein lysate preparation solutions (Chapter 2, Sections 
2.7.1 and 2.7.2) 
• Lysis buffer  
 100 mM NaCl, 20 mM Tris (pH8), 1 mM EDTA, 0.5% (v/v) BRIJ35, 4% (v/v) 
protease inhibitor, 1% (v/v) phosphatase inhibitor 
• Laemmli’s sample buffer 
 250 mM Tris (pH6.8), 40% (v/v) Glycerol, 10% (v/v) β-Mercaptoethanol, 5% (w/v) 
SDS (Sodium Dodecyl Sulfate) and 0.1% (w/v) Bromophenol Blue 
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A.1.3 Western blotting solutions (Chapter 2, Sections 2.7.4 - 2.7.5) 
• 10% Running gel  
 3.35 ml of 30% (v/v) Acrylamide Bis solution, 4 ml H2O, 2.5 ml 1.5 M Tris 
solution (pH8.8), 0.1 ml 10% (w/v) SDS, 0.1 ml 10% (w/v) Ammonium Persulfate 
and 0.01 ml TEMED 
• Stacking gel  
 0.43 ml 30% (v/v) Acrylamide Bis solution, 1.7 ml H2O, 0.32 ml 1.5 M Tris 
solution (pH8.8), 0.025 ml 10% (w/v) SDS, 0.025 ml 10% (w/v) Ammonium 
Persulfate and 0.005 ml of TEMED 
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2 000 J/m2 
64.8 J/s/m2 
 
= 30.8 s ≈ 31 s 
A.2 Output of UV lamps        
The UV detector measured the output in mW. The example below shows the 
calculations used to determine the exposure times to achieve the specific UV doses. 
 
Example: 
UV output of UVA lamp = 6.48 mW/cm2 (as measured by the UVA detector) 
UVA dose required = 2 kJ/m2 
 
Calculation: 
6.48 mW/cm2 = 0.00648 W/cm2 
0.00648 W/cm2 = 64.8 W/m2 
64.8 W/m2 = 64.8 J/s/m2 
(Note 1 W = 1 J/s) 
 
Therefore 1 sec of UVA exposure gives a dose of 64.8 J/m2. 
For 2 kJ/m2 of UVA dose the exposure time is, 
2 kJ/m2 = 2 000 J/m2 
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Viable or Dead (Attached or Detached) Cells     
 
Attached (Viable and Dead) Cells + 
Detached (Viable and Dead) Cells 
× 100%  Cell Viability of Attached or Detached Cells = 
564 
595 
× 100%  =  94.8%  Percentage of Attached  
Viable Cells = 
A.3 Cell viability 
Cell viability was determined using Trypan Blue exclusion assay. Viability of  attached 
and detached cells in the petri dish was examined. The data was presented as a 
percentage of total cell population (Attached and Detached cells).  
 
Example: 
Data 
 
 
 
 
Calculation:  
 
 
 
 
 
 
 
 
 
 
 
 
Cell Population 
Attached Cells Detached Cells  
Viable Dead Viable Dead 
Total 
Cell Population 
Cell Count 564 30 0 1 595 
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A.4 Protein determination 
An equation of the protein standard graph was generated from the BCA Assay and used 
to determine the amount of protein per sample.  
 
Example: 
Equation of protein standard graph:  y = 0.0992x  
Where,  y = absorbance of protein sample per well  
 x = mass of protein sample per well (µg) 
 
Calculation:  
Volume of protein sample per well = 5 µl 
Absorbance of protein sample per well = 0.745 
Mass of protein sample per well is, 
y = 0.0992x 
0.745 = 0.0992x 
x = 7.51 µg of protein in 5 µl sample 
 
For Western blotting, Laemmli’s sample buffer is added to the protein sample in a 1:4 
dilution. For example, 1.25 µl of Laemmli’s buffer is added to a 5 µl protein sample 
making it a total volume of 6.25 µl. Allowing for Laemmli’s sample buffer this would 
be 7.51 µg of protein in 6.25 µl of sample plus buffer solution. Therefore to add 50 µg 
cell lysate, 41.6 µl of sample plus buffer solution would need to be added to a lane in a 
SDS PAGE gel. 
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A.5 Phospho JNK levels 
The protein bands in the Western blot was analysed for densitometry using Quantity 
One Digital Imaging Software Version 4.5.1 (BioRad).  
 
 
                                  Density (INT/mm2) 
                       Lanes 
 
Phospho-JNK 1 Phospho-JNK2 
Lane 1 : 0 min (sham-irradiated control) 110 103 
Lane 2 : 5 min post UVB-irradiation 510 170 
 
 
Percentage of phospho JNK 1 in Lane 1 : [ 110 / (110 + 103) ] * 100% = 52%  
Percentage of phospho JNK 2 in Lane 1 : [ 103 / (110 + 103) ] * 100% = 48% 
Therefore, percentage of total phospho-JNK1/2 in sham-irradiated control is 100%.  
 
Percentage of phospho JNK 1 in Lane 2 : [ 510 / (110 + 103) ] * 100% = 239% 
Percentage of phospho JNK 2 in Lane 2 : [ 148 / (110 + 103) ] * 100% = 80% 
 
 
 
 
Figure A.1 A representative Western blot probed for phospho-JNK1/2 in HEK cells. 
The samples in lane 1 is from sham-irradiated control (0 min) and in lane 2 from HEK 
cells at 5 min post UVB-irradiation (2 kJ/m2)  
HEK Phospho-JNK1 
β-Actin 
Phospho-JNK2 
1     2     
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A.6 TNFα levels in tissue culture media 
An equation of the TNFα standard graph was generated from the ELISA and used to 
determine the amount of TNFα per media sample. This data is then expressed as Mass 
of TNFα (pg) /  Mass of Cell Protein (mg) per culture.  
 
Example: 
Equation of TNFα standard graph:  y = 0.0087x   
Where,  y = absorbance of TNFα per well  
 x = mass of TNFα per well (pg) 
 
Calculation:  
Volume of media sample per well = 500 µl 
Absorbance of TNFα per well = 0.00855 
Mass of TNFα per well is, 
y = 0.0087x   
0.00855 = 0.0087x   
x = 0.983 pg of TNFα in 500 µl media sample 
 
Therefore in 2 ml of media per culture, the amount of TNFα is 3.93 pg.  
For 0.00751 mg of cell protein per culture (Appendix A.4),  
the mass of total TNFα per culture is, 
 
 
 
 
 
3.93 pg 
0.00751 mg 
=   523.3 pg/mg of total TNFα released per mg cell protein 
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